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I. Summary 
The correct three-dimensional structure of a protein is essential for its biological function. In 
the cell, the adoption of this so-called native state must proceed in a rapid and reliable manner. 
In vivo, efficient folding of newly synthesized proteins relies on the assistance of molecular 
chaperones, which act to prevent aggregation and promote folding.  
Chaperonins are a specific class of barrel-shaped chaperones, present in almost all 
organisms. Newly synthesized proteins encapsulated by the chaperonin can attain their native 
structure unimpaired by aggregation during repeated cycles of ATP-dependent binding and 
release. Chaperonins are generally divided into two groups. Group I chaperonins, such as the 
barrel-shaped GroEL oligomer, are found predominantly in bacteria and cooperate with 
cofactors of the Hsp10 familly (i.e. GroES). The Group II chaperonins, on the other hand, do not 
require a Hsp10- cofactor and are found in the eukaryotic cytosol and in archaea. 
The function of GroEL is understood in great detail and the substrate interaction proteome 
has been recently identified. In contrast, our knowledge about the natural substrates of Group II 
chaperonins is deficient and as a consequence, mechanistical studies on Group II chaperonins 
have been limited to using the eukaryotic model substrates actin and tubulin as well as 
heterologous model substrates. 
In the present study, the complete substrate spectrum of a Group II chaperonin, the 
thermosome (Ths) of the mesophilic archaeon Methanosarcina mazei (M. mazei), was 
analysed for the first time. In addition, the unique coexistence of both the goup I and the group 
II chaperonins in M. mazei, which was confirmed in the initial part of the study, provided the 
opportunity to obtain new insights into how the substrate selection differs between the two 
chaperonin groups. For these purposes, the chaperonin substrates were isolated by 
immunoprecipitation of the chaperonin-substrate complexes and identified by liquid 
chromatography coupled mass spectrometry (LC-MS) using three different approaches: LC-MS 
after separation of the proteins (i) by classical 2D-PAGE, (ii) by difference gel electrophoresis 
(Ettan DIGE) and (iii) by 1D-PAGE. 
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Analysis of substrates of both the thermosome (MmThs) and GroEL/GroES (MmGroEL, 
MmGroES) of M. mazei revealed that each chaperonin handles a defined set of substrates, and 
both chaperonins contribute to the folding of ~17% of the proteins in the archaeal cytosol. 
Bioinformatic analysis revealed that the chaperonin specificity is governed by specific 
properties of substrate proteins. 
The study demonstrates that the chaperonin-substrate protein interaction is determined by 
a complex set of structural features of the client protein such as hydrophobicity, net charge and 
size of the substrate. Substrate selection is likely to be influenced by the initial contacts 
between the unfolded substrate protein and the accepting apical domains of the chaperonins. 
The hydrophobicity of the apical domains of GroEL can explain the preference for hydrophobic 
proteins, whereas the positively charged nature of the apical domains of Ths may explain the 
preferential interaction of MmThs with negatively charged proteins.  
The encapsulation mechanism of both chaperonins is expected to limit the size of substrate 
proteins. As expected, our study revealed that the majority of the MmGroEL substrates does 
not exceed 60 kDa, which corresponds to the theoretical size limit imposed by the folding cage. 
The upper size limit of MmThs substrates, however, is expanded to ~80 kDa. This upshift in 
size limit might be due to a more flexible closing mechanism of the Group II chaperonin. An 
aperture-like closure of the Ths cavity by helical protrusions of its apical domains may allow the 
cage volume of the chaperonin to increase.  
Previous work on the E. coli GroEL substrate proteome revealed that certain domain folds, 
such as the c-class domain fold in the Triosephosphate isomerase (TIM) β/α8 barrel, increase 
the tendency of a protein to interact with the Group I chaperonin. In this study, a prevalent 
interaction of the TIMβ/α8 barrel with the Group I chaperonin could also be confirmed for M. 
mazei. In addition, a significant fraction of MmGroEL interactors share similar domain folds of 
the c-class of alpha helical elements and mainly parallel beta sheets, such as the Adenine 
nucleotide alpha hydrolase-like and the UDP-Glycosyltransferase/glycogen phosphorylase 
folds. As expected, the MmThs-substrate interaction is also influenced by fold motifs. The 
thermosome associates preferentially with proteins of the ribonuclease H-like domain fold, a c-
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class domain fold with alpha helical elements, and the OB-fold, which has only beta-elements 
(b-class).  
In Methanosarcina, the group I chaperonin as well as a large fraction of other proteins are 
of bacterial origin, and therefore may preferentially interact. However, our analysis revealed that 
there was no direct relationship between the phylogeny of the substrate protein and its 
chaperonin interaction in M. mazei. The increased number of bacterial proteins among both 
chaperonin substrate sets indicates an important role in the acquisition and/or the maintenance 
of proteins derived from horizontal gene transfer. Interestingly, the analysis of the evolutionary 
state of the substrates suggests a role of Group II chaperonins in the evolution of protein 
structures, while the Group I chaperonin might rather contribute to the conservation of a protein. 
The interaction of a significant number of essential proteins with both chaperonin groups makes 
both MmGroEL as well as MmThs likely to be essential for M. mazei.  
In conclusion, substrate selection of chaperonins is defined by a combination of a variety of 
physical properties (hydrophobicity, net charge and size), structural features (i.e. the domain 
fold), and less concrete characteristics like the evolutionary status and, in this context, the 
phylogenetic origin of the substrate.  
The use of the identified chaperonin substrates in in vitro studies should give further insight 
into the mechanistic differences between the two chaperonin systems. In the future, M. mazei – 
harbouring not only both chaperonin systems, but also the chaperones NAC, GimC and 
DnaK/J/E  – will provide the opportunity to analyse the interplay of chaperones in a network 
containing the major components known to assist in de novo folding.  
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II. Introduction 
Proteins play an essential role in virtually all biological processes. They are structural 
building blocks and execute nearly all cellular functions as catalysts of manifold biochemical 
reactions. They also serve as active or passive transporters of most molecules across 
biological membranes - even between different cells. 
 
II.1 Proteins 
II.1.1 Protein structure 
The specific biological activity of a protein is determined by its three dimensional structure. 
The architecture of a protein is generally defined at four structural levels: the primary structure 
of a protein is described by the amino acid sequence of a polypeptide chain, which is defined 
by the encoding gene. The secondary structure is referred to as the three-dimensional 
arrangement of proximal amino acid side chains resulting in structures like the α-helix or the β-
sheet. The tertiary structure of proteins describes the three-dimensional arrangement of 
secondary elements within a single polypeptide chain, while the quaternary structure gives 
information on the interaction between different polypeptide chains in oligomeric proteins. 
 
II.1.2 Protein folding: from primary to quaternary structure 
 All information determining the native structure, which is generally the polypeptide 
conformation with the lowest Gibbs free energy of the complete system, is fully contained in the 
amino acid sequence of a protein. But the process of the formation of a native protein from the 
polypeptide, which is generally referred to as protein folding, involves a complex arrangement 
and rearrangement of non-covalent interactions of amino acid residues along the polypeptide 
chain.  
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In 1960 Christian Anfinsen showed that this process can occur spontaneously in vitro 
(Schechter et al., 1970). However, considering that a small protein with 150 amino acid 
residues can theoretically adopt ~10300 different conformations and transitions between these 
different states occur at a maximum rate of ~1011 s-1, it would take about 1011 years to search 
through the full repertoire of conformations. This so-called Levinthal paradoxon led to the 
conclusion that a protein can not adopt all possible conformations during the folding process, 
but the folding rather “is speeded and guided by the rapid formation of local interactions which 
then determine the further folding of the peptide. This suggests local amino acid sequences 
which form stable interactions and serve as nucleation points in the folding process” (Levinthal, 
1969). 
 
II.1.3 The protein folding mechanism 
Protein folding seems to follow a certain pathway through folding intermediates (Baldwin, 
1996; Baldwin and Rose, 1999; Privalov, 1996), reducing the amount of possible conformations 
and therefore allowing protein folding to occur in biological relevant time. The folding 
intermediates possess partially native and stabilized structural elements as well as unstructured 
non-native elements. The folding process can be illustrated by ´folding energy landscapes´ 
(Figure 1; (Dobson, 1998). The energy landscape describes the free energy of a molecule 
depending on certain variables.  In a folding energy landscape, the native state of a protein is 
defined by the global thermodynamic energy minimum. To reach this structure, the unfolded 
polypeptide may have to transit a variety of intermediates, which are defined by local energy 
minima. This reduction of possible conformations enables a protein to fold within milliseconds 
and resolves the “Levinthal paradoxon” (Schultz, 2000). 
. 
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Figure 1 : Schematic energy landscape of protein folding 
The free energy is represented as a function of the topology of its atoms. (a) representative 
starting structures, (b) transition state, (c) lowest energy structure, native state, (d) collapsed, 
hydrophobic internal, molten globule (Dobson, 2003, modified). 
 
II.2 Protein folding in vivo 
II.2.1 Protein folding in the cellular environment 
In contrast to an in vitro folding situation where proteins were shown to be able to fold 
spontaneously, protein folding inside a cell is not a spontaneous process.  In a living cell factors 
like temperature, pH-value and ion concentrations deviate from optimal conditions that can be 
provided in vitro. Also, in a living cell most proteins have an average size of 40-60 kDa and 
generally exceed the size of model proteins used in in vitro experiments (Dobson, 1998).  
More importantly the cellular environment with protein concentrations of 200-300 g/l, varies 
dramatically from the dilute solution used for refolding in vitro (Sakikawa et al., 1999).This high 
concentration of molecules causes excluded volume effects (macromolecular crowding), 
leading to increased thermodynamic activity and changes in binding equilibria (Minton, 1983; 
Zimmerman and Minton, 1993). The excluded volume effect favours compact structures relative 
to more expanded structures. Therefore, in vivo folding intermediates can be formed harbouring 
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secondary structures, while no stable tertiary structure is adopted yet (molten globules). In this 
state hydrophobic regions are often exposed, which would be hidden inside the molecule in the 
native state. These hydrophobic residues can lead to unspecific associations or irreversible 
aggregation of the protein (Ellis and Hartl, 1999).  
In some cases, contacts may be formed between regions of a polypeptide that are not 
associated in the native status, which can lead to a reversible misfolded state of the 
polypeptide, the so-called “kinetically trapped intermediates“ (Pande et al. 1998; Dobson and 
Karplus 1999; Dinner et al. 2000). In these misfolded structures hydrophobic residues can be 
exposed, contributing to an increased aggregation activity (Figure 2; Dobson et al. 1998).  
 
 
Figure 2 : Aggregation of unfolded polypeptide chains is a side-reaction of protein 
folding 
Molecular crowding (red arrows) in the cytosol can ampify these reactions as well as folding 
to the native state. U: Unfolded polypeptide chain, I: partially unstructured intermediate, N: 
native protein (Hartl and Hayer-Hartl, 2002).  
 
A special case of protein aggregation is the formation of amyloid fibrils, which were shown 
to be associated with several protein folding diseases, such as Alzheimer´s, Huntington´s, 
Parkinson´s and Creuzfeldt-Jacob´s disease (Dobson, 1999). These amyloids exhibit a highly 
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ordered fibrillar structure with a characteristic X-ray fibre diffraction pattern, consistent with a 
helical array of beta-sheets parallel to the fibre long axis, with the strands perpendicular to this 
axis. It is expected that all proteins have the potential to form amyloid structures, and such 
formations are favoured under conditions of extreme pH or elevated temperature. But in 
contrast, the proteins involved in protein folding diseases assemble into amyloids under 
physiological conditions. 
 
II.2.2 Protein folding upon de novo synthesis 
In contrast to the in vitro refolding situation, the complete polypeptide chain is not available 
for folding during de novo synthesis of proteins. Thus, the incomplete polypeptide chain has to 
be prevented from misfolding and aggregation during translation. The cell overcomes this 
problem by engaging a group of proteins termed molecular chaperons (Hartl 1996; Netzer und 
Hartl 1998; Ellis und Hartl 1999; Agashe und Hartl 2000; Feldman und Frydman 2000). These 
molecular chaperones reversibly bind to the nascent chain or the newly synthesized 
polypeptide preventing it from misfolding and aggregation, and can even promote folding to the 
native state. 
 
II.3 Molecular chaperones 
In a cell polypeptides are generated at the ribosome and released into the cytosol. During 
this process, the newly synthesized polypeptide exposes unstructured hydrophobic residues to 
the crowded cellular environment. In order to prevent aggregation of these non-native peptides, 
nascent chain interacting and downstream acting chaperones are necessary to shield the 
aggregation prone regions as soon as the peptide chains exits the ribosomal tunnel. 
Chaperones carry no structural information for the native state of their target protein. They  
generally bind non native states of newly synthesized or stress denatured proteins and promote 
their folding by repeated cycles of binding and release, a process often driven by ATP 
hydrolysis. Under stress conditions, for example elevated temperatures, many proteins tend to 
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unfold triggering the heat shock response mechanism, which results in a high level induction of 
chaperones (Lindquist 1986; Morimoto 1998, Ellis et al. 1987). Therefore molecular chaperones 
are also referred to as stress proteins or heat shock proteins.  
II.3.1 The chaperone system 
The genes of molecular chaperones are highly conserved and are divided into chaperone 
groups according to sequence homologies and molecular sizes, such as the Hsp60´s or 
Hsp70s. Among the three domains of life, universal groups of chaperones are found as well as 
domain specific groups. It is speculated that the chaperones inside a cell are organized in 
networks and a lot of effort has been put into understanding the interplay of chaperones. In 
principle there are two major groups of chaperones involved in the folding of newly synthesized 
proteins in the cytosol.  
   
Figure 3 : Model for de novo protein folding assisted by a network of molecular 
chaperones in the cytosol of Bacteria, Archaea and Eukarya. 
(A) Many proteins in the Bacterial cytosol fold without further assistance upon release from 
the ribosome and ribosome-bound TF. DnaK assists the remainder of proteins in folding, and 
can transfer substrates to the chaperonin system (GroEL/GroES). (B) Only some Archaea 
contain DnaK/DnaJ. Interaction of PFD with nascent chains and existence of NAC is not 
experimentally confirmed. (C) In the example of the mammalian cytosol, NAC probably 
interacts with nascent polypeptide chains, together with Hsp70 and Hsp40. The majority of 
proteins can fold upon release from these factors. A subset of Hsp70 substrates is transferred 
to the Hsp90 system. Furthermore, PFD interacts with nascent chains, and transfers these to 
TRiC, the eukaryotic chaperonin.  
N: Natively folded protein, TF: trigger factor, NAC: nascent chain-associated complex, PFD: 
prefoldin (Hartl and Hayer-Hartl, 2002). 
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The first contact upon synthesis is provided by the ribosome associated chaperones and 
the Hsp70 group associate with the nascent polypeptide chain. In the eukaryotic cytosol and in 
Archaea an additional co-factor termed prefoldin or GimC was also found to interact with newly 
synthesized polypeptides. The prefoldin and the Hsp70s are able to hand over their substrates 
to second type of chaperones the large cylindrical chaperonins (Hsp60´s), which act further 
downstream in the folding network. 
 
II.3.2 Ribosome associated chaperones 
The first chaperones to interact with a nascent polypeptide chain emerging from the 
ribosome are trigger factor (TF) in Bacteria and possibly the nascent chain associated complex 
(NAC) in Archaea and the eukaryotic cytosol. These chaperones bind to the nascent 
polypeptide and are themselves associated with the ribosome.  
The well studied trigger factor has been shown to bind to the protein L23 at the large 
ribosomal subunit (Kramer et al., 2002). From this docking site, TF supposedly scans the 
emerging peptide for hydrophobic regions in an ATP-hydrolysis independent manner 
(Hesterkamp et al., 1996). In addition to the chaperone activity, TF exhibits a peptidyl prolyl cis-
trans isomerase activity, a function that has been shown to be dispensable for the biological 
role of TF in protein folding (Genevaux et al., 2004; Kramer et al., 2004). 
In the eukaryotic cytosol the function of TF is probably taken over by the non homologous 
protein NAC, which was shown to be associated with the ribosome and interact with the 
emerging polypeptide (Wiedmann et al., 1994). However, a proof for the chaperone activity of 
NAC is still missing. Only recently though, was the presence of NAC homologs recognized in 
several Archaea. The presence of a ubiquitin-associated domain in the crystal structure of the 
Methanothermobacter marburgensis NAC suggests an additional, yet unidentified role for NAC 
in the cellular protein quality control system via the ubiquitination pathway (Kramer et al., 2004; 
Spreter et al., 2005). 
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II.3.3 The Hsp70s 
The function of TF overlaps with the further downstream acting Hsp70 system in stabilizing 
the newly synthesized polypeptide. Even though Hsp70 is not expected to bind directly to the 
ribosome, it was shown to interact with the nascent chain (Teter et al., 1999). For this reason a 
combined deletion of TF and DnaK resulted in increased protein misfolding and protein 
aggregation, leading to a loss of viability of cells at temperatures above 30°C (Deuerling et al., 
1999; Genevaux et al., 2004; Teter et al., 1999). The Hsp70- system is not only found in all 
Bacteria, but also in the eukaryotic cytosol and in some Archaea, as a result of horizontal gene 
transfer (HGT) from Bacteria (Macario and de Macario, 1999).  
The Hsp70s are involved not only in protein folding but also in a variety of functions such as 
disaggregation and degradation of proteins (Glover and Lindquist, 1998; Goloubinoff et al., 
1999; Hohfeld et al., 2001). The 70kDa chaperone action depends on the assistance of a 
variety of partners. In protein folding, the 40kDa proteins (Hsp40) and nucleotide exchange 
factors cooperate with Hsp70 (Craig et al., 2006), while interactions with the Hsp104/Clp 
recruits Hsp70 in protein disaggregation (Glover and Lindquist, 1998). In the eukaryotic cytosol, 
Hsp70 is also functionally linked to the Hsp90 system (Wegele et al., 2004). 
 
II.3.4 Prefoldin / GimC  
In the eukaryotic cytosol and in Archaea an additional chaperone is involved in the folding 
of newly synthesized proteins. Prefoldin(Pfd)/GimC, in an ATP-hydrolysis independent manner, 
stabilizes the newly synthesized polypeptide chain to maintain the non native protein in a 
folding competent state and to subsequently hand the substrate over to the downstream folding 
machinery. Prefoldin has the appearance of a jellyfish: its body consists of a double beta barrel 
assembly with six long tentacle-like coiled coils protruding from it. The distal regions of the 
coiled coils expose hydrophobic patches and are required for multivalent binding of nonnative 
proteins (Figure 4; Siegert et al. 2000).  
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Figure 4 : Prefoldin structure from Methanobacterium thermoautotrophicum.  
Side view (left) and bottom view (left) of the prefoldin complex. A large central cavity is 
bordered by six long tentacles formed by rods of α-helical coiled coils. The coiled coil tentacles 
point away from a platform consisting of two eight-stranded up and down β barrels. Each 
prefoldin subunit (pfd a: yellow, pfd b: blue) forms one coiled coil that is tightly anchored to the 
platform via its proximal end(Siegert et al., 2000). 
 
The distal ends of these N and C-terminal tentacles expose hydrophobic residues that were 
shown to bind substrate proteins. 
The eukaryotic prefoldin homolog was shown to bind co-translationally to newly 
synthesized actin and tubulin and and is therefore referred to as GimC (Genes involved in 
microtubule biogenesis). Pfd/GimC subsequently hands over these substrate proteins to the 
Group II chaperonin TRiC (TCP-1 ring Complex; also termed CCT (chaperonin containing 
TCP-1)) (Vainberg et al. 1998; Hansen et al. 1999; Siegers et al. 1999). The role of Pfd in 
archaeal protein folding remains unclear as the Archaea do not posses cytoskeletal proteins 
such as tubulin or actin. 
. 
II.3.5 The chaperonins 
The chaperonins are highly conserved and structurally related proteins (Figure 5) and they 
are present in virtually every living cell. Hemmingsen first identified this specific class of large 
double-ring oligomeric complexes of ~800 kDa (Figure 5; Hemmingsen et al. 1988). Two 
groups of chaperonins are known, and even though they share only little sequence homology 
they show a very similar topology. Group I chaperonins, also referred to as Hsp60s, are 
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exclusively found in Bacteria and eukaryotic organelles, which are known to be of bacterial 
origin. The Group I chaperonins cooperate in protein folding with a member of the Hsp10 family 
that covers the barrel shaped chaperonin in a lid-like manner. In contrast, the Group II 
chaperonins fulfil their function independently; they are equipped with helical protrusions that 
work as a built-in lid. Group II chaperonins are found in Archaea as the thermosome and in the 
eukaryotic cytosol as the so-called TRiC or CCT (Trent et al. 1991; Gao et al. 1992; Lewis et al. 
1992; Kubota et al. 1995 (Frydman, 2001)). 
Chaperonins do not only prevent the aggregation of proteins by shielding exposed 
hydrophobic residues, they actually encapsulate their substrate into the central cavity of the 
barrel shaped complex – serving as a so-called folding chamber, where the unfolded protein is 
protected from non productive interactions with macromolecules of the cellular environment and 
can undergo folding (Mayhew et al., 1996; Weissman et al., 1995). This typical encapsulation 
mechanism as well as the downstream position in the chaperone network may contribute to a 
narrower substrate set for chaperonins than for the more promiscuous upstream chaperones. 
Only 10-15% of all newly synthesized proteins in the bacterial cytosol were shown to interact 
with the bacterial Hsp60 typically referred to as GroEL/GroES (Ewalt et al., 1997). 
 
       
Figure 5 : Structure of chaperonins 
(A) side view and (B) topview  of the closed hexadecamer thermosome (Ditzel et al. 1998). 
(C) side view and (D) topview of the GroEL-GroES-(ADP)7 complex (Xu et al. 1997). 
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II.4 The Group I chaperonin system 
II.4.1 Structure and function of the Group I chaperonin system GroEL/GroES 
 Detailed insights into the structural and mechanistic principles of chaperonins arose from 
extensive studies on the Group I chaperonin in E. coli, referred to as EcGroEL and its co-factor 
GroES. The double ring structure of EcGroEL, in which two rings of seven identical 57kDa 
subunits are stacked back to back, was shown in several crystallographic (Boisvert et al., 1996; 
Braig et al., 1994; Xu et al., 1997) and electron microscopic studies (Ranson et al., 2001; 
Roseman et al., 1996; Saibil et al., 1991). 
The GroEL monomer is divided into three domains (Figure 6). The apical domain exposes 
hydrophobic residues at the entrance of the cavity for substrate binding and subsequent 
interaction with the co-chaperone EcGroES (Fenton et al. 1994; Hartl 1996; Bukau und Horwich 
1998; Sigler et al. 1998). It is expected that the substrate binding is mediated by cooperation of 
apical domains of several subunits within one ring (Farr et al. 2000). The equatorial domain 
contains the nucleotide binding pocket and forms inter-subunit contacts within the GroEL ring 
and also between the two GroEL rings. Both domains are connected via an intermediate 
domain which passes, in a hinge like manner, allosteric information between the apical and 
equatorial domain. 
Essential for the functionality of GroEL is the 10kDa co-factor GroES, a single homo-
heptameric dome like structure (Ellis 1996; Hartl 1996; Fenton und Horwich 1997; Bukau und 
Horwich 1998). GroES binds to the apical domains, covering the central cavity like a lid. This 
action results in the formation of asymmetric, bullet-shaped GroEL/GroES complexes. The 
cavity interacting with GroES is defined as the cis cavity and the ring opposing is termed as 
trans cavity. The interaction contacts are formed between the so-called mobile loops of GroES 
at the base of the dome structure and the substrate binding sites of the apical domain of GroEL. 
Therefore binding of GroES is expected to force the release of apical bound substrates into the 
central cavity of GroEL (Xu et al. 1997; Bukau und Horwich 1998; Richardson et al. 1998; Sigler 
et al. 1998), allowing the non native substrate to undergo folding within a shielded environment 
(Martin et al. 1993; Mayhew et al. 1996). 
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Figure 6 : Hinge rotations in the GroEL subunit upon binding of GroES 
The three domains of the GroEL subunit are coloured individually (apical in red, 
intermediate in green and equatorial in blue). A schematic representation (upper left) and 
backbone ribbon of the atomic structure (lower left) of unliganded GroEL are shown. Upon 
binding of GroES and ADP (GroES not shown), a 60° opening and a 90° rotation of the apical 
domain is seen (upper right and lower right respectively). Modified from Xu et al., 1997 
 
 
II.4.2 Mechanism of the GroEL/GroES system 
The folding mechanism of the bacterial GroEL/GroES system has become well understood 
within the last years. 
The folding process initiates with the binding of the non native substrate to the apical 
domains of one GroEL ring, subsequent ATP binding induces structural rearrangements of the 
apical domains in the cis-ring. This allows association of GroES and displacement of the 
substrate into the folding cage. Binding of GroES also results in an increase of the volume of 
the cis cavity (Hayer-Hartl et al.1994; Farr et al. 2000; Chen et al.1999). During the next 10-15s 
of ATP-hydrolysis, the encapsulated protein can undergo folding (Hayer-Hartl et al. 1995; Rye 
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et al. 1997). Following hydrolysis of ATP in the cis ring, binding of ATP to the trans ring causes 
dissociation of ADP and GroES from the cis cavity allowing the substrate protein to leave the 
folding chamber. Depending on the substrate, cycles of rebinding, folding trials and release are 
repeated until the protein reaches its native state (Figure 7). 
 
 
Figure 7 : Schematic drawing of the GroEL/GroES folding cycle 
Unfolded protein binds (red) to the hydrophobic substrate binding site of GroEL (green). 
GroES (dark blue) and ATP bind the so-called cis ring. This leads to a conformational change in 
GroEL and the substrate protein gets included into the folding chamber. During hydrolysis of 
ATP, the substrate undergoes folding inside the GroEL/GroES cavity. Binding of ATP and 
GroES to the trans ring leads to dissociation of ADP and ES from the cis ring, resulting in a 
release of the substrate. The substrate can rebind and undergo additional folding cycles until it 
reaches its native state. 
  
II.4.3 Substrates of the GroEL/GroES system 
Even though much is known about the structure and mechanism of GroEL, information 
about the natural substrates of GroEL has only recently become available. 10-15% of the 
cellular protein was shown to interact with the GroEL chaperonin system (Ewalt et al., 1997), 
but only little was known about their identity and therefore most functional studies used 
heterologous model proteins, which do not interact with EcGroEL in vivo. Several endogenous 
substrates were identified in 1999 (Houry et al., 1999), and in a recent study, the virtually 
complete EcGroEL interaction proteome was identified revealing three different classes of 
substrates (Kerner et al., 2005). The non stringent class I substrates occupy the capacity of 
GroEL only to a very limited extent (2%) and class II substrates are able to switch to other 
chaperones, such as the bacterial Hsp70 DnaK, for folding assistance. Only the class III 
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substrates were shown to be absolutely dependent on the chaperonin system to reach their 
native state. The presence of essential proteins among the class III substrates explains the 
essential requirement of GroEL itself. Class III preferentially contains proteins with sizes 
compatible with the available space inside the GroEL/GroES cavity, with an upper limit of 
approximately 55 – 60 kDa. Bioinformatic analysis of the GroEL interactome revealed a 
significant enrichment of a particular αβ fold (the Triosephosphate isomerase (TIM) (αβ)8 barrel) 
among the stringently GroEL-dependent class III substrates. This suggests that certain TIM 
barrel proteins tend to populate kinetically trapped folding intermediates that depend on 
encapsulation by the chaperonin for acquisition of their native state. 
   
II.5 The Group II chaperonin system 
II.5.1 Structure and function of Group II chaperonins 
Compared to the abundance of information about Group I chaperonins, our knowledge 
about Group II chaperonins is lagging behind. Electron micrographs and crystallographic 
studies revealed the typical double-ring structure with each ring offering a folding cavity. In 
contrast to GroEL, the building blocks are variable, and the rings are formed by up to eight 
different subunits. Additionally, depending on its phylogenetic origin, the symmetry of the group 
II chaperonin ring varies from 8-9 fold (Gutsche et al., 1999; Leroux, 2001).  
So far the crystal structure of an archaeal Group II chaperonin has been solved (Bosch et 
al., 2000; Ditzel et al., 1998); Klumpp et al. 1997). The thermosome from Thermoplasma 
acidophilum consists of two rings, each composed of eight subunits of alternating α and β 
monomers. The rings are arranged in a back to back manner mediated by contacts between 
identical subunits forming homodimers (Figure 8). 
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Figure 8 : General architecture of Group II chaperonins.  
(a) Ribbon diagram of an α subunit of the thermosome from Thermoplasma acidophilum. 
The equatorial ATPase domain (red) is linked to the substrate-binding apical domain (yellow) by 
a flexible hinge or intermediate domain (blue). The helical protrusion, which is unique to Group 
II chaperonins, is in green. (b) Bead models of the ATP-induced transition from the open to 
closed state for Group II chaperonins. The model of the nucleotide-free, open state (left) is 
based on electron tomographic studies on the thermosome. The closed state is from the X-ray 
structure of the thermosome and presumably reflects the ATP-induced state (Spiess et al., 
2004). (c) Top view of the apical domains in their ring context in the open (coloured) and closed 
(grey) conformations. The diagram shows the rotational and translational movement of one 
apical domain between the open and the closed conformations. The axis of the rotation is tilted 
by 60° against the paper (or x-y) plane (Gutsche et al., 1999).  
 
Analogous to the GroEL complex, single subunits with a size of ~ 60kDa are themselves 
divided into three domains (Figure 8a). The apical domain exposes hydrophobic residues at the 
entrance of the cavity for substrate binding. The equatorial domain contains the nucleotide 
binding pocket and forms contacts between the two rings. The intermediate domain functions 
as a hinge between the apical and equatorial domains passing sterical information. 
In contrasts to the Group I chaperonins, the thermosome and eukaryotic TRiC do not 
depend on the assistance of a co-chaperonin. Group II chaperonins are thought to contain a 
built in lid formed by helical protrusions on the apical domains (Klumpp et al. 1997). 
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II.5.2 Mechanism of Group II chaperonins 
The mechanism of protein folding assisted by Group II chaperonins is only poorly 
understood. Crystallographic data and neutron diffraction data of thermosome in different 
nucleotide bound states suggest a mode of action similar to Group I chaperonins (Gutsche et 
al. 2000; Gutsche et al. 2000; Figure 9).  
 
 
 
Figure 9 : Folding mechanims of Group II chaperonins 
 (1) The substrate (blue) is bound by the apical domains (green) of the thermosome. 
Binding of ATP to the equatorial domain (red) leads to rotation of the apical domains (2). 
Hydrolysis of ATP result in closing of the folding chamber by the helical protrusion (bright 
green) of the apical domain. The substrate undergoes folding in the closed environment until it 
gets released by the opening of the apical domains (4). (Model from(Kusmierczyk and Martin, 
2001)). 
 
First, the open thermosome, exposing the helical protrusions to the environment, accepts 
the substrate protein at the apical domain. Binding of ATP to the equatorial domain causes a 
rotational movement of the apical domains, leading to substrate release into the folding 
chamber and a simultaneous closure of the cavity by the helical protrusions. After ATP- 
hydrolysis, ADP is released from the nucleotide binding pocket inducing a conformational 
change in the apical domain and opening the folding cavity to release the substrate (Ditzel et 
al., 1998). 
It is expected that the helical protrusions of the apical domains replace the lid function of a 
GroES like co-chaperonin, but proof is still missing. So far it is not clear whether the helical 
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protrusions and/or hydrophobic residues of the apical domain are responsible for substrate 
binding (Llorca et al., 2001; Llorca et al., 2000). 
The use of a flexible built-in lid instead of an independent lid structure is a major difference 
between Group II chaperonins from the bacteriotypic Group I homologs. It is speculated that 
this different closing mechanism enables the thermosome and TRiC to encapsulate substrate 
proteins exceeding the calculated size of the closed cavity of ~ 130 000 Å3, giving space for 
proteins of sizes up to 50kDa (Ditzel et al., 1998). The fact that the eukaryotic chaperonin was 
shown to successfully fold firefly luciferase, a 62 kDa protein, suggests that substrates do not 
have to be completely encapsulated for efficient folding to occur. This might enable the Group II 
chaperonin to interact co-translationally with substrates in vivo, explaining the experimentally 
observed association of TRiC with nascent polypeptide chains (Frydman et al., 1994). The 
ability of TRiC to accept a growing nascent polypeptide in the active “closed“ state promotes 
co-translational folding, which is specific to eukaryotic systems (Netzer and Hartl, 1997).The 
domain-wise folding of polypeptides in a cavity also allows folding of proteins too large to be 
encapsulated. 
 
II.5.3 Substrates of Group II chaperonins 
So far no comprehensive study has been performed on endogenous substrates of Group II 
chaperonin. Several proteins were shown to depend on CCT/TRiC in eukaryotes in vitro and in 
vivo (Dunn et al., 2001; Spiess et al., 2004), but no in vivo substrates of thermosomes have 
been identified yet. However, the potential of the archaeal chaperonin to prevent aggregation 
and to promote refolding of proteins has been shown for several heterologous model substrates 
(Gutsche et al., 1999). Although, the low efficiency of the thermosome in refolding of these non 
natural substrate proteins may not allow direct conclusions about the in vivo situation. 
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II.6 Archaea 
It was a revolutionary view, when in 1977 Carl Woese first proposed, based on sequence 
comparisons of a single molecule, the 16S rRNA, that all life forms can be divided into the three 
kingdoms: Eukarya, Bacteria and Archaea (Woese and Fox, 1977).  
As illustrated in the so-called universal tree of life, Archaea represent a clear and separate 
domain that is as distantly related to Bacteria as it is to Eukarya. 
 
   
Figure 10 : Universal tree of life 
Universal tree of life based on 16SrRNA sequences. Archaea (red) are a clearly separate 
line from Bacteria (blue) and Eukaryotes (green). Most hyperthermophile organisms (thick lines) 
are found among Archaea, only some among Bacteria  
 
According to mostly rRNA information, Archaea themselves are subdivided into four 
subkingdoms: the Euryarchaeota, comprising the methanoges, halophiles, thermoacidophiles 
and thermophiles, the  crenarchaeotes, a group of only hyperthermophilic members (Woese et 
al., 1990), the recently discovered Nanoarchaeota (Hohn et al., 2002), a probably exclusively 
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parasitical group of organisms, and the Korarchaeota (Barns et al., 1996), which have not been 
successfully cultivated until now. 
The in-between position of Archaea in the phylogenetic tree reflects their mixed ancestry. 
Archaeal genes, which code for metabolic properties, have homologies to bacterial 
counterparts, while other archaeal gene products clearly resemble the eukaryotic counterparts. 
It is even speculated that fusion of an archaeal cell with a bacterium gave rise to the eukaryotic 
cell (Martin and Muller, 1998).  
Like Bacteria, Archaea contain no defined nucleus. Even though Bacteria and Archaea are 
very similar in cell size, Archaea typically adopt irregular cell shapes. Bacterial and archaeal 
cells are usually protected by cell walls, but the archaeal envelope is built up from a variety of 
compounds, depending on the particular organism, and is never composed of peptidoglycans 
(Kandler and Konig, 1998). Typical for both prokaryotic kingdoms is their enormous repertoire 
of different metabolism compared to eukaryotes. 
The information processing machinery of Archaea resembles the eukaryotic system, and 
this is reflected in its insensitivity to antibiotics impairing transcription or translation (Table 1). 
Also, archaeal components of the protein folding machinery share strong homology with the 
eukaryotic system: there are homologues to eukaryotic NAC as well as prefoldin. 
As a unique archaeal feature, the cell membrane lipids are ether linked, which is expected 
to contribute to a higher stability of archaeal membranes (De Rosa and Gambacorta, 1988). 
Many Archaea are exclusively found in extreme environment such as hydrothermal vents with 
temperatures exceeding the boiling point of water, areas of saturated salinity or pH values 
below 2. 
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Table 1: Common features among the domains of life 
 
In the past it seemed a typical hallmark of Archaea to populate only niches hostile to life, 
but environmental surveys indicate that the Archaea are diverse and abundant not only in 
extreme environments, but also in soil, oceans and freshwater, where they may fulfil a key role 
in the biogeochemical cycles of the planet (Robertson et al., 2005).  
 
II.6.1 The Methanogens 
The biological production of methane is exclusively carried out by a highly specialized 
group of Euryarchaeotes- the methanogens. Although methane is a relatively minor component 
of the global carbon cycle, it is of great importance. Most methanogens use CO2 as their 
terminal electron acceptor, H2 generally serves as electron donor. Despite the obligate 
anaerobiosis and the specialized metabolism of methanogens, they are quite widespread on 
earth. Although high levels of methanogenesis only occur in anoxic environments, such as 
swamps and marshes, or in the rumen, the process also occurs in habitats that might be 
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considered oxic, such as forest and grassland soils. In such habitats, methanogenesis occurs in 
microenvironments, for example, in the midst of soil crumbs. 
So far a variety of morphological types of methanogenic Archaea have been isolated, and 
studies of their physiology and molecular properties served to classify the methanogens into 
seven major groups containing a total of 17 genera. 
Especially now as the need for alternative energy sources becomes eminent, methanogens 
are gaining more and more importance for industry. Methane production is widely used as a 
renewable source of energy, and methanogens are also essential components of all urban, 
agricultural and industrial waste-treatment facilities.  
 
II.6.2 The genus Methanosarcina 
The genus Methanosarcina was first described by Kluyver and van Niel as “irregular 
spheroid bodies occurring alone or typically in aggregates of cells” (Kluyver and Niel, 1936). 
Methanosarcina belong to the subkingdom of Euryarchaeota and grow like all methanogens 
that gain energy from converting CO2 and H2 to methane under strictly anaerobic conditions. 
Among methanogens, the members of the genus Methanosarcina can in addition convert short 
chained carbon sources like acetate, methanol, monomethylamine, dimethylamine, 
trimethylamine and possibly CO to methane. Members of the genus Methanosarcina are found 
in diverse oxygen free environments, such as rice fields, sea- or fresh water sediment and 
typically in rennet. 
The irregular, non motile cocci have a size of 1-3 µm defined by a proteinous cell wall 
adjacent to the cell membrane, which may be surrounded by an additional 
heteropolysaccharide layer- a polymer that is similar to the eukaryotic chondroitin and is 
therefore referred to as methanochondoritin. The methanochondroitin serves as matrix in which 
the single cells are embedded, giving rise to the formation of manifold pseudoparenchyma, 
such as packets (sarcina, lat.: packet), laminas and cysts (Figure 11;  Macario 1995; Lange et 
al. 1997).  
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Figure 11 : Morpgology of the genus Methanosarcina 
Phase constrast micrograph of Methanosarcina single cells (left), electronmicrographs of 
Methanosarcina tetrads (middle, from the Deparment of Agricultural and Biological 
Engeneering, University of Florida, http://www.agen.ufl.edu/~chyn/age4660/lect/lect_08x/ 
lect_08.htm ) and Methanosarcina packets (right, from Ralph Robinson / Visuals Unlimited, 
http://www.visualsunlimited.com/browse/vu197/vu197368.html ) 
 
The metabolic versatility makes this genus of methangens an interesting tool to study 
methanogenesis and to develop techniques to genetically engineer methanogenic Archaea. Not 
only the unusual growth in different life cycles has drawn the attention of many scientists, 
recent studies revealed the existence of an additional 22nd aminoacid pyrrolysine in the genus 
Methanosarcina (Srinivasan et al., 2002). Sequences of the complete genomes of several 
Methanosarcina species revealed the presence of a high percentage of genes of bacterial 
origin in the unusual big genomes of more than 4 Mbp. Interestingly, the major components of 
the bacterial folding machinery are present in all genomes of the Methanosarcina species that 
were sequenced so far ((Deppenmeier et al., 2002; Galagan et al., 2002; Klunker et al., 2003; 
Macario et al., 1991); http://www.jgi.doe.gov/). 
 Recently the genus Methanosarcina, represented by the type species M. barkeri and M. 
mazei, M. acetivorans, M. frisia and M. thermophila (Maestrojuan et al., 1992) were accreted by 
three new species: M. lacustris, M.balitca and M. semesiae (Lyimo et al., 2000; Simankova et 
al., 2001; von Klein et al., 2002).  
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II.6.3 Methanosarcina mazei Gö1 
The mesophilic M. mazei strain Gö1 was isolated from a sewage plant in Göttingen and 
grows optimally at a neutral pH of 6,8 - 7,2 and salinity around 0,5 M (Deppenmeier et al., 
1988). The poor energy yield from methanogenesis at moderate temperature results in a 
relatively long doubling time, depending on the energy source, of 9 hours on CO2, 17 hours on 
acetate and 7-15 h on methanol and methylamines (Baumer et al. 2000). 
In 2002 the circular chromosome of M. mazei, amounting to 4.2 Mbp has been sequenced 
(Deppenmeier et al. 2002). 3371 open reading frames (ORF) could be identified and 2450 
ORFs were annotated to a known function. Surprisingly 1043 ORFs making up one third of the 
total genome, were identified as being of bacterial origin. These bacterial genes probably 
originated from multiple events of horizontal gene transfers as they are dispersed all over the 
genome. Many of these genes are thought to contribute to the metabolic versatility of M. mazei, 
as Methanosarcina are the only methanogens known to date that can convert short chained 
carbon sources, such as acetate, methanol and methylamines to methane (Deppenmeier et al. 
2002). Surprisingly among these bacterial originated proteins of M. mazei, the major 
components of the bacterial folding machinery, the complete dnaK, dnaJ and grpE – and the 
groEL/groES operon, were also identified. 
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II.7 Aim of the project 
There is a great deal of structural information on the Group II chaperonin thermosome, 
obtained either from X-ray diffraction (Ditzel et al., 1998; Klumpp et al., 1997) or electron 
microscopy (Nitsch et al., 1998), revealing that the overall thermosome structure is similar to 
the Group I chaperonin. But in contrast to detailed functional studies on Group I chaperonins, 
there is only limited information on the mechanism of Group II chaperonins, especially those of 
archaeal origin. The proposed function of the thermosome is mostly based on comparisons to 
eukaryotic and bacterial counterparts; so far, only heterologous substrate proteins were used in 
in vitro refolding experiments (Gutsche et al., 1999) the result of which may not accurately 
describe thermosome function in vivo. Even the function of the thermosome as a structural 
element in the natural membrane of Archaea remains controverse(Trent et al., 2003).  
The aim of this study was on the one hand to identify the natural substrate spectrum of a 
thermosome in order to draw conclusions regarding on the substrate selectivity of Group II 
chaperonins and to enable functional studies on thermosomes using natural substrates. On the 
other hand, the unique co-existence of both chaperonin groups in Methanosarcina mazei, 
allowed a direct bioinformatic comparison of their substrate spectra, providing detailed insights 
into how the Group I and Group II chaperonins select their substrate proteins. 
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III. Materials and Methods 
III.1 Materials 
III.1.1 Chemicals 
Chemicals were of pro analysi grade and purchased from Sigma-Aldrich (Steinheim, 
Germany) unless stated otherwise. 
 
Amersham Pharmacia Biotech (Freiburg, Germany): ECL™ detection kit, ECF™ 
detection kit; Thiourea; CyDye DIGE Fluor minimal dyes; PlusOne Bind-Silane and Reference 
Markers. 
BioMol (Hamburg, Germany): IPTG; HEPES. 
BioRad (Munich, Germany): ethidiumbromide; AffiGel 10/15 columns. 
Difco (Heidelberg, Germany): Bacto tryptone, Bacto yeast extract, Casitonine Bacto agar. 
Fluka (Deisenhofen, Germany): activated charcoal, soda lime, Ammoniumcloride, 
Iodacetamide. 
New England Biolabs (Frankfurt am Main, Germany): restriction enzymes, T4 DNA ligase. 
Promega (Hilden, Germany): Wizard Plus SV Miniprep and Midiprep system, Wizard SV 
Gel and PCR Clean-Up System 
Pierce Biotechnology (Rockford, USA): DMP (Dimethyl pimelimidate•2 HCl) 
Roche (Basel, Switzerland): ATP; ADP; benzonase; Complete protease inhibitor; 
hexokinase; Pefabloc; proteinase K (PK, Tritriachium album); shrimp alkaline phosphatase. 
Roth (Karlsruhe, Germany): Formaldehyde, Calciumchlorid. 
Serva (Heidelberg, Germany): Pefabloc Protease inhibitor (4-(2-aminoethyl) 
benzenesulfonyl-fluoride HCl); Resazurin (Diazoresorcinol). 
Schleicher&Schuell BioScience (Dassel, Germany): protan nitrocellulose transfer 
membrane 
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VWR (Darmstadt, Germany): ampicillin; Potassiumdihydrogenphospate, Potassium-
hydrogenphospate, Magnesiumsulfate Calciumcloride, Sodiumchloride, Methanol, Ethanol, 
Acetic acid, Sodiumacetate. 
 
Gases were purchased from Linde Gas AG (Pullach, Germany): Biogon (N2/CO2= 80/20), 
Formiergas (N2/H2=95/5). The gas pipe system was installed by Draeger (Lübeck, Germany). 
 
Instruments 
Abimed (Langenfeld, Germany): Gilson Pipetman (2, 10, 20, 100, 200, 1000 µl). 
Alcatel Hochvakkumtechnik (Ismaning, Germany): Vacuum pump. 
Amersham Pharmacia Biotech (Freiburg, Germany): electrophoresis power supply EPS 
3500; FPLC systems; SMART-System; prepacked chromatography columns: HiPrep Desalting, 
MonoQ, HiTrap Heparin, Sephacryl S200/S300, Superdex 200, Superose 6; chromatography 
resins: Q-Sepharose, DE52,Source 30 Q, Source 30 S. IPGphor II IEF Unit; Ettan DALT twelve 
230 V; Typhoon Variable Mode Imager; Ettan Spot Picker; DeCyder - DIA, Differential In-gel 
Analysis software, ImageQuant software version 5.2 (Molecular Dynamics). 
Amicon (Beverly, MA, USA): vacuum filtration unit (0.2 µm); concentration chambers 
(Centriprep, Centricon). 
Beckmann (Munich, Germany): DU 640 UV/VIS Spectrophotometer; centrifuges: Avanti J-
25, Avanti J20 XP, J-6B, GS-6R, Optima LE-80k ultracentrifuge. 
Biometra (Göttingen, Germany): T3 PCR-Thermocycler. 
Bio-Rad (München, Germany): electrophoresis chambers MiniProtean 2 and 3; 
electrophoresis power supply Power PAC 300. 
Eppendorf (Hamburg, Germany): centrifuges 5415C and 5417R, Thermomixer Comfort. 
Fisher Scientific (Schwerte, Germany): pH meter Accumet Basic. 
Fuji (Tokyo, Japan): FLA 2000 Phosphoimager. 
Hoefer Scientific Instruments (San Francisco, USA): SemiPhore blotting transfer unit. 
Invitrogen (Karlsruhe): 4-16 % BisTris-NuPage Novex Gels, NuPAGE MES SDS Running 
Buffer, Colloidal Blue Staining Kit and XCell SureLock Mini-Cell 
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Mettler Toledo (Gießen, Germany): balances AG285, PB602. 
Millipore (Eschborn, Germany): deionization system MilliQ plus PF, Millex-HA filters 
0.22µm. 
Misonix Inc. (New York, USA): sonicator Ultrasonic Processor XL. 
Müller + Krempel AG (Bülach, Swiss): 1000 ml  serum bottles, aluminium rings GL45. 
New Brunswick Scientific (Nürtingen, Germany): orbital shaker and incubator 
Innova4430. 
Ochs Glasgerätebau (Bovenden/Lenglern, Germany): 100 ml serum bottles (N20), butyl 
rubber septa (N20/GL45), aluminium rings (N20), 1ml syringes (Ersta); Thoma counting 
chamber. 
Oxoid (Hampshire, UK): oxoid anaerobic jar. 
Raytest (Straubenhardt, Germany): AIDA gel imaging software version 2.31; LAS-3000 
CCD-Imaging System. 
Toepffer Lab systems (Göppingen, Germany): two person vinyl glove box (Coy Labs). 
VWR (Darmstadt, Germany): Dispensette® bottle-top dispenser; viton-hoses. 
Zeiss (Göttingen, Germany): Axiovert 200 M fluorescence microscope; AxioVision software 
version 3.1. 
III.1.2 Buffers and Media 
Buffers 
Competence buffer I: 100 mM KCl, 30 mM KOAc, 60 mM CaCl2, 15 % glycerol; pH 5.8, 
adjusted with acetic acid. Filter sterilized and stored at 4 °C. 
Competence buffer II: 10 mM MOPS, 10 mM KCl, 75 mM CaCl2, 15 % glycerol; pH 6.8, 
adjusted with NaOH. Filter sterilized and stored at 4 °C. 
PBS:  137 mM NaCL, 2.7 mM KCl, 20mM KH2PO4/K2HPO4, pH 7.4 
TBS:  25 mM Tris-HCl, 140mM NaCl, 3mM KCl, pH 8.0 
TBST:  TBS + 0.05% (v/v) Tween 20 
TAE:  40 mM Tris-Acetate, 1mM EDTA, pH 8.3 
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Media 
Media were prepared with demineralized H2O and autoclaved after preparation.  
LB medium:           
10 g/l Tryptone, 5 g/l Yeast Extract, 5 g/l NaCl, (+ 15 g/l agar for solid medium) are 
dissolved in ddH2O and adjusted to pH 7.0 with NaOH (Sambrook et al., 1989). 
Medium 120a (modified): 
K2HPO4 0,348g 
KH2PO4 0,227g 
NH4Cl 0,5g 
MgCl2x7H2O 0,5g 
CaCl2x2H2O 0,25g 
NaCl 2,25g 
FeSO4x7H2O 0,002g 
Vitamin solution (141) 10ml 
Trace element solution SL-10 1ml 
Resazurin 0,001g 
NaHCO3 3g 
2.5 M sodium acetate 10ml 
Methanol 10ml 
Na2Sx9H2O 0,5g 
ddH2O ad 1000 ml 
 
The medium is prepared anaerobically under a N2/CO2 (80:20, 100 kPa) atmosphere, 
adjusted with acetic acid to pH of 6.5- 6.8.  Methanol (50% v/v) and 10 g/l of sodium acetate are 
heat sterilized separately under N2 atmosphere in tightly closed tubes. Appropriate volumes of 
the solutions are injected into the autoclaved medium with hypodermic syringes. 
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Vitamin Elixir (Balch et al., 1979, modified): 
D (+) Biotin 2.00 mg 
Folic acid 2.00 mg 
Pyridoxamindihydrochloride 10.00 mg 
Thiaminedihydrochloride 5.00 mg 
Riboflavine 5.00 mg 
Nicotinic acid 5.00 mg 
Calcium- D- pantothenate 5.00 mg 
Cyanocobalamine 0.10 mg 
Para-aminobenzoic acid 5.00 mg 
DL- Lipoic acid 5.00 mg 
ddH2O           ad 1000 ml  
 
The vitamin solution is filter sterilized (0.2 µm) and kept in dark bottles at 4°C. 
Trace Element Solution SL-10: 
HCl (25%; 7.7 M)   10 ml 
 FeCl2 x 4 H2O   1.5 g 
 ZnCl2   70 mg 
 MnCl2 x 4 H2O   100 mg 
 H3BO3   6 mg 
 CoCl2 x 6 H2O   190 mg 
 CuCl2 x 2 H2O   2 mg 
 NiCl2 x 6 H2O   24 mg 
 Na2MoO4 x 2 H2O   36 mg 
 ddH2O  ad 1000 ml 
 
First FeCl2 is dissolved in the HCl. After dilution in ddH2O the other salts are added, finally 
ddH2O is added to the final volume. 
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III.2 Anaerobic cultivation  
III.2.1 Set up of an anaerobic cultivation system 
Gas distribution system 
For an even distribution of the appropriate gas environment on the media a gas distribution 
system for 10 gas inflow/evacuation sources was designed (Figure 12). Therefore an electronic 
relay was constructed to control gas inflow or the connection to a vacuum pump to the medium 
bottles. The relay allows not only manual switch between gas inflow or vacuum position, the 
`automatic` option starts a series of three evacuation steps followed by gas inflow in which both 
steps a variable in time spans from 30s to 5 min. The pressure of the gas inflow is adjusted at 
the manometer at the gas source tubing and can be checked at the gas rake manometer. 
For bubbling of media a rubber hose with a perforated ending is connected through a butyl 
rubber plug to a needle of the gas distribution (N2, 120-140 kPa). The rubber hose is placed 
into the dissolved medium in 1 l glass bottle and before plugging of the bottle a counter needle 
is placed into the rubber to provide gas out flow. 
To distribute the appropriate gas phase on the media, the sealed serum bottles are placed 
in to a protective metal cavity and the gas phase is supplied with 200 kPa. An automated series 
of three 5 min evacuation steps followed by 1 min gas inflow steps guarantees a complete 
exchange of the appropriate gas against the chamber gas. 
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Figure 12 : Gas Distribution System 
The electronic relay (a) provides manual options between gas/vacuum and an automated 
option for a series of three step of evacuation/gas flow-in. The gas is led through the distribution 
rake (b) with rubber hoses ending in injection needles (c) either into another rubber hose (f) in a 
1 l serum bottle containing the dissolved medium compounds (e) to bubble the solution and is 
released through the safety needle (d). Or the gas is directly led onto the gas phase of the 
reduced and pH- adjusted media in sealed bottles, the automated gas exchange program finally 
provides a homogenous gas phase at the adjusted pressure.  
 
III.2.2 Anaerobic cultivation 
Cultivation in medium bottles 
The dissolved components are bubbled with 120-140 kPa N2 for 30 min and subsequently 
reduced with 0.5 mg/l Na2S x 7-9 H2O. After pH adjusting the medium is aliquoted into serum 
bottles inside the anaerobic chamber, sealed with butyl rubber plugs (Hungate et al., 1966) and 
fused with aluminium rings, finally the indicated gas phase is applied. After autoclaving the 
medium is ready for injection of sterile substrates. Cells were routinely inoculated in a 1:10 - 
1:50 ratio. 
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Cultivation in a Glass Fermentor 
The medium components are dissolved in the 10 l glass fermentor, bubbled with N2 for 30 
min, sealed with a rubber plug and autoclaved. After connection to the cultivation system 
supplying a constant and low gas flow rate, the medium is reduced and adjusted to the final pH. 
After addition of substrates the cells are inoculated in a 1:10 - 1:50 ratio. Stirring at a speed of 
5-10 rpm provides even distribution of gas (Figure 13).  
 
Figure 13 : Glass Fermentor 
The temperature of the fermentation system is externally regulated by a water bath. To 
provide anaerobic conditions the glass fermenter (a) is sealed with a butyl rubber. The rubber 
plug holds perforations for glass capillaries to provide gas inflow from the gas source tubing (d), 
gas outflow (f) and sample collection (e). g: stirring device    
 
Large scale cultivation in a Teflon Fermentor 
Large scale fermentation was performed at the Archaeen Zentrum, University of 
Regensburg. The medium compounds were dissolved inside the fermentor and bubbled with N2 
during the heating up phase to 121°C, then autoclaved at 121°C/200 kPa for 40 min. After 
reaching the incubation temperature of 35°C the pH was adjusted through a septum with sterile, 
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anaerobic acid. Before inoculation with 10-15 l of culture sterile, anaerobic substrate was 
injected.  
Cells were harvested anaerobically after shock cooling to 4°C (Durchlaufkühler, 
Feichtenschläger, Neusäss) though a flow centrifuge (Type 416, Padberg, Lahr) and a maximal 
speed of 8 l/h. The cell suspension then was directly used for co-immunoprecipitation 
experiments or shock frozen in liquid nitrogen and kept at -80°C. 
 
III.2.3 Sterilisation 
Media and stock solutions are autoclaved for 20min at 121°C/200 kPa. Syringes, glass 
equipment etc. are sterilized for 40 min at 121°C/200 kPa. Organic compounds and heat labile 
substances are filter sterilized (0.2 µm). 
 
III.2.4 Light microscopy 
Cell growth was monitored by light microscopy with a phase contrast microscope or by 
fluorescence microscopy using the filter set FS 01 (excitation at 365/12 nm). If necessary the 
cell number was determined in a Thoma cell counting chamber (cell depth 0.02 mm, length 
0.0025mm).  
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III.3 Molecular biochemical methods 
III.3.1 Preparation and transformation of E. coli 
For preparation of chemically competent E. coli cells, LB medium (including antibiotic, if 
applicable) was inoculated with a single colony and cells were grown to an optical density 
(OD600nm) of 0.25 - 0.5. The culture was then chilled on ice for 15 min and centrifuged at 1500 g 
for 15 min at 4 °C. The cell pellet was resuspended in one third of the original volume of 
competence buffer I and incubated on ice. After 1 h the cells were pelleted and resuspended in 
1/25 of the original volume competence buffer II, incubated on ice for 15 min and shock-frozen 
in liquid N2 in 20-100 µl aliquots. 
For transformation, ~50 µl competent cells were mixed with 0.05 - 0.2 µg plasmid DNA or 
1-5 µl ligation reaction and incubated on ice for 30 min. The cells were heat shocked at 42 °C 
for ~ 40 s and subsequently placed on ice for 2 min. 450 µl of LB medium was added and the 
cells suspension was shaken for 1 h at 37 °C. The cells then were plated on selective solid 
media and incubated at 37 °C, until colonies had developed (typically 10-16 h). 
 
III.3.2 DNA analytical methods 
DNA concentrations were measured by UV absorption spectroscopy at λ=260 nm. A 
solution of 50 µg/ml of double stranded DNA in H2O exhibits approximately A260nm = 1. 
Agarose gel electrophoresis was performed in TAE buffer and 1 – 2 % TAE-agarose gels, 
supplemented with 1 µg/ml ethidium bromide, at 4 – 6 V/cm. 
DNA sequencing was performed by Medigenomix GmbH (Martinsried, Germany) or 
Sequiserve (Vaterstetten, Germany). 
 
PCR amplification 
PCR (polymerase chain reaction) mediated amplification of DNA was performed according 
to the following protocol:  
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DNA template 250 ng or less (bacterial genomic DNA)  
20 ng (plasmid DNA) 
Primers 20 pmol each 
dNTPs 200 µM each 
Taq or Pfu Polymerase 2.5 U 
Polymerase buffer 5 µl 
Additives 4 % DMSO if GC content was >50 %,7 % DMSO if GC 
content was >60 %, 
MgCl2 (3 µl), if Taq Polymerase was used. 
Final volume 50 µl 
  
III.3.3 DNA restriction/ligation methods 
DNA restriction was performed according to product instructions of the respective enzymes. 
Typically, a 50 µl reaction contained 1-2 µl of each restriction enzyme and 30 µl purified PCR 
product or 1-5 µg plasmid DNA in the appropriate reaction buffer. Digested vector DNA was 
dephosphorylated with shrimp alkaline phosphatase. For ligation, 50-100 ng (~1-2 µl) 
dephosphorylated vector DNA, 200-300 ng (~5-10 µl) DNA insert and 1 µl (100 U) T4 ligase 
were incubated in ligase buffer at 25 °C for 1 h or, for increased efficiency, at 16 °C overnight 
and transformed into competent E. coli DH5α cells. 
 
III.3.4 Plasmid purification 
LB medium containing the appropriate antibiotic was inoculated with a single E. coli colony 
harbouring the DNA plasmid of interest and shaken 8 – 14 h at 37 °C. Plasmids were isolated 
using the Promega Wizard Plus SV Miniprep or Midiprep according to the instructions. 
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III.4 Protein biochemical methods 
III.4.1 Protein expression and purification 
For protein expression E. coli BL21 (DE3) Gold cells harbouring the indicated expression 
plasmid, grown at 37 °C in 6 l LB medium containing 100 mg/l ampicillin were induced with 1 
mM IPTG at an OD600 ~0.6 for 5 – 6 h and harvested by centrifugation for 30 min at 2500 g. 
Cells were resuspended in 50 mM Tris-HCl pH 7.8, 50 mM NaCl, 1mM EDTA and Complete 
protease inhibitor (1 tablet/25 ml). The suspension was frozen in liquid N2 and thawed before 
addition of lysozyme (~0.5 mg/ml) and Benzonase (~200 units). Lysis was achieved by 
homogenization of the cell suspension in an EmulsiFlex C5 device kept on ice. Cell debris was 
removed by ultracentrifugation for 30 min at 4 °C and ~100 000 g and subsequent filtration (0.2 
µm)All protein purifications steps were performed using a FPLC system at 4 – 8 °C unless 
stated otherwise. Every column used was equilibrated in the indicated running buffer prior to 
loading the protein solution. After every separation step on a column the eluted fractions were 
analyzed by SDS-PAGE visualized by coomassie staining. The purified proteins were aliquoted 
and shock frozen ion liquid nitrogen and kept at -80°C. 
 
MmGroEL  
The cell lysate was applied to a DE52-column (Whatman) and washed with two column 
volumes of 30mM Tris-HCl pH 7.6, 1 mM DTT. The bound proteins were eluted with a NaCl- 
gradient in above described buffer. The collected fractions were dialysed against 25 mM 
Histidin-HCl pH 5.8, 1 mM EDTA, 1 mM DTT o.n. and supplied to a 200ml Source30Q-Säule 
(Pharmacia). After washing with two column volumes running buffer the bound proteins were 
eluted by a NaCl-gradient from 10-500 mM NaCl. After an overnight dialysis of the collected 
fractions against 30 mM Tris-HCl pH 7.8, 1 mM DTT the protein solution was separated on a 
heparin-HiTrap-column followed by a NaCl gradient (0-1M NaCl) dependent elution in 30 mM 
Tris-HCl pH 7.8, 1 mM DTT.  As a final step the proteins were separated according to their 
molecular size on a gel-filtration column (S-300 HR 26/60, Pharmacia) in 20 mM MOPS-NaOH 
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pH 7.4, 100 mM NaCl, 10% Glycerol. Fractions containing MmGroEL or MmGroES were 
collected, concentrated using a Centriprep concentrator, frozen in aliquots in liquid N2 and 
stored at -80 °C.  
 
GroEL-D87K (GroEL-Trap) (Fenton et al., 1994; Weissman et al., 1994) was purified with 
modifications to the purification protocol of wild type GroEL.  
Additional MonoQ anion exchange chromatography steps were introduced between 
heparin and final size exclusion chromatography. GroEL was eluted from MonoQ in 50 mM Tris 
pH 7.8 and 7.1, using very shallow NaCl gradients at GroEL elution concentrations.  
 
MmThsα, β, γ   
The clarified lysate was supplied to a Source30Q Io exchange column and the bound 
proteins were eluted in a gradient from 50-500 mM NaCl in 30 mM Tris-HCl, pH 8,0, 2 mM 
EDTA, 5 mM β-Mercaptoethanol. Monomeric MmThs were released from the column at ~180 
mM NaCl while oligomeric thermosomes eluted at a ionic strength of ~250 mM NaCl. The 
elution fractions containing monomeric thermosome subunits were concentrated using a 
Centriprep concentrator and six-fold diluted in buffer (30 mM Tris-HCl, pH 7,5, 5 mM β-
Mercaptoethanol), separated on four consecutive Heparin-Sepharose HiTrap columns and 
eluted in a NaCl gradient from 0.05-1-0 M in 30 mM Tris-HCl, pH 7,5, 5 mM β-
Mercaptoethanol). Fractions containing thermosome subunits ere collected, concentrated and 
supplied to a final purification step on a size exclusion column (S300 HR column) in 30 mM 
Tris-HCl, pH 7,6, 50 mM NaCl, 10 % Glycerol. Fractions containing thermosome subunits were 
collected, concentrated using a Centriprep concentrator, frozen in aliquots in liquid N2 and 
stored at -80 °C.  
 
MmPrefoldin  
The clear cell lysate was loaded onto a Sepharose-30Q and bound proteins were eluted in 
a NaCl-Gradienten of 10-800 mM NaCl in running buffer (30 mM Tris-HCl, pH 7,6, 1 mM DTT). 
The elution fractions containing MmPfd subuntis were equilibrated overnight against buffer (25 
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mM Histidin-HCl, pH 5,8, 30 mM NaCl) and put on a Heparin-Sepharose HiTrap column and  
the  bound proteins were eluted in a 10-600 mM NaCl gradient in buffer (30 mM Tris-HCl, pH 
7,6, 1 mM DTT). The protein solution was dialysed o.n. in 50 mM Na2HPO4, pH 7,0, 1,5 M 
(NH4)2SO4 and supplied to a  Phenylsepharose column where bound proteins were eluted in a 
(NH4)2SO4 gradient from 1,5 M-0 M (NH4)2SO4 in buffer (50 mM Na2HPO4, pH 7.0). During the 
concentration step pure MmPfd precipitated and was resuspended over night in buffer (100 mM 
NaCl, 5 mM MgCl2, 10 % Glycerol).Purified MmPfd complex was aliquoted and kept at -80°C. 
 
MmDnaK-(His)6 
Cell lysate from cells harboring the plasmid pProEX-MmDnaK-N(His)6 was prepared as 
described above, but EDTA was omitted from all solutions . The lysate was diluted with running 
buffer (20 mM HEPES, pH7.4 500mM NaCl) and applied to a 8 ml Ni-NTA column using fresh 
or regenerated resin. The column was washed with 5 volums of running buffer containing 10 
mM imidazole. Elution was achieved by applying a shallow imidazole gradient from 50 to 250 
mM. Fractions containing DnaK-N(His)6 were pooled and applied to a MonoQ ion exchange 
chromatography column (20 mM HEPES, pH 7.4, NaCl gradient from 0.05 to 0.5 M NaCl) 
followed by size exclusion chromatography in 20 mM HEPES, 50 mM NaCl and 10 % glycerol 
and a final concentration step. 
 
III.4.2 Protein analytical methods 
Determination of the protein concentration 
Protein concentrations of purified proteins were determined spectroscopically at λ= 280 
according to the theoretical extinction coefficient (calculated by ProtParam tool at the ExPASy 
proteomics server http://www.expasy.org). The protein concentration of cell lysates or complex 
protein solutions was estimated according to the Bradford-method (Bradford 1976) using the 
BioRad Protein Assay.  
 
____________________________________________________________________III-39 
 
 
 
SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
For analysis of proteins and complex protein solutions the proteins were separated 
electrophoretically according to their molecular weight by SDS-Polyacrylamide 
gelelectrophoresis (PAGE, Laemmli 1970). While the stacking gel was kept at a concentration 
of 30%/0.8% - Acrylamide/Bisacrylamide in the separation gel varied according to the molecular 
size of the proteins of interest between 8 and 16%. SDS-PAGE was performed using a 
discontinuous buffer system (Laemmli, 1970) in BioRad Mini-Protean II or 3 electrophoresis 
chambers employing a constant voltage of 160-220 V in 50 mM Tris-Base, 380 mM glycine, 0.1 
% SDS (pH 8.3). SDS loading buffer was added to the protein samples. Polyacrylamide gels 
were fixed and stained in 0.1 % Coomassie brilliant blue R-250, 40 % ethanol, 7 % acetic acid 
for 1 h or longer and destained in 20 % ethanol, 7 % acetic acid for removal of unspecific 
background stain.  
For a better separation of MmThsβ and MmThsγ subunits the pH of the separating gel was 
set to 7.5.  
2D- polyacrylamide gel electrophoresis (2D-PAGE) 
Complex protein samples were separated by two dimensional PAGE. Therefore the TCA 
precipitated and acetone washed protein sample is resuspended in a final volume of 340 µl 7M 
urea, 2M thiourea, 4% CHAPS, 0.002% Bromphenol blue, 0.5% IPG buffer (ampholytes), 
20mM DTT and soaked for at least 10 hrs into a Immobiline Dry strip, 18cm, pH 3-10, NL 
(Amersham Biosciences). The proteins were focused to their isoelectric point by applying 
following voltage steps on the Ettan IPGphor II system (Amersham Biosciences):   
step  500V 1hr 
gradient 1000V 1hr 
gradient 8000V 3hrs 
Step 8000V 4hrs 
    
After reduction in 65mM DTT, 6M urea, 1%SDS, 26% glycerol, 50mM Tris, pH 8.8 and 
acylation in 135mM iodoactedamide, 6M urea, 1%SDS, 26% glycerol, 50mM Tris, pH 8.8 the 
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immobiline strips were placed on SDS-16% Polyacrylamide gels and fixed by overlaying with 
0.5% agarose, 0.002% bromphenol blue in SDS-PAGE running buffer. The size dependent 
separation was performed on the ETTAN DALT twelve system separation unit (Amersham 
Biosciences) for 30 min at 2.5 W per gel followed by a 17 W per gel run for four to seven hours.  
Ettan DIGE 
For quantitative comparison up to three different protein samples were fluorescently 
labelled with distinct CyDye DIGE Fluor minimal dyes following the instruction manual, pooled 
and subjected to 2D-GE.  
To allow picking of the protein spots by the Ettan Spot Picker the polyacrylamide gel is 
covalently attached on the glass plates. Therefore the glass plate is evenly coated with 4ml 
bind-silane solution (0.1% bind-silane, 80%Ethanol, 2% HOAc). The silane solution is dryed on 
the glas plate for 45 min (fume hood) and excess of the solution is removed by careful washing 
with conventional scavenger and subsequent rinsing with ddH2O. To allow orientation of the 
spot picker reference markers are positioned on the glass plate as indicated in (Figure 14). The 
silanized glass plates are immediately used for poring of SDS-PA gels to prevent evaporation of 
the Bind-Silane from the coated glass plate to the covering glass plate. 
 
Figure 14 : Position of Reference Markers on Ettan DIGE 
The reference markers (grey spots) are placed at positions on the gel, where they will not 
interfere with the pattern of the protein spots in the gel (the Immobiline strip is shown in red).   
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Silver staining 
Silver staining of proteins was employed to detect proteins of low amount (1ng-200ng) after 
SDS-PAGE. Immediately after electrophoresis the gels were placed into fixing solution for 30 
min to precipitate the proteins and to allow diffusion of SDS out of the gel. Then gels were 
transferred into incubation solution for 30 min to oxidize the proteins. After three washing steps 
for 5 min in ddwater the silver solution is poured on the gel and incubated for 40 min. Finally the 
protein spots are visualized in developing solution, the reaction is stopped by addtition of 5mM 
EDTA, pH 8.0. The gels are kept in 10% glycerol at least 30 min and can be dried then. 
 
Fixing solution 400 ml ethanol 
 100 ml acetic acid 
 ad 1l H2O 
  
Incubation solution 300 ml ethanol 
 68 g sodium acetate x 3 H2O 
 2g sodium thiosulphate x 5 H2O  
 ad 1l H2O 
  
silver solution 1g silver nitrate  
 ad 1l H2O 
 250 µl formaldehyde, prior to usage   
  
Developing solution  26 g sodium carbonate 
 ad 1l H2O 
 125 µl formaldehyde, prior to usage   
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III.4.3 Polyclonal antibodies 
Rabbit and goat polyclonal antibodies were generated at the animal facilities of the MPI for 
Biochemistry according to Harlow and Lane (1988). Purified proteins were injected 
subcutaneously as water in oil emulsion formed out of 1 volume of protein solution (~0.2 – 0.5 
mg, rabbit; 0.5-1mg, goat) in PBS and 1 volume Freund’s adjuvant (Freund and McDermot, 
1942). Complete Freund’s adjuvant was used for the initial immunization and incomplete 
Freunds adjuvant for 4 – 6 succeeding boosts, which were injected at intervals of 4 – 7 weeks. 
Serum was taken ~10 days post injection.  
 
III.4.4 Affinity purification of antibodies 
As described in the manual 9mg of antigen was attached to Affigel 15 (Biorad). Several 
times 10ml of serum was passed through the antigen column and then washed with 20 bed 
volumes of 10mM Tris, pH 7.5 and 20 bed volumes of 10mM Tris, pH 7.5, 500 mM NaCl. The 
bound antigen was eluted in 10 bed volumes of 100mM glycine, pH 2.5 and the eluate was 
immediately neutralized by addition of 100 µl1M TRIZMA to 1ml. The column was then wash 
with 10mM Tris/HCl, pH 8.8 followed by 10mM Tris/HCl, pH 7.5 until the pH of the buffer was 
reached in elution. From this step either again serum was headed onto the column or the 
column was stored in 10mM Tris/HCl, pH 7.5, 0.01% merthiolate at 4°C. The eluted fractions 
were analysed by SDS-PAGE and the antibody containing fractions were pooled and 
concentrated.  
Antibodies that were used for co-immunoprecipitations were purified of antibodies that 
potentially reacted with the “negative antigen” (the α-MmGroES- and the α-MmGroEL 
antibodies against thermosome α, β,γ ;  the α− MmThsα and MmThs β against MmGroEL and 
MmGroES; the α− FFLuc antibody against any chaperonin subunit). Therefore the serum was 
passed several times through a “negative antigen” column and the run though was kept as 
negative-purified antibody serum, the washing steps were neglected and the column was 
regenerated as described above.  
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III.4.5 Western blotting 
Proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes in a 
semi-dry western blotting unit (SemiPhore) in 25 mM Tris, 192 mM glycine, 20 % methanol, pH 
8.4 at constant current of ~0.5 – 0.8 mA/cm2 gel size for 1.5 h (Towbin et al., 1979). 
Nitrocellulose membranes were blocked in 5 % skim milk powder in TBST for 1 h. The 
membranes were then incubated with a 1:2000 – 1:10000 dilution of primary antibody serum in 
TBST and extensively washed in TBST before incubation with a 1:5000 dilution of secondary 
antibody in TBST (Anti-rabbit IgG, whole molecule – horseradish peroxidase conjugate. 
Antibody produced in goat or vice verca. Sigma). After extensive washing, protein bands were 
detected by incubating the membranes with ECL chemiluminescence solution and exposure to 
X-ray film or LAS-3000 CCD-Imaging System. 
 
III.4.6 Preparation of antibody beads 
Serum was mixed with in H2O equilibrated protein A beads and gently rocked for 2 hrs at 
room temperature.  The beads were transferred to a poly-Prep column and solution was passed 
through by gravity force. The beads were washed with 10 bed volumes of 100mM Tris/HCl, pH 
8.0 and equilibrated in 0.2 M Triethanolamine, pH 8.9. The antibody was crosslinked by 
addition of 10 fold molar excess of dimethylpimelimidate (DMP) for 1 hr at RT. The reaction was 
stopped by addtition by a wshing step in 5 bed volumes of 0.1M glycine, pH 2.5 and neuralized 
by washing TBS. The beads were stored after addition of 0.01% merthiolate at 4°C. 
 
III.4.7 Analytical gel filtration 
Protein samples were applied to a size-exclusion column (Superdex 200 or Superose 6, 
Pharmacia) in aliquots of 50-100 µl, at room temperature with a flow rate of 40 µl/min and 
fractions of 100 200 µl were collected. The columns were calibrated with thyroglobulin (669 
kDa), ferritin (460 kDa), catalase (206 kDa), aldolase (158 kDa), BSA (67 kDa), carbon-
anhydrase (29 kDa) und α-lactalbumin (14 kDa) (Pharmacia) as proteins size standards. 
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III.5 Functional analysis methods 
III.5.1 Co-immunoprecipitations  
Exponentially grown M. mazei cells were shock cooled by a radiator coil and harvested at 
3800 rpm/4°C. The cell pellet was lysed in 25mM Tris/HAc pH 7.4, 20mM glucose, 100 U 
hexokinase/ml, 0.01% Tween 20, 250 U benzonase, 2 mM Pefabloc and adjusted to 150mM 
NaCl. To remove cell debris the solution is spun twice at 21000 x g/for 15 min at RT. After 
estimation of the protein concentration using the Bradford method antibody-bead solution is 
added in a 1:5 ratio of antibody and antigen, assuming a 1% abundance of the chaperonins in 
the cell lysate. After gentle rocking for 1.5 - 2hrs at RT the beads are washed with 200 bed- 
volumes of 50 mM Tris/HCl pH 8.0, 1% Triton-X-100, 0.5% DOC, 150mM NaCl, 5mM ADP 200 
bed- volumes of 50 mM Tris/HCl pH 8.0, 1% Triton-X-100, 500 mM NaCl, 5mM ADP and 200 
bed- volumes of TBS, 5mM ADP. The bound antigen is eluted from the beads in 5 bed- 
volumes of 100mM glycine pH 2.5.  
For immunoprecipitation at denaturing conditions the lysate was denatured in 1% SDS at 
95°C for 1 min. After 20 fold dilution into 25mM Tris/HAc pH 7.4, 0.01% Tween 20, 250 U 
benzonase, 2 mM Pefabloc, adjusted to 150mM NaCl and spun twice at 21.000 x g for 15 min 
at 4°C. The clarified solution was then subjected to the immunoprecipitation experiment 
described above, but at 4°C to prevent reassociation of the chaperonin subunits into functional 
complexes. 
For immunoprecipitation from denatured lysate xxx mg of cell pellet was resuspended in 3M 
guanidine/HCl. After centrifugation the lysate was diluted 50-fold into 25mM Tris/HAc pH 7.4, 
0.01% Tween 20, 250 U benzonase, 2 mM Pefabloc containing the indicated recombinant 
chaperonins. After adjusting to 150mM NaCl and two spins at 21.000 x g for 15 min at RT, the 
immunoprecipitaion protocol above was followed. 
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III.5.2 Substrate release experiments 
The co-immunoprecipitation experiment was performed as described above, but before 
elution of the antigen the beads were transferred into refolding buffer (100mM KCl, 5mM MgCl2, 
500mM (NH4)2SO4, 20mM MOPS/7.4). After addition of 5mM TRAP-EL at 35°C, the experiment 
was started with 5mM ATP and time points were taken by stopping depleting ATP from the 
reaction by addition of 100 U/ml hexokinase, 20mM glucose. After collection of the end time 
point the samples were washed with 100 bed-volumes of each washing buffer and eluted in 5 
bed volumes of 0.1M glycine, pH2.5. 
III.5.3 PK digestion 
MmGroEL/ES/substrate complexes were prepared as described above and immediately 
neutralized by addition of equal amount of 1M Tris/HCl, pH 8.0. After estimation of the protein 
concentration according to the Bradford method Proteinase K was added at 25 °C in a 1:20 
weight ratio of Proteinase K: immunoprecipitate. At indicated times, samples were taken and 
the digestion was stopped with 10 mM PMSF. 
 
III.6 Biophysical methods 
III.6.1 Mass spectrometry of protein spots from 2D PAGE 
Protein spots of interest were picked using the Ettan spot picker. The mass spec analysis 
was performed by Magda Puype and Evy Timmermann at the Department of Medical Protein 
Research (VIB09), Ghent University.   
The gel spots were transferred to a Biopure Eppendorf  tube and washed with water (LC-
MS graded, Biosolve, Valkenswaard, Netherlands), then with 50% (v/v) acetonitrile (HPLC 
graded, Baker, Amsterdam, Netherlands) in water and finally with 100% acetonitrile. The gel 
spots were submerged in 50 mM ammonium bicarbonate at pH 8.0 and 0.05 µg sequencing 
grade modified trypsin (Promega Corporation, Madison, WI, USA) was added. After overnight 
digestion at 37°C, the mixture was acidified with formic acid to pH 2-3 to deactivate the trypsin. 
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The peptide mixture was then centrifuged, transferred to a new Eppendorf tube, dried and 
re-dissolved in 20 µl of  0.1% formic acid in 2/98 (v/v) acetonitrile/water (solvent A).  10 µl of 
this peptide mixture was applied for nano-LC-MS/MS analysis on an Ultimate (Dionex, 
Amsterdam, The Netherlands) in-line connected to an Esquire HCT mass spectrometer 
(Bruker, Bremen, Germany). The sample was first trapped on a trapping column (PepMap™ 
C18 column, 0.3 mm I.D. x 5mm, Dionex (Amsterdam, The Netherlands)). After back-flushing 
from the trapping column, the sample was loaded on a 75 µm I.D. x 150 mm reverse-phase 
column (PepMap™ C18, Dionex (Amsterdam, The Netherlands)) The peptides were eluted with 
a linear gradient of 3% solvent B (0.1% FA in water/acetonitrile (3/7, v/v)) increase per minute 
at a constant flow rate of 0.2 µl/min. Using data dependent acquisition, the multiply charged 
ions with intensities above threshold (adjusted for each sequence according to the noise level) 
were selected for fragmentation. During MS/MS analysis a scan time of 40 ms was used and 
MSMS fragmentation amplitude ramped from 30% to 300% of 0.7V. 
The fragmentation spectra were converted to mgf files using the Automation Engine 
software (version 3.2, Bruker) and were searched using the MASCOT database search engine 
(http://www.matrixscience.com) against the Methanosarcina mazei Gö1 database derived from 
the NCBI database. Peptide mass tolerance was set at 2 Da and peptide fragment mass 
tolerance at 0.5 Da, with the ESI-IT as selected instrument for peptide fragmentation rules. 
Variable modifications were set to methionine oxidation, pyro-glutamate formation of amino 
terminal glutamine, acetylation of the N-terminus and propionamide modification of cysteines.  
 
III.6.2 Coupled liquid chromatography – mass spectrometry system (LC-
MS/MS) 
Mass spectrometry and data analysis of the mass spectrometric output was performed by 
Morten Kirkegaard (Center for Experimental BioInformatics, Department of Biochemistry and 
Molecular Biology, University of Southern Denmark – Odense) and Dr. Francesca Forner 
(Department for proteomics and signal transduction, MPI of Biochemistry, Martinsried). 
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Sample preparation  
200 µg of the respective MmGroEL/MmGroES-substrate or MmThs-substrate complexes 
were separated by SDS-PAGE (4-16 % BisTris-NuPage, 1 mm, 200 V for 35 min, Invitrogen). 
The gel was Coomassie stained (colloidal blue staining kit, Invitrogen) and the entire lanes 
were cut out and sliced into 5-6 pieces. After in-gel reduction, alkylation the proteins were in gel 
digested with trypsin as described (Lasonder et al., 2002). After extraction of peptides from gel 
pieces using 3 % trifluoroacetic acid (TFA) and 30 % acetonitrile, the sample volume was 
partially reduced by vacuum evaporation and the residual solutions were applied to StageTips 
to desalt, filtrate and concentrate the peptide samples (Rappsilber et al., 2003). 
 
Coupled liquid chromatography – mass spectrometry system (LC-MS/MS) 
For the in gel separation approach, 200 µg of proteins (Bradford assay) were loaded onto a 
4-12% gradient polyacrylamide pre-cast gels (NuPAGE Novex Bis-Tris gels, 1 mm, Invitrogen) 
and stained with colloidal Coomassie (Invitrogen). Gel lanes were cut into 6 slices and 
subjected to in gel tryptic digestion essentially as described (Schevchenko et al., 1996). Briefly, 
following complete de-staining, gel slices were cut, washed with 50 mM ammonium bicarbonate 
and shrinked with ethanol. Reduction/alkylation of proteins was performed with 10 mM DTT and 
55 mM iodoacetamide. After two wash steps with ammonium bicarbonate/ethanol, the gel was 
dried with ethanol and incubated with 12.5 ng/µl trypsin (Promega) in 50 mM ammonium 
bicarbonate at 4°C for 15 min. The supernatant was then discarded and replaced with 50 mM 
ammonium bicarbonate and the reaction allowed proceeding overnight at 37°C. The reaction 
was stopped with 1% TFA, 0.5% acetic acid and 3% acetonitrile and the supernatant 
recovered. Additional peptide extraction steps were performed with 30% acetonitrile and 100% 
acetonitrile. Supernatants were concentrated to low volume and then diluted to approximately 
200 µl with 0.5% acetic acid, 3% acetonitrile, 1% TFA. Resulting tryptic peptides were desalted 
and concentrated on reversed phase C18 StageTips (Rappsilber et al., 2003). Peptides were 
resuspended in 10 µl of 3% acetonitrile, 1% trifluoroacetic acid, 0.5% acetic acid before 
injection. Liquid chromatography was performed on a 15 cm fused silica emitter (75 µm ID  from 
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Proxeon Biosystems, Odense, Denmark) packed in-house with reversed phase ReproSil-Pur 
C18-AQ 3 µm resin (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany). The injection 
volume was 5 µl, and the flow rate was 250 nl/min after a tee splitter. The experiments were 
performed on an Agilent 1100 nanoflow system connected to a 7-Tesla Finnigan linear 
quadrupole ion-trap Fourier transform (LTQ-FT) mass spectrometer (Thermo Electron, Bremen, 
Germany) equipped with a nanoelectrospray ion source (Proxeon Biosystems, Odense, 
Denmark).  
The peptide mixtures were injected onto the column with a flow of 500 nL/min and 
subsequently gradient-eluted with a flow of 250 nL/min from 5% to 40% CH3CN in 0.5% acetic 
acid. Gradients were 140 minutes long. The mass spectrometer was operated in the data 
dependent mode to automatically switch between MS, MS2 and MS3 acquisition essentially as 
described (Olsen and Mann, 2004). Survey full scan MS spectra (from m/z 350 – 1550) were 
acquired in the ICR cell with resolution R=25,000 at m/z 400 and accumulation to a target value 
of 5,000,000 charges. The three most intense ions were sequentially isolated for accurate mass 
measure in the FT-ICR cell (SIM) and fragmented in the linear ion trap by collisionally induced 
dissociation at a target value of 10,000 charges. For MS3, the three most intense ions in each 
MS2 spectrum were further isolated and fragmented. Target ions already selected for MS/MS 
were dynamically excluded for 30 seconds. General mass spectrometric conditions were: 
electrospray voltage, 2.3 kV; no sheath and auxiliary gas flow; ion transfer tube temperature, 
150ºC; collision gas pressure, 1.3 mTorr; normalized collision energy, 35% for MS2. Ion 
selection threshold was 500 counts for MS2. An activation q = 0.25 and activation time of 30 ms 
was applied for MS2 acquisitions.   
Proteins were identified by automated database searching (Mascot Daemon, Matrix 
Science) against an in-house curated version of the Methanosarcina Mazei protein sequence 
database. The database was obtained from 
ftp://ftp.ebi.ac.uk/pub/databases/integr8/fasta/proteomes/89.M_mazei.fasta.gz. and was 
complemented with frequently observed contaminants (porcine trypsin, achromobacter lyticus 
lysyl endopeptidase and human keratins). Search parameters specified an initial MS tolerance 
of 10 ppm and an MS/MS tolerance at 0.4 Da and Trypsin/P+DP specificity allowing for up to 2 
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missed cleavages. Carbamidomethylation of cysteine was set as a fixed modification and 
oxidation of methionines, N-protein acetylation and N/Q deamidation were allowed as variable 
modifications. The 99 percent significance threshold in the Methanosarcina mazei Gö1 
database search was a Mascot score of 19. Acceptance criteria for protein identifications were 
at least one sequenced non redundant peptide with mass accuracy better than 5 ppm, Mascot 
score higher than 19 and MS3 event. A total of 4926 unique peptide sequences with more than 
5 amino acids in length and mass accuracies better than 5 ppm were identified.  
 
Semi-quantitative protein abundance calculation using emPAI scores 
To estimate the absolute protein content in the different samples we calculated emPAI 
scores (Ishihama et al., 2005) based on the number of unique peptides. emPAI is defined as 
10PAI-1, where PAI is the ratio between the number of observed and observable peptides per 
protein. It has been shown that there is a roughly linear relationship between protein 
concentration and emPAI score, therefore the ratios between emPAI scores from different 
samples is an approximation to the ratio of protein amounts.  
 
 
III.7 Bioinformatic methods 
III.7.1 Sequence data analysis 
Protein and nucleotide sequences were compared using BLAST (Basic Local Alignment 
Search Tool; www.ncbi.nlm.nih.gov; (Altschul et al. 1997).  
Sequence alignments were performed using the multialin interface page „Blosum62-12-2“ 
(Henikof und Henikof 1992; http://www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html). 
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III.7.2 Structure data analysis 
Structural assignment of M.mazei lysate proteins according to the SCOP database 
(Structural Classification Of Proteins,(Lo Conte et al., 2002)) was derived from the HMM library 
and genome assignment server (Gough et al., 2001) (http://supfam.mrc-
lmb.cam.ac.uk/SUPERFAMILY/index.html). Domain folds according to the SCOP data base 
were downloaded from the Protein Data Base (http://pdbbeta.rcsb.org/pdb/Welcome.do). 
Proteins containing transmembrane domains are identified Munich Information Center for 
Protein Sequences (MIPS, http://pedant.gsf.de/) and validated using DAS- Transmembrane 
Prediction server of the Stockholm Informatics center 
(http://www.sbc.su.se/~miklos/DAS/maindas.html). 
 
Functional assignment of M. mazei proteins according to the COG database (Clusters of 
Orthologous Groups of proteins) (Tatusov et al., 1997) was downloaded from the Integrated 
Microbial Genomes (IMG) system (http://img.jgi.doe.gov/) (Markowitz et al., 2006). COGs are 
based on phylogenetic classification of proteins encoded by multiple complete genomes. 17 
distinct functional categories are assigned to COGs, which can be further summarized as 
subgroups of information storage and processing, cellular processes, metabolism, and poorly 
characterized proteins. 
Physical data, such as hydrophobicity, net charge, pI, and calculation of the evolutionary 
scope of the M. mazei proteins were obtained using the gi|numbers for identification from the 
Evolutionary and Functional Genomics Server (EMU) at the Institute for Molecular Bioscience 
at the University of Queensland (http://emu.imb.uq.edu.au/index.php). 
Essentiality was attributed to proteins from M. mazei according to the function of the protein 
in an essential pathway according to the Kyoto Encyclopedia of Genes and Genomes (KEGG). 
A protein was judged to be essential if the protein plays a critical role in a pathway 
indispensable for cell viability and no other functional homolog of this protein was present in the 
genome of M. mazei.  
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IV. Results 
Analysis of the genome of the mesophilic, methanogenic archaeon Methanosarcina mazei 
Gö1 (M. mazei) revealed that this organism contains not only the genes encoding the complete 
archaeo-typical Group II chaperonin system (thermosome; MmThs), but surprisingly also an 
operon of the bacterio-typical group I chaperonin genes (MmGroEL/GroES). This offers the 
unique opportunity to study the function of both chaperonins under the absolute same 
environmental conditions: the archaeal cell. 
 
IV.1 Production of recombinant proteins and polyclonal antibodies 
To analyse the chaperones of Methanosarcina we cloned the genes encoding for the three 
thermosome subunits (MmThs α, MmThs β, MmThs γ), for the two prefoldin subunits (MmPfd α, 
MmPfd β), MmGroEL, MmGroES and MmDnaK. The respective proteins were expressed in 
E.coli BL21 and purified as described in the section materials and methods.  
Polyclonal antibodies against MmThsα and MmThsβ, MmPfd β and MmGroEL and 
MmGroES were raised in rabbits to detect the corresponding proteins in M. mazei lysate. The 
specificity of the antibodies was tested in immunoblotting experiments and no significant 
crossreaction was detected (data not shown). 
Because of the high sequence homology of the MmThs-subunits (MmThsα and 
MmThsγ are identical in 70% and similar in 85% of their aminoacid sequence; MmThsα and 
MmThsβ are identical in 47% and similar in 69% of their aminoacid sequence; MmThsβ and 
MmThsγ are identical in 47% and similar in 68% of their aminoacid sequence), the specificity of 
the antibodies against the MmThsα and MmThsβ was tested on recombinant MmThs-subunits 
under native and denaturing conditions. In immunoblotting experiments no significant cross 
reaction of anti-MmThsα and the recombinant MmThsβ subunit was detected and vice versa. In 
immonublotting experiments, probably because of the strong homology of MmThsα and 
MmThsγ, the anti-MmThsα showed minor cross reactivity of against the non-native MmThsγ 
subunit (Figure 15a). Under native conditions though, when the antibodies were used in 
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immunoprecipitations from lysate of E.coli BL21 expressing a specific MmThs subunit, 
exclusively only the corresponding MmThs subunit was precipitated (Figure 15b). 
   
 
Figure 15 : Specificity of anti-MmThsα- and anti-MmThsβ- antibodies 
(A) Specificity of antibodies against non native MmThs subunits: Purified recombinant Ths 
α,β,γ subunits were separated by 16% SDS-PAGE (pH 6.5) and imunoblotted with either 
anti-MmThsα (left)or anti-MmThsβ (right). (B) Specificity of antibodies against native MmThs 
subunits: soluble extracts from E. coli BL21 expressing the indicated MmThs subunit were 
immunoprecipitated with immobilized antibodies either anti-MmThsα or anti-MmThsβ. 
Precipitates were analysed for MmThs subunits by immunoblotting using a mixture of the 
antibodies. 
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IV.2 Both chaperonins and their cofactors are expressed at similar 
levels and as oligomeric proteins  
IV.2.1 Group II chaperonin: The MmThs consists of three different subunits  
All archaeal species analysed so far have Group II chaperonins composed of one to two 
different subunits. Only members of the family Methanosacrinacaea were shown to posses an 
additional gene coding for a thermosome subunit. Within the genome of M. mazei three 
different thermosome genes exist, termed α, β and γ with a molecular mass of 58.9, 58.5 and 
58.2 kDa, respectively. Sequence alignment with their respective archaeal and eukaryotic 
homologs showed homologies of 50-80%. Sequence comparisons of apical domains of the 
subunits showed a high identity and similarity between the MmThsα and MmThsγ subunit of 
~70% and ~85%, the MmThsβ subunit shares only ~35% identity and ~70% similarity with 
MmThsα or MmThsγ subunit. The MmThsα subunit shows a high degree of similarity to Ths α 
subunits of other archaeal species and to the TCP-I subunit of the eukaryal group II chaperonin 
TRiC/CCT. 
Immunoblotting-analysis of M. mazei lysate confirmed that all three subunits are expressed 
under standard conditions. Comparison of signal intensities of the respective MmThs subunit in 
M. mazei lysate with standard quantities of recombinant MmThs-subunits revealed that the 
thermosome subunits are expressed in a 2:1:1 ratio of α:β:γ (Figure 16).The abundance of 
MmThs complex was assessed to a level of about 2% of total soluble proteins. 
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Figure 16 : expression levels of group II chaperonins in M. mazei lysate 
(A) Relative amounts of MmThs subunits in Mmlysate detected by immunoblotting after 
separation by 16% SDS-PAGE, signal intensities of endogenous MmThs subunits were 
compared to signal intensities of recombinant MmThsα,β,γ subunits as indicated. (B) 
Quantitation of immunoblots of three independent experiments. 
 
MmThs was also quantified from defined numbers of cells (data not shown). At an average 
cell size of ~ 1 µm in diameter, implying a single cell volume of 4 x 10-15 l, a concentration of 
60µM of monomer was calculated and 2 µM of the thermosome complex supposing a 
hexadecameric structure. At a theoretical total protein concentration of 200 g/L in the archaeal 
cell, this value is consistent with an abundance of thermosome at 2% of total soluble proteins 
shown above. 
Subsequent immunoblotting of M. mazei total cell lysate, fractionated on a size-exclusion 
chromatography column (superdex 600) showed that all thermosome subunits were exclusively 
detected within the high molecular weight fractions. This allows to the conclusion that all the 
subunits are associated as thermosome double ring complexes (Figure. 17A).  
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Figure 17 : Analysis of the composition if the group II chaperonin complexes in M. mazei 
lysate 
(A) Size exclusion chromatography of M. mazei lysate on a superdex 600 column. After 
separation by SDS-PAGE (pH 6.5) the MmThs subunits were detected by immunoblotting using 
a mixture of anti-MmThsα and β. (B) Analysis of the endogenous MmThs complex by co-
immunoprecipitation of the MmThs subunits. MmThs-complexes were precipitated from the 
lysate using the specific antibodies anti-MmThsα or anti-MmThsβ. The subunit composition of 
the precipitated complexes were analysed after separation by 16% SDS-PAGE (pH 6.5) by 
immunoblotting against MmThsα and MmThsβ, increasing amounts of recombinant subunits 
were used as standard. 
  
The composition of the endogenous thermosome complexes was estimated by precipitation 
of the chaperonin complexes from the lysate using immobilized MmThs subunit specific 
antibodies. In both cases, when the MmThs complex was precipitated with anti-MmThsα or with 
anti-MmThsβ, similar ratios of the three subunits were found in the pull down experiments 
(Figure 17B). This similar subunit composition of the precipitated complexes by the different 
antibodies suggests an overall homogeneous population of the thermosome complexes in the 
archaeal cytosol. Quantification of the MmThs subunits from the co-immunoprecipitations 
revealed that the endogenous subunits preferentially associate in 2:1:1 ratio of α:β:γ, in line with 
the ratio that was shown for the lysate.  
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IV.2.2 Group II chaperonin: the supposed co-chaperon prefoldin  
Also genes for the potential cofactor prefoldin were also found to be present in the genome 
of M. mazei- represented by two genes as it is typical for Euryarchaeotes (Karlin et al., 2005). 
The prefoldin α subunit (MmPfdα) has a predicted mass of 15.3 kDa and the prefoldin β subunit 
(MmPfdβ) a mass of 13.5 kDa. Sequence comparisons of MmPfd α with the α subunit of 
prefoldin from Methanobacterium thermoautotrophicum (MtPfdα) show 29% identity and 58% 
homology, the Pfd β subunits of these organisms are 46% identical and 71% similar.  
 
Figure 18 : Sequence comparison of the Pfd subunits from M. mazei and  M. 
thermoautotrophicum 
“Coiled coil“regions are marked as blue squares, a/d represent hydrophobic amoniacids 
typically found in „coiled coil“regions. Beta sheets are marked with blue arrows. 
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The crystal structure of MtPfd showed that the functional MtPrefoldin has the appearance 
of a jellyfish: its body consists of a double beta barrel assembly with six long tentacle-like coiled 
coils protruding from it. The distal regions of the coiled coils expose hydrophobic patches and 
are required for multivalent binding of non native proteins (Siegert et al., 2000). From the strong 
homology of MmPfd and MtPfd, a similar structure of the complexes can be expected. 
Additionally, sequence comparisons with known coiled coil structures (Lupas et al. 1991) 
predict this typical coiled coil motif of prefoldin on the distal areas of both subunits.  
This assumption was experimentally supported when recombinant MmPfd −complexes was 
run on a size exclusion column. The MmPfdα and the MmPfdβ subunit elute simultaneously at 
an expected size (~200 kDa due to the unusual jelly fish like shape; Vainberg et al. 1998; 
Siegers et al. 1999) with the β−subunit as being the more prominent band on a coomassie 
stained SDS-PAGE (theoretical ratio β:α = 2:1; Figure 19A). Similarly the endogenous MmPfd 
subunits were detected by immunoblotting in the expected size fractions for the complex 
(Figure 19B). From quantitative Immunoblotting an abundance of 0.25 - 0.5% of MmPfd β in the 
Mmlysate was estimated (Figure 19C). Proposing a protein concentration of 200g/L in the 
archaeal cell and supposing that MmPfd is present as the typical α2β4 complex a concentration 
of the MmPfd complex around 10 µM in the archaeal cell can be expected. 
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Figure 19 : Analysis of the subunit composition of recombinant and  endogenous MmPfd 
 (A) SDS-PAGE analysis of recombinant MmPfd after size fractionation. The 85 kDa Pfd 
complex elutes around 200 kDa due to ist unusual shape. (B) Immunodetection of endogenous 
MmPfd subunits in size fractionated M. mazei lysate (arrows: Calibration of the size exclusion 
[kDa] : 669-thyroglobulin, 460-ferritin, 206-catalase, 158-aldolase, 68-albumin). (C) Abundance 
of MmPfd β in M. mazei lysate shown by comparative immunoblot analysis of lysate (right) and 
recombinant protein (left). 
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IV.2.3 Group I chaperonin MmGroEL and the Co-chaperone MmGroES  
Most surprisingly the analysis of the M. mazei genome revealed the presence of a groE 
operon encoding for the complete group I chaperonin MmGroEL and its cofactor MmGroES. 
The general structure of the operon resembles the organisation in gram (-) bacteria. However 
the promoter and the heat shock element are of archaeal origin.  
To ensure that the groE operon is expressed in the archaeal cell M. mazei total soluble 
protein was separated by SDS-PAGE. In Immunoblotting experiments both the MmGroEL and 
the MmGroES could be detected by the specific antibodies at the expected size of 60 kDa for 
the group I chaperonin and 10 kDa for the co-chaperone.  
Comparison of signal intensities of the chaperones from M. mazei lysate to standard 
amounts of the recombinant proteins revealed an expression level of the chaperonin MmGroEL 
of ~ 1% and 0.1- 0.25% of the co-chaperone MmGroES was estimated (Figure. 20A, B). 
In cell lysate that was fractionated on a size exclusion column MmGroEL and MmGroES 
were exclusively detected as oligomeric complexes. Compared to the elution profile of standard 
proteins MmGroEL was detected in fractions from a superdex 600 column corresponding to a 
size above 669 kDa, MmGroES eluted at a size bigger than 67 kDa (Figure 20C). 
Taken together and assuming a cellular protein concentration of 200g/L the functional 
Group I chaperonin complex is present at concentration of 2µM, while the co-chaperon 
MmGroES is present in a up to 3fold excess at 3-6 µM. 
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Figure 20 : Group I chaperonin system in M. mazei cells 
(A) Abundance of MmGroEL and MmGroES in M. mazei lysate detected by immunoblotting 
after separation by 16% SDS-PAGE, signal intensities of the endogenous chaperones were 
compared to standard amounts of recombinant proteins as indicated. (B) Quantification of 
immunoblots of three independent experiments. (C) Size exclusion chromatography of M. 
mazei lysate on a superdex 600 column. After separation by SDS-PAGE the MmThs subunits 
were detected by immunoblotting. 
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IV.2.4 Both chaperonins are moderately induced under heat shock conditions 
The similar abundance of both chaperonin argues for an equivalent contribution of both 
systems to protein folding in the cell under standard conditions. To asses the role of both 
chaperonins in the stress response of M. mazei the cells were subjected to heat stress at 45°C. 
After 15min, increased levels of both chaperonins in the lysate could be detected by 
immunoblotting, reaching a maximum expression level of 2-3 fold amounts after 30 min (Figure 
21 A, B). Under heat stress no significant deviation in the response kinetics or the final level of 
the group I and the group II chaperonins were detected. 
 
 
Figure 21 : Heat shock induction of M. mazei chaperonins 
(A) Immunodetection of endogenous amounts of M. mazei chaperonins under heat stress. 
While the heat stress shows no significant effect on the protein pattern of the M. mazei lysate 
on a Coomassie stained 16% SDS-PAGE, increased amounts of MmThs and MmGroEL can be 
detected after 15 min at 45°C. (B) Quantification of expression levels of M. mazei chaperonins 
in three independent heat shock experiments.  
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IV.3 Substrate identification 
Several studies have been performed to identify substrate spectrum of the GroEL/GroES 
system in E.coli (Houry et al., 1999; Kerner et al., 2005) and several proteins have been found 
to interact with the group II chaperonin in the eukaryotic cell (Dunn et al., 2001). So far no 
comprehensive study of the interaction proteome of group II chaperonins has been performed 
(Gomez-Puertas et al., 2004). Analysis of the polypeptide flux though the eukaryotic group II 
chaperonin TRiC in mammalian cells showed that about 9-15% of the newly synthesized 
proteins can be expected to interact with the eukaryotic group II chaperonin, similar to EcGroEL 
(Thulasiraman et al., 1999). Our knowledge about the thermosome is lagging behind in terms of 
its natural substrates and also its mode of action. Thermosomes of some hyperthermophilic 
Archaea have been shown to prevent aggregation and to promote refolding of heterologous 
model substrates, such as of green fluorescent protein (GFP) or citrate synthase (CS) (Gutsche 
et al., 1999). However, only the use of natural substrates for biochemical and functional studies 
will give detailed insights into the mechanism of chaperonin assisted folding in the archaeal 
cytosol.  
Therefore in this study, not only the GroEL/GroES of M. mazei Gö1 interacting proteins 
were identified, for the first time, a comprehensive identification of also the Group II chaperonin 
substrates was performed.  
Most importantly the unique co-existence of both chaperonins in the same compartment 
allows the most differentiated comparison possible between the substrate specificity for either 
the Group I or the Group II chaperonins. 
 
IV.3.1 Co-precipitation of chaperonin-substrate complexes 
For a fast and efficient isolation of the chaperonin-substrate complexes single step 
purifications via immunopulldowns were performed. To precipitate the chaperonin-substrate 
complexes from M. mazei Gö1 cell lysate specific antibodies against the Group I and the Group 
II chaperonin proteins, which were raised in rabbits, were covalently linked to ProteinA –
Sepharose Fast Flow beads before use to minimize the protein complexity of the precipitations 
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for the analysis by mass spectrometry. It was shown by Figueiredo et al. that MmGroES and 
MmGroEL form stable complexes in the presence of ADP at room temperature (RT). This 
interaction turned out to be sufficient to allow co-precipitation of the MmGroEL/GroES/substrate 
complex when specific antibodies against the co-chaperone MmGroES were used. 
Thermosome-substrate-complexes were isolated from M. mazei Gö1 lysate using specific 
antibodies against the MmThsβ subunit (anti-MmThsβ, Figure 22A). 
Due to stringent washing conditions and specific elution of the chaperonin complexes from 
the corresponding antibody the background level was efficiently reduced. In the control 
experiment an unspecific antibody against firefly luciferase (FF-Luc) was used and virtually no 
proteins could be detected when equivalent amount of the experimental samples was analysed 
by SDS-PAGE (Figure 22A). Three independent immunoprecipitations from shock-cooled and 
subsequently lysed M. mazei Gö1 cells were performed.  
 
Figure 22 : Co-Immunoprecipitations form M. mazei lysate 
(A) Large scale co-immunoprecipitation of M. mazei chaperonins and interacting proteins 
(lane 1:  MmGroEL/GroES and substrates, lane 2: MmThs and substrates, lane 3: control). (B) 
After denaturation of proteins from the lysate at 95°C for 1 min in presence of 1% SDS only the 
corresponding M. mazei chaperone subunits were precipitated (lane 1:  anti-MmGroES, lane 2: 
anti-MmThsβ and lane 3: anti-FF-Luc), 16% SDS-PAGE, silver stained. 
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To prove specificity of the employed antibody-beads, the co-immunoprecipitation (co-IP) 
experiment was carried out on denatured lysate, where the chaperonin complexes are 
expected to be disrupted. For this purpose the lysate proteins were denatured at 95 °C for 1 
min in the presence of 1% SDS. After renaturation by dilution only the β−subunit of the MmThs 
and the co-chaperonin MmGroES were precipitated- proving not only the specificity of the 
antibodies themselves, but also confirming the low background level of the experimental 
procedure, which has been already shown above by using the unspecific antibody (Figure 21b). 
 
IV.3.2 The MmGroEL/GroES complex is stable during the experimental 
procedure 
Interestingly recombinant MmGroES shows a faster migration on SDS-PAGE than 
endogenous MmGroES, which might be due to posttranslational modification in the archaeal 
cell. This deviation in mobility though, allows differentiation between the recombinant and 
endogenous MmGroES.  
To exclude possible rearrangements of the GroEL/GroES complexes and their 
corresponding substrates during the experimental procedure, recombinant MmGroES was 
added in excess over endogenous MmGroES during lysis.  When the MmGroEL/GroES 
complex was precipitated in this case by using a specific antibody against MmGroEL (anti-
MmGroEL), no replacement of the endogenous MmGroES by the recombinant MmGroES was 
detected, proving the stability of the endogenous MmGroEL/GroES complex. The additional 
appearance of recombinant MmGroES is probably due to an association of the recombinant co-
chaperone to MmGroEL complexes that had endogenous MmGroES bound. 
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Figure 23 : Stability of MmGroEL/GroES complex  
M. mazei lysate was subjected to co-IP using an anti-MmGroEL antibody without (lane 1) 
and after addition of recombinant MmGroES in excess (lane 2, asterisk: recombinant 
MmGroES) during lysis and influence of the addition of recombinant MmGroES in excess (lane 
4) on the amount of endogenous MmGroES in the precipitated MmGroEL/GroES complexes  
was detected by silver staining of 16% SDS-PAGE.   
 
IV.3.3 GroEL/GroES complexes contain mainly encapsulated cis-ring bound 
substrates 
In the ADP-bound status of GroEL/GroES complexes, the substrates are expected to be 
encapsulated mainly in the cis-cavity undergoing folding (Figure 24). In addition, some proteins 
can be expected to be bound to the trans-GroEL ring, especially proteins exceeding the volume 
of the GroEL/GroES cavity.  It is speculated by Kerner et al. that probably the proteins identified 
among the EcGroEL substrates with a monomeric size exceeding the estimated cut-off (60 
kDa) might interact with the trans cavity of the GroEL/GroES complex.  
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Several studies (Langer et al., 1992a, Mayhew et al., 1996) have shown that association of 
GroES on GroEL in presence of  ADP efficiently prevents the entry of proteinase K (PK) into 
the cis-cavity environment. Therefore only cis-encapsulated non-native substrate-proteins as 
well as the flexible carboxy-termini of GroEL in the cis-cavity of the chaperonin complex are 
protected from PK digestion. Substrate proteins bound in trans and the carboxy-termini of the 
trans cavity will be digested by PK. The asymmetric digestion of only the GroEL carboxy-termini 
of the trans-ring gives rise to a characteristic GroEL double band on SDS-PAGE (Figure 24).  
 
 
Figure 24 : Model of the action of proteinase K on the asymmetric GroEL/GroES complex 
Substrate proteins (black) can be accommodated in the cis (left) or the trans cavity of 
the asymmetric GroEL/GroES complex (pink). When the GroEL/GroES complex is 
stabilized (i.e. in the presence of ADP) only the trans cavity can be accessed by 
Proteinase K. Therefore only substrates bound in trans and the C-termini of the trans 
cavity are digested, giving rise to the characteristic GroEL/GroELΔC double band on a 
SDS-PAGE.  
 
In order to test if the co-precipitated proteins were encapsulated inside the cis-cavity or 
associated to the trans-ring, the precipitated MmGroEL/GroES-complex were eluted from the 
antibody beads at acidic conditions and immediately neutralized by addition of 1/10 volume of 
1M Tris/HCl, pH 8.0. When the immunoprecipitates were submitted to proteinase K digestion in 
presence of ADP the substrate bands of the chaperonin-substrate complexes were still 
detectable after 5 and 60 min. After 60 min the typical MmGroEL/MmGroELΔC double band 
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becomes visible, due to the digestion of the carboxy-termini of the trans-cavity by PK (Figure 
25A). As a control the PK digestion experiment was performed in presence of ATP. ATP allows 
the cycling of the co-chaperone on and off GroEL and therefore proteinase K can access both 
GroEL-rings similarly. Under this condition the bands representing the non native substrate 
proteins disappear after 60 min as they are completely digested by PK (Figure 25B). Moreover, 
the MmGroEL/MmGroELΔC double band can not be detected as there is no stable formation of 
the asymmetric GroEL/GroES complex that would lead to a protection of the carboxy-termini in 
the cis-cavity. 
 
Figure 25 : Nucleotide dependent Proteinase K digestion of MmGroEL substrates   
Proteinase K digestion of MmGroEL-substrate-complexes was performed in presence of 
ADP (A) and after addition of ATP (B). Stabilization of the GroEL/GroES complex by ADP led to 
a protection of the C-termini of the MmGroEL cis-cavitiy, resulting in the characteristic double 
band of MmGroEL/MmGroELΔC. The protection of substrates from digestion is due to 
encapsulation in the cis cavity. Addition of ATP allows cycling and abolishes the protective 
effect of MmGroES. This leads to a digestion of all MmGroEL C-termini and the MmGroEL-
GroES-substrates. 
IV.3.4 The co-precipitated proteins can be released from the corresponding 
chaperonin in a nucleotide dependent manner 
Non-native proteins are captured by the chaperonin systems of GroEL/GroES and 
thermosome followed by their nucleotide dependent, transient enclosure for folding and release 
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into bulk. When the client protein has reached its native and no longer exposes surface motifs 
for chaperonin interaction, it will not rebind to the chaperonin.  
To ensure that the co-precipitated proteins were associated with their corresponding 
chaperonins in a folding competent state, the nucleotide dependent substrate release from the 
chaperonin cavities was monitored. Different conditions were tested for the release of 
substrates. Addition of ATP led only to a very limited release of proteins from the chaperonins 
(data not shown), which may be due to several reasons. Firstly, the function of the chaperonin 
could be negatively influenced by the association to the antibody-beads. Secondly, a co-
fraction relevant for folding and/or release of the client protein may have been missing. Thirdly, 
many of the proteins might be members of oligomeric structures and preserve exposed 
hydrophobic surfaces for binding the corresponding interaction partner. Such proteins will 
continuously rebind to chaperones until they have associated with their natural interaction 
partner (Figure 25, left side).  
To overcome the rebinding of the substrate proteins can be trapped from the chaperonin 
upon release by addition of an excess of a mutant version of the EcGroEL chaperonin, the so-
called TRAP-EcGroEL (Figure 25, right side). This mutant GroEL binds proteins, which expose 
hydrophobic surfaces, with a similar affinity as EcGroEL, but is defective in its ATPase activity 
and is therefore not able to undergo cycling, resulting in a stable binding of the client protein.  
Although this experiment does not demonstrate successful folding, it shows a nucleotide 
dependent interaction of the chaperonin and substrate proteins. 
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Figure 26 : Schematic drawing of the “TRAP” EcEL driven substrate release  
Addition of ATP to the antibody bound MmGroES (brown)-MmGroEL (orange)- substrate 
(blue) will lead to cycling of the chaperonin system, the substrate will rebind until no 
hydrophobic surfaces are exposed. As many proteins are part of oligomeric complexes, they 
will expose hydrophobic surfaces also under native conditions and therefore continuously 
rebind. A similar scenario can be expected for MmThs(blue)- substrate complexes. Rebinding 
of substrates during cycling of the M. mazei chaperonins is prevented by addition of TRAP-
EcEL (pink), which can not undergo cycling and therefore stably binds the released substrate. 
 
When MmGroEL/GroES substrates complexes were incubated with ATP in the presence of 
10-fold excess TRAP-EcGroEL, an efficient release of the substrate proteins was observed 
already after 5 min (Figure 27A, lane 1-3 and 27C, lane 1-3), while a considerable amount of 
substrates was still bound on the thermosome even after 60 min (Figure 27A, lane 4-6).  
To rule out if this lower release efficiency was due to a cycling deficiency of the 
thermosome complex under the experimental conditions or due to a lower affinity of TRAP-
EcGroEL for the thermosome associated proteins, TRAP-EcGroEL was added at increasing 
amounts. When TRAP-EcGroEL was used at 100-fold excess the substrate proteins were 
released from MmThs within 60 min (Figure 27B, lane 4-6), while at a 10-fold excess of TRAP- 
EcGroEL efficient release was only detected after 120 min (Figure.26b, lane 1-3). The 
inefficient transfer of proteins from the thermosome to TRAP-EcGroEL is potentially caused by 
a limited affinity of TRAP-EcGroEL for thermosome substrates.  
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Figure 27 : TRAP-EL promoted substrate release  
(A) Nucleotide dependent release of substrates from MmGroEL/GroES- complexes (lane 1-
3) and MmThs complexes (lane 4-6) in the presence of 10x excess TRAP-EcGroEL. (B) 
Release of substrates from MmThs complexes depending on excess of TRAP-EcGroEL. 
Efficient release from MmThs can be provoked by 100x excess of TRAP-EcGroEL over 
MmThs. (C) The release of substrates (lane 1-3) is not due to replacement of MmGroEL by 
TRAP-EcGroEL, which shows only very little and nucleotide independent affinity for the 
antibody-column bound MmGroES. (D) The addition of TRAP-EcGroEL to the experimental 
procedure had no significant effect in the control experiment with the unspecific anti-FF-Luc. 
   
As a control, to confirm the inability of TRAP- EcGroEL to bind the co-chaperone 
MmGroES, which excludes that the observed  substrate release from MmGroEL could be due 
to exchange of MmGroEL against TRAP-EcGroEL, TRAP- EcGroEL was added to purified 
recombinant MmGroES that was bound to protein A sepharose via the MmGroES antibody. 
Only limited amount of TRAP-EcGroEL was found associated with MmGroES independent of 
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the duration of the experiment (Figure 27C, lane 4-6). In the background control experiment 
using anti-FF-Luc no influence of the addition of TRAP-EcGroEL on the immunoprecipitation 
was detected (Figure 27D). 
 
IV.3.5 Chaperonin-substrate complexes captured under native conditions differ 
from in vitro reconstituted Chaperonin-substrate complexes 
The co-precipitations showed remarkable differences in the substrate spectra of Group I 
and Group II chaperonins - as visualized on 1D or 2D- SDS-PAGE. These differences might be 
due to different affinities of the chaperonin groups for newly synthesized polypeptides, but also 
other cellular factors- for example upstream acting chaperones- may also play an important role 
in sorting proteins to the respective chaperonins. To investigate if the chaperonin substrate 
interaction is driven only by the amino acid sequence of the polypeptide chain, the co-IPs were 
compared to in vitro generated chaperonin and M. mazei protein complexes. Chemically 
denatured M. mazei lysate was diluted into a solution containing both recombinant M. mazei 
chaperonins in the presence of 5mM ATP. The formed chaperonin-protein complexes were 
stabilized by the addition of hexokinase/glucose/ADP, resulting in hydrolysis of ATP to ADP, 
and then precipitated using the respective antibody beads. Both the MmThs- and the MmGroEL 
lysate protein complexes generated in vitro (Figure 27, lane 1, 2) significantly differed from 
complexes precipitated from M. mazei cells (Figure 27, lane 4, 5). The in vitro formed 
chaperonin-substrate complexes showed similar protein pattern for both the Group I and the 
Group II chaperonin and several band of substrates of the in vivo precipitated MmThs and 
MmGroEL were present on both in vitro chaperonin-substrate complexes.  
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Figure 28 : In vitro formed M. mazei chaperonin-substrate complexes compared to 
endogenous chaperonin substrate complexes 
After thermal denaturation at 95°C in the presence of 1% SDS for 1 min the M. mazei 
lysate was diluted into buffer containing both M. mazei chaperonins allowing the formation of 
MmThs-substrate (lane 1) and MmGroEL/GroES-substrate complexes  (lane 2). The 
chaperonin-substrate complexes were co-immunoprecipitated and were compared to 
complexes precipitated from M. mazei cells (lane 4: MmThs- substrate complexes, lane 5: 
MmGroEL/GroES-substrate complexes; control- immunoprecipitations with FF- antibody under 
“in vitro” (lane3) and in vivo conditions (lane 6). 
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IV.3.6 Substrate Identification 
Routinely three independent, large scale experiments were performed to precipitate M. 
mazei chaperonin-substrate complexes including the corresponding background control. Three 
different analysis methods were employed to identify the co-precipitated substrate proteins. 
Firstly, the classical 2D PAGE was performed on the chaperonin-substrate complexes to 
visualize differences in the substrate spectra, and spots were selected identification by LC-
MS/MS. Secondly, the proteins precipitated in another large scale experiment were analysed 
by the Ettan-DIGE technique - a more differentiated method of 2D-PAGE – followed by LC-
MS/MS of specific protein spots. Thirdly, because of the greater sensitivity, the 1D-LCMS was 
chosen as a more comprehensive substrate identification method. 
  
Substrate identification by 2D-PAGE-MS 
On the one-dimensional SDS-PAGE the precipitated MmGroEL/GroES substrate- and 
MmThs substrate- complexes showed remarkable deviations in their protein pattern and, for a 
better visualisation of these differences, the chaperonin – substrate complex were separated by 
2D- PAGE (Figure 29). After visual inspection 145 protein spots from the anti-MmThs and 107 
protein spots from the anti-MmGroEL/GroES pull down were picked and analysed by LC-
MS/MS (Table 2). In the background control no proteins could be detected and therefore no 
proteins were picked (Figure 29E). 40 proteins of the thermosome pull down could be identified, 
19 (47.5 %) of these were categorized as MmThs-specific substrates (Figure 28A) as they were 
never found in any MmGroEL/GroES-IP (including the 1D-LCMS analysis). Analogously 9 (32 
%) of the 28 proteins identified in the anti-MmGroES pull down were defined as 
MmGroEL/GroES specific substrates (Figure 29B). The majority of the identified proteins from 
the MmThs pull down (21 proteins, Figure 29C) and from the MmGroEL pull down (19 proteins, 
Figure 29D) were identified in IPs of both chaperonins. These proteins interact with both 
chaperonin groups and were therefore categorized as overlapping substrates. 
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Figure 29 : 2D-PAGE of M. mazei chaperonin substrate complexes  
Proteins from the MmThs substrate and MmGroEL/GroES were focused to their isoelectric point at a range between pH3 and pH10 and then separated by 16%- 
SDS PAGE. Proteins were detected by silver staining and spots were picked by visual inspection. MmThs specific proteins are depicted in turquoise (A), 
MmGroEL/GroES specific proteins in orange (B), overlapping proteins that were present in the MmThs complexes (C) as well as in the MmGroEL/GroES (D) 
complexes are labelled in pink. No proteins were detected in the background control (E).  
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Substrate identification by Ettan DIGE-MS 
The chaperonin – substrate complex samples were also subjected to a modified 2D-PAGE 
analysis, the 2-D Fluorescence Difference Gel Electrophoresis (Ettan DIGE). In this technique 
up to three samples are labelled with distinct fluorescent dyes (CyDye DIGE Fluors, minimal 
dyes), which do not affect the electrophoretic properties of the proteins. The mixture of the 
three labelled samples is then separated by 2D-PAGE and the presence of a protein is 
detected by its fluorescence signal. This technique allows a more reliable comparison of up to 
three different protein samples, because the samples are analysed on the identical gel and 
therefore artificial deviations in the protein pattern are minimized, which are due to deviations of 
different 2D-PAGE. Additionally, because of the minimal labelling technique, the amount of a 
given protein can be compared quantitatively between the different samples as the 
fluorescence intensity is directly correlated to the amount of a protein.  
Here the MmGroES-substrate complexes and the MmThs-substrate complexes were 
analyzed together with the background control sample (Figure 30) or with the sample 
containing the total soluble proteins of M. mazei (Figure 31). After detection of the present 
proteins by a Typhoon reader the peak intensities of the protein spots were quantified using the 
DeCyder software. 
Firstly, the MmGroEL/GroES- substrate (Figure 30A) and the MmThs–substrate sample 
(Figure 29B) were compared. In the visual overlay  proteins only present in MmGroEL 
precipitations appear in red, while proteins specifically associated MmThs appear in green 
(Figure 29D). Proteins that are found at similar levels in both precipitations appear in yellow. No 
proteins were detected in the background control sample (Figure 30C).   
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Figure 30 : 2D-DIGE analysis of M. mazei chaperonin substrate complexes 
MmGroEL/GroES substrate complexes (A) labelled with Cy3, MmThs substrate complexes (B) 
labelled with Cy5  and the control sample labelled with Cy2 (C) were pooled, separated on 2D-
PAGE and visualized by fluorescence on a Typhoon reader and intensities were overlaid for 
direct comparison (D). As the fluorescence signal is directly proportional to the amount of a 
protein, the fluorescence intensities of the proteins were integrated and compared using the 
DeCyder software. Proteins spots showing a more than 2.5 fold deviation among the IP-
samples were defined as proteins specifically present in the corresponding IP. These proteins 
were picked and analysed by mass spectrometry. This way 61 protein spots were defined as 
specifically associated with MmGroEL/GroES and 58 with MmThs (Table 2). 
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To prove the specific association of overlapping substrates with both chaperonin groups, 
the enrichment of these proteins on the chaperonins compared to their presence in the lysate 
was demonstrated. Therefore the fluorescence intensity of these proteins in the M. mazei 
chaperonin-substrate samples (Figure 31A, B) was compared to the fluorescence intensity of 
these proteins from a equivalent amount of total soluble protein of M. mazei (Figure 31C). 
Proteins at similar levels among both chaperonin- substrate complexes appear in yellow in the 
overlap of the MmGroEL-IP and the MmThs-IP (Figure 30D, i.e. indicated by the yellow arrow). 
Overlapping substrates appear in both overlays of the IPs and lysate in the colour 
corresponding to the IP sample (Figure 30 E, F). This allows the conclusion that these proteins 
were enriched in both IP samples compared to the lysate. These proteins can be expected to 
specifically interact with both of the chaperonins and were therefore defined as overlapping 
substrates. When the fluorescence intensities were compared using the DeCyder software, 31 
proteins had more than 2.5 fold higher intensities in both precipitations than in the lysate (Table 
2). 
 
 
  
Table 2: M. mazei chaperonin substrates identified from 2D-PAGE 
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Figure 31 : 2D-DIGE analysis of M. mazei chaperonin substrate complexes and M. mazei lysate 
MmGroEL/GroES substrate complexes 
(A) labelled with Cy5, MmThs substrate 
complexes (B) labelled with Cy3  and a 
equivalent amount of M. mazei lysate 
labelled with Cy2 (C) were pooled, 
separated on 2D-PAGE and visualized by 
fluorescence on a Typhoon reader and 
intensities were overlaid for direct 
comparison (D-F). Examples of 
overlapping substrates are indicated by 
arrows. 
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Substrate identification by 1D-LCMS 
 
150- 200ug of each sample of all three large scale experiments were separated on one 
dimensional SDS-PAGE and each one was cut into 5-6 gel-fragments (Figure 32). After in-gel 
trypsin digestion the peptides were separated by reverse phase chromatography and identified 
by a coupled QSTAR Pulsar quadrupole TOF tandem mass spectrometer (Lasonder et al., 
2002).  
 
 
Figure 32 : 1D-SDS-PAGE of large scale IP of M. mazei chaperonins 
Before in-gel trypsin digestion 150-200 µg of the large scale IPs, an equivalent volume on 
the background control or 20-50 ug of M. mazei lysate (not shown) were separated by SDS-
PAGE (4-16% BisTris-NuPage) and visualized by staining with colloidal Coomassie Brilliant 
Blue. The lanes of the MmGroEL and the MmThs IP were separated and cut as indicated. 
 
Proteins that were identified in at least two of the three independent co-IP experiments with 
the corresponding chaperonin and absent in both analyzed background controls were defined 
as substrates. In total 454 proteins from M. mazei were identified as interacting with the 
chaperonins (Table 3). Out of these chaperonin-dependent proteins 315 proteins were found to 
be associated with the group II chaperonin MmThs, 227 proteins with the group I chaperonin 
MmGroEL. Each chaperonin substrate set is composed of a fraction of specific substrate 
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proteins, which were exclusively identified in context with the corresponding chaperonin, and 
the fraction of overlapping substrate proteins, which interact with both chaperonin groups. 
Among both chaperonin substrate sets about 2/3 of the proteins are found to interact with both 
chaperonins (Table 3).  
Deviations in the number of proteins in the overlap fraction of MmThs and MmGroEL 
proteins (198 overlapping proteins in the MmThs substrate set, 153 overlapping proteins in the 
MmGroEL substrate set) are due to the evaluation of identified proteins. Several proteins from 
the MmThs overlap fraction were identified in only one of the MmGroEL samples and therefore 
not categorized as MmGroEL substrates and vice versa. 
 
Table 3: M. mazei chaperonin substrates identified from 1D-LCMS 
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IV.3.7 Overview of the Proteomic Data Set  
A total of 454 proteins were reproducibly identified as specifically associated with either of 
the chaperonins. LC-MS/MS also identified 711 of the 2546 predicted proteins in the M. mazei 
lysate.  
To define basic rules that lead to chaperonin dependence of a protein for folding, the sets 
of MmThs and MmGroEL interactors were compared with proteins in M. mazei lysate by a 
variety of criteria. The proteins were compared according to their relative abundance, which is 
indicated by the corresponding emPAI score (exponentially modified Protein Abundance Index; 
(Lasonder et al., 2002). As the emPAI score is a relative unit of a protein within one sample, the 
emPAI scores were normalized. 
The substrate sets of both chaperonins show a considerable overlap and therefore four 
different substrate sets were defined for the bioinformatic analysis: all proteins that were found 
to interact with MmThs or MmGroEL were subsumed to the MmThs substrate set or the 
MmGroEL substrate set, respectively. Additionally, to refine the differences between the two 
chaperonin groups, the specific substrate set were compared. The MmThs specific and the 
MmGroEL specific substrate set comprises of proteins that are only found on the respective 
chaperonin. 
 
Contribution of the specific substrates to the total chaperonin substrate set 
As mentioned above, the substrate sets of both chaperonins show a high degree of 
overlap. 263 (60%) of the 454 identified substrate proteins were identified as interacting with 
the group I and group II chaperonin. Among both the MmThs substrates and the MmGroEL 
substrates about 30% were specific substrates (Table 4).  
To assess the contribution the substrate specificity of each chaperonin to the protein folding 
in the cell, the abundance of specific substrates within the corresponding substrate set was 
compared. The abundance of a protein was calculated from the normalized emPAI score from 
each substrate sample. Similar to the absolute number of specific substrates among the 
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complete substrate set, specific substrates contribute ~ 30% of the total mass of the 
corresponding substrate set (Table 4).  
To rule out if this similarity is due to an average frequency of specific substrates throughout 
the total substrate set, the abundance of the distinct specific proteins was assessed (Figure 
32). Specific substrates were present at all levels of abundance of the substrate set. 
 
Table 4 : Distribution of specific and overlapping substrates of M. maze chaperonins 
 
 
 
Figure 33 : Abundance of specific substrates on the M. mazei chaperonins 
Comparison of the frequency of specific MmThs (A) and specific MmGroEL (B) to the 
complete substrate sets. Specific substrates are evenly distributed among the complete 
substrate sets. 
 
  IV-83 
 
 
 
Essentiality of Substrates. 
GroEL and GroES are generally essential in bacteria, this is also the case for TRiC in 
Eukarya and can be expected for the thermosome in Archaea (Kapatai et al., 2006). However, 
due to the lack of genetic tools to manipulate M. mazei, it can only be assumed that both 
chaperonins are essential for survival of M. mazei.  
The essentiality of GroEL/GroES in E. coli cells can be explained by its requirement for 
efficient folding of several (13) essential proteins. Due to the lack of information about 
essentiality of proteins in M. mazei all MmThs specific and MmGroEL specific substrates were 
manually checked for their potential indispensability for cell survival. First all the proteins were 
compared with essential proteins of bacteria. But, because of the limited homologies between 
many archaeal and bacterial proteins, all substrate proteins of known function were assigned to 
their pathway according to the Kyoto Encyclopedia of Genes and Genomes (KEGG, 
http://www.genome.jp/kegg/). If a protein was judged to play an irreplaceable role in a pathway 
important for cell viability, this protein was categorized as an essential protein. This way 17 
(14.5%) of the 117 MmThs specific substrates and 14 (19%) of the 74 MmGroEL specific 
substrates were classified as potentially essential (Table 5A, B).  
Two of the 14 potentially essential MmGroEL specific substrates, a PPIase (gi|20907465) 
and the suppressor protein suhB (gi|20907414), are homologous to stringent GroEL interactors 
in E.coli (Kerner et al., 2005). The interaction of both chaperonin groups with a significant 
number of essential proteins suggests that both proteins are required for cell survival, yet it can 
not be excluded that the folding of these essential proteins could be taken over by the other 
chaperonin group.  
Interestingly, two of the potentially essential proteins are of bacterial origin. These proteins, 
MutS (gi|20906191) and the ribosomal protein S6 modification protein (gi|20906929), interact 
specifically only with the bacterial group I chaperonin. Essential proteins that interact 
specifically with MmThs are exclusively of archaeal origin.  
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Table 5A: Essential Proteins among MmGroEL Specific Substrates 
 
Table 5B: Essential Proteins among MmThs Specific Substrates 
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Concentration of substrate proteins in the cytosol 
In order to asses the quantitative contribution of the chaperonins to the protein folding in 
the archaeal cell, the substrates were analysed for their relative abundance in the cytosol.  The 
abundance was calculated according to the abundance of the substrate proteins in the M. 
mazei lysate. 
 
Figure 34 : Abundance of M. mazei chaperonin substrate proteins in the cytosol 
The abundance of substrate proteins from the chaperonin interacting (A) and specifically 
interacting was assessed and analysed according to the abundance of these proteins in the 
corresponding substrate set 
 
The majority of substrates of both chaperonins are found at low expression levels between 
10 and 100 ppm in the cell (Figure 33A). MmGroEL specific substrates are present at levels 
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below 500 ppm at similar frequency as the average of the lysate proteins, the majority of 
MmThs specific substrates are expressed below 100 ppm of the soluble proteins (Figure 33B).  
More than half of each substrate set could not be identified in the cytosol fraction (Table 6). 
This might be due to a very low abundance of these proteins and underline the low abundance 
of M. mazei chaperonin substrates in the cell. On the other hand it can not be excluded that 
proteins were not found because the lysate was analysed only once and only 711 (20%) of the 
3370 annotated gene products were identified.  
 
Table 6: M. mazei chaperonin substrates - not identified in the M. mazei lysate 
 
 
Significance of structural properties for chaperonin dependence 
 Size distribution among chaperonin substrates 
The GroEL/GroES folding cage has a volume capacity of for proteins up to 60 kDa in size 
(Sakikawa et al., 1999). Such a size limitation is not expected for Ths substrates because of the 
different closing mechanism of the cavity by the helical protrusions. It is speculated that 
proteins exceeding the theoretical cavity size could eventually be accommodated in part, with 
the remaining of their sequence protruding from the cage. 
The molecular mass distribution of both the group I and the group II chaperonin substrate 
sets are shifted towards larger sizes compared to that of the total lysate proteins. The majority 
of the substrates is found at sizes below 50kDa, preferentially between 20 kDa and 30 kDa, 
consistent with the dependence on an encapsulation mechanism for folding assistance (Figure 
35A). Proteins smaller than 10 kDa are thought to fold mostly spontaneous and are rarely found 
as M. mazei chaperonin interactors. 
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Figure 35 : Size distribution among chaperonin substrates 
Size distribution of proteins interacting with MmThs or MmGroEL (A) and of specifically 
interacting substrates (B) according to their relative abundance compared with relative 
abundance in M. mazei lysate.  
 
Differences on the size of the chaperonin substrates become apparent among the specific 
substrate sets. There is no significant change in the size preference of MmGroEL specific 
substrates and the complete MmGroEL substrate set (between 10 and 40 kDa). But in contrast 
to the complete substrate set, a relevant fraction of MmThs specific substrates is found at a 
range between 60 and 80 kDa and also below 10 kDa.  Proteins above 100 kDa show no 
preferential interaction with the group II chaperonin MmThs (Figure 35B). 
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Isoelectric point distribution of substrates 
The isoelectric point (pI) is defined as the pH at which a protein carries no net electrical 
charge. In biological systems, where prevalently neutral pH values are given, a isoelectric point 
(pI) value close to pH 7 indicates that a protein is mostly uncharged. The pIs of the annotated 
genes of M. mazei were downloaded from http://www.neurogadgets.com. 
Compared to the average pI of lysate proteins, the pIs of both the substrates of group I and 
the group II chaperonin show a shift of 0.5 towards a neutral value (Figure 36). It is likely that 
the cytosolic pH of M. mazei is like in most organisms close to pH 7.0 and therefore at 
physiological conditions these proteins exhibit a lower overall net charge than an average 
cellular protein, a property that is expected to enhance the tendency of proteins to aggregate at 
non native folded states (Chiti et al., 2002).This effect is more pronounced for MmGroEL 
substrates than for MmThs substrates, especially for the MmGroEL specific substrates. 
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Figure 36 : pI distribution among M. mazei chaperonin substrates 
pI distribution of substrates interacting with M. mazei chaperonins (A) and 
MmThs/MmGroEL specific substrates (B) compared to lysate proteins. Both chaperonin 
substrate set are shifted towards neutral pI. 
 
Relative hydrophobicity of substrates 
GroEL is known to bind substrates via hydrophobic interactions. Therefore it may be 
expected that MmGroEL interacts preferentially with proteins characterized by a higher content 
of hydrophobic aminoacid side chains than average. The hydrophobicity of a protein is 
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indicated by the product proportion of hydrophobic amino acids, these being Ala, Ile, Leu, Met, 
Phe, Pro, Trp, Val of an ORF. The hydrophobicity index of M. mazei proteins were obtained 
from http://www.neurogadgets.com.  
The total of the chaperonin substrates displays no significant preference for proteins with a 
higher hydrophobicity index compared to the lysate fraction (Figure 37). However substrates, 
which interact specifically only with MmGroEL, exhibit a significantly higher hydrophobicity than 
the average lysate proteins. In contrast, proteins interacting specifically with the MmThs 
showed a reduced hydrophobicity (Figure 37B).  
 
Figure 37 : Hydrophobicity of M. mazei chaperonin substrate proteins 
Relative hydrophobicity of substrates interacting with M. mazei chaperonins (A) and 
MmThs/MmGroEL specific substrates (B) compared to lysate proteins. MmGroEL specific 
proteins show an increased hydrophobicity than MmThs (specific) substrates and lysate 
proteins.   
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Net charge of substrate proteins 
In contrast to the group I chaperonins that are supposed to bind substrates proteins via 
hydrophobic interactions, group II chaperonins are thought to bind proteins via polar 
interactions, at least in part. Analysis of the substrate binding domains of the eukaryotic group II 
chaperonin TRiC revealed that relevant positions are occupied by amino acids that are 
positively charged at physiological pH (Pappenberger et al., 2002). 
 
Figure 38 : Net Charge Distribution among M. mazei chaperonin Substrates 
Net charge distribution among substrates interacting with M. mazei chaperonins (A) and 
MmThs/MmGroELspecific substrates (B) compared to lysate proteins. A relevant fraction of 
MmThs specific substrates show high negative charge. This is not found for MmGroEL 
(specific) substrates, which are mostly uncharged.   
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Intriguingly, the comparison of the net charge distribution (obtained from 
http://www.neurogadgets.com) of MmThs specific substrates shows that a substantial fraction 
of these proteins is negatively charged under physiological pH, which is not seen for the 
average lysate proteins or GroEL interacting proteins (Figure 38B). 
 
Transmembrane domains 
Proteins that are associated with membranes usually use the so-called translocon system 
for insertion or transport through the membrane (Eichler and Duong, 2004). Neither the group I 
nor the group II chaperonin system is expected to be generally involved in these machineries. 
Though, productive interaction of GroEL with membrane proteins has been reported for some 
membrane proteins (Bochkareva et al., 1998; Goulhen et al., 2004; Gozu et al., 2002; Hanninen 
et al., 1997; Sun et al., 2005).  
Therefore it is not surprising that only a very minor fraction of M. mazei chaperonin 
substrates exhibit transmembrane domains (obtained from http://pedant.gsf.de/index.html, 
Figure 39A). Three among MmGroEL specific and two MmThs specific proteins contain  
predicted membrane-spanning domains, the role of the interaction of the chaperonins with this 
proteins will have to be further elucidated (Table 7). 
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Table 7A:  MmGroEL Substrates exhibiting Transmembrane Motifs 
 
Table 7B:  MmThs Substrates exhibiting Transmembrane Motifs 
 
Table 7C : Overlapping Substrates exhibiting Transmembrane Motifs 
 
 
Multidomain Proteins 
Because of the different closing mechanism of the group II chaperonins via the helical 
protrusion this chaperonin has been speculated to be more suited for folding of multidomain 
proteins. The closing mechanism could enable the group II chaperonin to encapsulate the 
protein domains sequentially and allow independent folding of these protein modules. However, 
analysis of the substrate sets of MmThs showed no preference for multidomain proteins 
(obtained from http://supfam.mrc-lmb.cam.ac.uk/SUPERFAMILY) (Figure 39B).  
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Figure 39 : Distribution of  Proteins  harbouring Transmembrane Domains and 
Multidomain Proteins  
Proteins exhibiting transmembrane domains are rarely found to interact with chaperonins, a 
significant number of these proteins interact with MmGroEL (A). Proteins consisting of more the 
one domain fold show no preferential binding to any M. mazei chaperonin (B). 
 
Domain fold distribution among substrates     
A recent study by Kerner et al. concluded that fold types play an important role in the 
substrate selection by the group I chaperonin in E. coli. It was shown that proteins containing 
domains with the TIM barrel are overrepresented among GroEL substrates compared to the 
total lysate proteins.  
Analysis of the domain fold distribution of M. mazei proteins that interact with the 
chaperonins (obtained from http://supfam.mrc-lmb.cam.ac.uk) gives a more differentiated 
picture of fold type preferences of the chaperonins (Figure 40).  In contrast to other organisms, 
where only one chaperonin is available, proteins have the choice between both chaperonins 
and therefore proteins of archaeal origin can also interact with the bacterial chaperonin and vice 
versa. 
 The fold-categorisation of the identified chaperonin substrates in M. mazei according to the 
SCOP data base confirmed that the TIM barrel fold represents the largest fraction of interactors 
with the bacterial group I chaperonin (12% of total GroEL interactors and 10 % if specific GroEL 
interactors according to their relative abundance). This fraction of GroEL interactors comprises 
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19 proteins of all GroEL substrates and 3 proteins of the GroEL specific substrates. A 
significant number of TIM barrel proteins (20) interact also with the Group II chaperonin, but in 
this case the TIM barrel domain proteins present only 5% of the fraction of all known folds, 
insignificantly higher than the average abundance of this fold in the lysate fraction (3%). 
In addition to the TIM barrel fold, structurally related members of c-class folds, defined as 
alpha and beta proteins (α/β) of mainly parallel beta sheets (β/α/β/ units) are of high relative 
abundance among MmGroEL (specific) substrates:  the adenine nucleotide alpha hydrolase-
like (c.26; core: 3 layers, α/β/α; parallel beta-sheet) and the UDP-glycosyltransferase/glycogen 
phosphorylase fold (c.87; two non-similar domains with 3 layers (α/β/α) each domain parallel 
beta-sheets).  
The fraction of proteins with the c.26 domain fold (8% of the total GroEL substrates and 
10% of the specific GroEL substrates by relative abundance) comprises 14 proteins of the total 
GroEL substrates and 4 proteins of the specific GroEL substrates. Again the c.26 domain fold is 
also found among MmThs substrates. The c.26 domain fold is found among 12 MmThs 
interactors and at similar frequency as among lysate proteins (4% and 1.5% among MmThs 
and MmThs specific substrates, respectively and 1.5% in the lysate). 
8 proteins and 4 proteins sharing the c.87 domain fold represent 2% of the total GroEL 
interactors and 4% of the specific GroEL interactors, respectively. Proteins with the c.87 
domain fold are underrepresented among MmThs substrates (2 proteins, 0.3% of MmThs 
substrates) and not found among MmThs specific substrates. This domain fold has also not 
been identified in the lysate fraction, suggesting a low abundance of proteins sharing this 
domain fold in the archaeal cell. 
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Figure 40 : Fold distribution of  M. mazei chaperonin substrates according to the SCOP 
database 
Domain folds of MmGroEL and MmThs substrates (A) and specific MmGroEL and MmThs 
substrates (B). Members of the c - class folds c.1, c.26 and c.87 show preferential binding to 
MmGroEL, while the c-class fold c.55 and the b-class fold b.40 accumulate on MmThs. c.1: TIM 
β/α barrel; c.2: NAD(P)-binding Rossmann-fold domains; c.26: Adenine nucleotide alpha 
hydrolase-like; c.87: UDP-Glycosyltransferase/glycogen phosphorylase; c.2; c.55: 
Ribonuclease H-like motif; b.40: OB-fold; g.41: Rubredoxin-like; d.37: CBS-domain.  
 
Intriguingly, among the folding types of MmThs substrates, members of the ribonuclease H- 
like fold, which includes the family of actin ATPase like- domain superfamily (c.55.1). 9 of the 
11 MmThs substrate proteins belonging to this fold class interact exclusively with the group II 
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chaperonin. All proteins identified in the lysate sharing this fold were also identified in complex 
with MmThs.  
In contrast to the group I chaperonin substrates members of the class-b folds (only beta) 
are also prominent members of the group II chaperonin substrates. The OB-fold (b.40, beta- 
barrel, closed or partly opened) is frequently found among MmThs substrates, but excluded 
from the MmGroEL substrates. Likewise, proteins of the nucleic-acid-binding protein- 
superfamily (b.40.4) occupy only 2% of the total MmThs capacity, but represent 7.5% of the 
mass of specific MmThs interactors. 
 
Unknown folds 
Analysis of the fold distribution in M. mazei is limited by the number of soluble proteins with 
structural information, 933 (~35%) of the 2610 predicted soluble proteins in the genome of M. 
mazei show no homology to any known domain fold.  
The abundance of proteins that show no homology to any known structure among 
MmGroEL and MmGroEL specific is found at similar levels as among the lysate fraction (20%). 
Interestingly, this fraction of proteins without any homology known structures is significantly 
increased among the MmThs substrates and highest (40%) among MmThs specific substrates 
(Figure 41). 
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Figure 41 : Distribution of unknown folds  
35% of the soluble proteins in identified in the genome M. mazei show no structural homology 
to any known domain fold, 20% of the protein mass in the lysate fulfils this criterion. Among 
MmThs, but not MmGroEL substrates this value increases two-fold. 
 
Function of substrates 
It is not expected that the function of a substrate protein could define the specificity of the 
client protein for the chaperone type as the function is not influencing the structural features of 
a protein. When the function distribution of substrate proteins were analysed according to the 
Clusters of Orthologous Groups (COGs) (obtained from The Integrated Microbial Genomes 
(IMG) system, http://img.jgi.doe.gov/cgi-bin/pub/main.cgi)  no obvious trend of M. mazei 
chaperonin substrate proteins to be involved in a specific function could be detected. 
The majority of the substrates fulfil functions that can only be defined by general prediction, 
among MmThs specific substrates most of the proteins can not be assigned to any known 
function at all. Proteins that are involved in translation are significantly reduced among M. 
mazei chaperonin substrates compared to lysate proteins (Figure 42). 
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Figure 42 : Function of M. mazei chaperonin substrates 
Aminoacid metabolism (AA), carbohydrate metabolism (CH), cell cycle control (CCC), cell 
motility (Mot), cell wall biogenesis (CW), chromatin structure (ChS), coenzyme transport and 
metabolism (CoE), defense mechanism (Def), energy production and conversion (E), function 
unknown (UF), general function prediction only (GF), inorganic ion transport and metabolism 
(II), intracellular trafficking, secretion and vesicular transport (TF), lipid transport and 
metabolism (L), nucleotide transport and metabolism (N), posttranslational modification, protein 
turnover, chaperones (Mod), replication, recombination and repair (R), rna processing and 
modification (Rna), secondary metabolites (2nd M), signal transduction (ST), transcription 
(TC), translation (TL). For most M. mazei chaperonin substrates only a general function can be 
assigned, most MmThs specific substrate can not be assigned to a known function. 
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Phylogenetic origin 
Analysis of the genome of M. mazei revealed an unusual high frequency of genes of 
bacterial origin that were acquired via horizontal gene transfer (HGT). Therefore it could have 
been expected that these originally bacterial proteins would preferentially interact with the 
group I chaperonin, which is also of bacterial origin. However, bacterial proteins occur at similar 
levels among MmGroEL substrates as among MmThs substrates (Figure 43). Interestingly, 
there seems to be a strong tendency of proteins derived from HGT to interact with chaperonins.  
In contrast to the high frequency of 30 % of bacterial proteins annotated in the genome of M. 
mazei only 5% of the lysate proteins were identified as originally bacterial proteins. This can be 
explained on the one hand by a high contribution of transposons to the fraction of bacterial 
genes on the archaeal chromosome. On the other hand the presence of a gene gives no 
information on its expression level and many bacterial genes might be not expressed under 
standard condition.  
 
Figure 43 : Phylogenetic origin of M. mazei chaperonin substrates  
Abundance of bacterial proteins in the lysate fraction and among M. mazei chaperonin 
substrates. Bacterial proteins show no preferential interaction with the bacterial chaperonin 
MmGroEL  
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Evolutionary scope  
Recently, it was shown by Cowen L.E. and Lindquist S. that the eukaryotic chaperone 
Hsp90 may influence evolution by supporting genetic variations of proteins in response to 
environmental change. There are so far no Hsp90 homologues found in Archaea and thus the 
question arose whether chaperonins could play a role in supporting evolution of proteins in the 
archaeal cell.  
The evolutionary scope value of a protein (obtained from http://www.neurogadgets.com) 
gives the mean distance between members of order Methanosarcinales, if a phylogenetic tree 
was based on the sequence of this protein.  Proteins have a low evolutionary scope that if they 
show a higher homology to proteins from Methanosarcinales than to proteins from other 
organisms. So a low evolutionary scope indicates a relatively high frequency of mutation in a 
protein. Conserved proteins have a high evolutionary scope, because they artificially elongate 
the phylogenetic distance between the species. 
When the M. mazei chaperonin substrates were analysed by their evolutionary scope, a 
significant fraction of MmThs substrates and especially MmThs specific substrates showed an 
unusually low evolutionary scope value below 0.25 compared to the average lysate proteins. 
Proteins that interact with the group I chaperonin can be expected to be highly conserved 
during evolution (Figure 44). 
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Figure 44 : Evolutionary scope of M. mazei chaperonin substrates 
Evolutionary scope of M. mazei chaperonin substrates (A) and MmThs and MmGroEL 
specific substrates (B). A low evolutionary scope indicates a recent development of the protein, 
while a highly conserved protein is indicated by a high evolutionary scope. A relevant fraction of 
MmThs (specific) substrates shows a recent development, MmGroEL interacts preferentially 
with highly conserved proteins. 
 
Because proteins of bacterial origin are found at similar frequency with both chaperonin 
groups, the evolutionary scope of these bacterial proteins was of special interest. Analysis of 
the conservation of the bacterial proteins that interact with M. mazei chaperonins revealed that 
the bacterial proteins that interact with MmGroEL show an even higher conservation than it has 
been shown for all MmGroEL substrates above (Figure 45A, C). Bacterial proteins that interact 
with MmThs are at a similar evolutionary state as the average of MmThs substrates.  Substrate 
proteins of archaeal origin show no deviation in the distribution of the value for the evolutionary 
scope from the complete substrate sets (Figure 45B, D). 
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Figure 45 : Evolutionary scope of bacterial and archaeal substrate proteins 
Substrates of M. mazei chaperonins were analysed according to their phylogenetic origin 
for their evolutionary scope. MmGroEL proteins of bacterial origin (A, C) show an unusual high 
conservation, while bacterial MmThs substrate change at similar frequency as average MmThs 
substrates and even faster that average bacterial lysate proteins. Proteins of archaeal origin (B, 
D) develop at a similar rate independent of the chaperonin dependency. 
 
Even though the evolutionary scope of Group I interacting proteins showed an overall high 
conservation of these proteins compared to all available sequences, the evolutionary distance 
of the specific substrate proteins was analysed within the members of Methanosarcinales 
separately. It would be expected that especially proteins that depend on the Group I chaperonin 
in M. mazei are more different to homologous proteins from a relative that holds no GroEL 
(Methanococcoides burtonii) than to other Methanosarcina, which also have GroEL.  
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Therefore the specific substrate proteins were blasted against the genomes of 
Methanosarcina acetivorans and M. burtonii. Proteins that interact with GroEL specifically 
showed significantly reduced similarities and identities in the aminoacid sequence to M. 
burtionii than to M. acetivorans (Figure 46). 
 
 
Figure 46 : Similarities and Identities of identified proteins to homologs in M. acetivorans 
and M. burtonii 
Aminoacid sequences of proteins identified in the lysate and in complex with chaperonins 
were compared to homologous seuqencens from other members of Methanosarcinales. 
Methanococcoides burtonii was chosen a closed relative holding no GroEL and 
Methanosarcina acetivorans as closed member possessing GroEL. Compared to lysate 
proteins, Ths interactors and overlapping substrates are GroEL specific substrates more 
distantly related to proteins from M. burtonii than to M. acetivorans.  
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IV.4 Analysis of the role of chaperonins in the network of M. mazei 
Due to a high degree of horizontal gene transfer, M. mazei handles all major players in the 
folding of newly synthesized proteins. Thus Methanosarcina is not only the prefect model to 
study differences in the substrate specificity of group I and group II chaperonins, it also offers 
the possibility to investigate the interplay with other chaperones.  
In order to analyse the connections within the chaperone network of M. mazei an substrate 
chaperone complexes of MmPfd and MmDnaK were isolated in addition to the M. mazei 
chaperonin substrate complexes (Figure 47). 
 
Figure 47 : Co-Immunoprecipitations form M. mazei lysate 
(A) Large scale co-IP of M. mazei chaperonins and interacting proteins (lane 1: 
MmGroEL/GroES and substrates, lane 2: MmThs and substrates, lane 4: MmPfd and 
substrates, lane 3, 5: MmDnaK and substrates, lane 6: control). The cells were lysed in the 
presence of Hexokinase/glucose and ADP to stabilize chaperone- substrate interactions. 
MmDnaK complexes were also precipitated from cells in presence of ATP (lane 5). The 
nucleotide had no influence on the substrate pattern of MmDnaK. 
  IV-106 
 
 
 
 
Analysis by SDS-PAGE showed a significant overlap of then protein pattern of MmPfd and 
MmDnaK. Similarities can be found between the MmPfd or MmDnaK co-precipitations and both 
M. mazei chaperonin substrate pattern. Identification of the substrate sets by mass 
spectrometry will reveal detailed insights about the interplay within the chaperone network of M. 
mazei. This model system will elucidate how chaperones are arranged for the folding of newly 
synthesized proteins in the cell. 
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V. Discussion 
In a living cell, the folding of many newly synthesized proteins is dependent on a special 
class of assisting proteins, the so-called chaperones. The specific set of chaperones, which is 
thought to be organized in a network-like manner, is one important hallmark of the three 
domains of life. Extensive work has been performed on the analysis of the bacterial chaperone 
network - especially the E. coli chaperones. Also the eukaryotic system with a main focus on S. 
cerevisiae has been investigated in detail. The archaeal folding machinery is thought to reflect a 
more ancient and therefore simpler version of the eukaryotic system. Structural analysis of 
archaeal chaperones, i.e. the Group II chaperonin thermosome, revealed details of these 
components of the archaeal as well as in the eukaryotic folding machinery.  
The major components in the de novo folding system in the cell are represented by (i) the 
ribosome associated elements like trigger factor (TF) in Bacteria and probably the nascent 
chain associated complex (NAC) in Archaea and Eukarya, (ii) the downstream operating Hsp 
70/40 system, which is found in Bacteria as well as in Eukarya; Hsp70 components identified in 
Archaea originated form horizontal gene transfer of the bacterial hsp70/40-proteins and  (iii) the 
barrel-shaped chaperonins. The major difference in the chaperone content among the domains 
of life is the presence of the Group I chaperonin-system in Bacteria and the Group II 
chaperonins in Archaea and Eukarya. 
V.1 The co-existence of Group I and Group II chaperonins  
It was extraordinarily surprising when the genes encoding for the group I chaperonin GroEL 
(MmGroEL) and its co-chaperone GroES (MmGroES) were identified in the genome sequence 
of Methanosarcina mazei - in addition to the thermosome that is usually found in Archaea. This 
frontier crossing was established in the genus Methanosarcina by horizontal gene transfer 
(HGT), probably before the formation of the different Methanosarcina species, because this 
operon is found in all members of this genus. 
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Biochemical analysis of M. mazei cells proved the actual co-existence of the complete 
group I (MmGroEL/MmGroES) and the group II chaperonin system (MmThs) at similar levels of 
~1% of total cellular protein of both chaperonins under standard growth conditions.  
Immunoblotting analysis of size fractionated lysate revealed that both proteins are present 
in their functional oligomeric state of ~ 800 -1000 kDa. Additionally, immunoprecipitations of the 
endogenous chaperonin complexes demonstrated that MmGroEL forms homo-oligomeric 
complexes and the endogenous thermosome complex of M. mazei is composed of three 
different subunits MmThsα, MmThsβ and MmThsγ. The ratio of the thermosome subunits was 
assessed by quantitative immunoblotting analysis of immunoprecipitated thermosome 
complexes to be 2:1:1 of MmThsα: MmThsβ: MmThsγ and a homogeneous population of this 
thermosome complex is expected. An independent study (L. Figueiredo, B. Haas) suggests that 
Ths complex formation is likely coordinated with transcriptional and/or translational levels in the 
cell, as spontaneous complex formation of the three subunits occurs to only a very limited 
extent in vitro. 
It might have been expected that there is a specific response of each chaperonin to 
environmental stress, but surprisingly, thermal stress lead to an 2.5 fold increase in expression 
of both MmGroEL/ES as well as MmThs. No other stress conditions were tested, but based on 
the similarity of the promoter regions it is likely that both chaperonins contribute in a similar 
manner to protein folding in the cell.  
Unfortunately, because genetic manipulations of M. mazei are not possible, it is only 
possible to speculate that both chaperonins are essential, because of their similar and high 
expression levels.  
V.2 Substrates of group I and group II chaperonins 
A similar, principal mechanism for the bacterial and the eukaryotic/archaeal chaperonins is 
proposed, but analysis of their respective substrate spectra will reveal detailed insights into 
differences between the bacterial and the eukaryotic/archaeal system.  
So far most effort for investigation of natural substrates has been focused on GroEL/ES 
client proteins in E.coli (Houry et al.,1999; Kerner et al., 2005) and a virtually complete set of 
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substrates has been identified and qualitatively analyzed by their dependency on GroEL for 
successful folding. In the case of the group II chaperonins, there are several proteins known as 
natural substrates of the eukaryotic CCT/TRiC, this compilation is still far from completeness. In 
the case of the archaeal group II chaperonin, no natural substrates are known to date 
Thus, the unique combination of both chaperonin systems in the methanosarcinal cell 
provides not only the possibility to gain a more complete picture of group II chaperonin 
substrates, but also the opportunity to analyze defining features of substrate specificity of those 
chaperonins. For several million years, substrate proteins had accessibility to both chaperonin 
systems and interactions to the optimal chaperonin may have evolved. Analysis of the substrate 
specificity in M. mazei may reveal fundamental differences in substrate selection that would 
otherwise be hidden in comparisons of substrates of group I and group II chaperonins from 
different organisms.  
The study presented here provides extensive insights into the substrates specificity of 
group I and group II substrates. 
 
V.2.1 Substrate identification techniques 
In the study, three different techniques were employed to demonstrate differences in the 
substrate specificity of Group I and Group II chaperonins. As expected the more sensitive 
technique, 1D- LCMS, resulted in a higher number of identified proteins. Thus, from the 
incongruity of the number of overlapping substrates in the MmThs substrate set (198) and the 
MmGroEL substrate set (153), the identification is not complete yet. This discrepancy is due to 
the validation of substrate proteins, which had to be identified at least twice in a sample. 68 
substrates from the MmThs overlap were identified only once in a MmGroEL sample and are 
therefore not valid MmGroEL substrates. Vice versa 17 proteins from in the MmGroEL overlap 
were identified only once in the MmThs samples. Additional mass spectrometrical analysis of 
the samples would eliminate this problem.  
Despite little information about the identity of the substrates from the 2D-PAGE techniques, 
these methods, especially the Ettan-DIGE, are more suitable for visualizing differences in the 
substrate spectra. Several proteins identified as substrates in 2D-PAGE approaches had to be 
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excluded as false positives, as they were detected in the background control sample by 1D-
LCMS. These unspecifically precipitated proteins were apparently below the detection limit of 
the 2D techniques. Although some of these proteins might actually be substrate proteins, a 
specific interaction above background level could not be demonstrated. 
The Ettan-DIGE technique represents a clear improvement of classical 2D-PAGE. Due to 
the possibility to directly compare samples the same gel, less false positive proteins were 
identified. In addition, the detection of proteins by fluorescence allows quantitative comparison 
of a given protein between the different samples.  
There is no discrepancy of the results from the 2D-PAGE techniques and the 1D-LCMS. 
 
V.2.2 Substrate sets of MmThs and MmGroEL 
Similar to E. coli (Ewalt et al., 1997) and mammalian cells (Thulasiraman et al., 1999), 
about 17% of the total cellular proteins were associated with chaperonins in M. mazei.  These 
454 proteins show different affinities for the two co-existing chaperonins. While 73 proteins 
were exclusively associated with MmGroEL, 117 proteins interact exclusively with the MmThs. 
About 263 of the identified proteins are found associated with both chaperonins, but again most 
of these show a significant preference for one of the two chaperonins.  
Thus, in the methanosarcinal cell there is a balanced cooperation between the bacterially- 
derived and the archaeally-derived folding machinery, without a strong bias towards the 
“original” archaeal chaperonin, the thermosome. The similar impact of chaperonins on folding in 
the archaeal cell can be due to a principal commutability of both chaperonin systems to a high 
degree, as 45% of the substrate proteins show a promiscuous chaperonin dependency. On the 
other hand the methanosarcinal proteome may have adapted, to some extent, to the bacterial 
chaperonin over several million years. An extensive adaptation of the client proteins to the two 
folding machineries may also be reflected in the similar distribution of the proteins from 
archaeal and bacterial origin among the substrate sets of both chaperonins. 
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V.2.3 Phylogenetic origin of the substrate proteins 
From the fact that M. mazei acquired 15-30% of its total genome by horizontal gene 
transfer (HGT), one might expect that especially these bacterially-derived proteins are the most 
likely candidates for MmGroEL substrates proteins. However, analysis of the distribution of 
bacterial proteins showed no increased fraction of these bacterial proteins among MmGroEL 
interactors compared to MmThs substrates. As mentioned above a co-evolution of the bacterial 
proteins in M. mazei with the co-existing archaeal chaperonin would erase a potential “bacterial 
protein- MmGroEL“-dependency and vice versa. This hypothesis is supported by the fact that 
the bacterial proteins, which show a strict dependency on MmGroEL, are highly conserved 
proteins, according to their evolutionary scope and a significant number of the bacterial 
proteins, which interact specifically only with the archaeal chaperonin, are fast developing 
proteins.  
In addition, the dependence of bacterial proteins on the archaeal chaperonin (MmThs) 
might be explained by HGT prior to the acquisition of MmGroEL. In this case proteins that were 
depending on a chaperonin would have had to interact with the MmThs and might have 
adapted to this interaction before the transfer of GroEL.  
Interestingly, the fraction of bacterial proteins among substrates interacting with both 
chaperonins is increased compared to the fraction of bacterial proteins in the M. mazei lysate. 
This might implement an important role of the chaperonins in maintenance of new functions 
derived from other organisms, which might then lead to an evolutionary advantage. While 
MmGroEL would be predestined to assist the folding of newly transferred bacterial components 
in the new archaeal environment; MmThs on the other hand may assist adaptation of bacterial 
proteins to the new conditions.   
Assistance in the evolution of a protein can be especially expected from the group II 
chaperonin, because 20% of the specific MmThs substrates show an unusual low evolutionary 
scope (<0.25), which means that these proteins are evolving fast. And indeed, when these 
proteins were compared to known sequences using the global BLAST program, only similarities 
to fragments of mostly eukaryotic proteins could be identified outside the family 
Methanosarcina.  
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MmGroEL on the other hand apparently favours interaction with conserved proteins. This 
becomes even clearer among the 39 bacterial chaperonin substrate proteins out of which 22 
proteins were found to interact with the Group I chaperonin. Bacterial proteins that interact 
specifically with the MmGroEL are exclusively highly conserved proteins. This role of a keeper 
of the status quo of a protein for MmGroEL might be a basic feature of the Group I chaperonins, 
because the class III substrates in the EcGroEL interactome show also a significantly higher 
conservation than the average lysate of E. coli (Figure 47). 
 
Figure 48 : Evolutionary scope of stringent GroEL substrates in E. coli 
The evolutionary scope of stringent GroEL interacting substrates (class III) is increased 
compared to the evolutionary scope of proteins in the lysate 
 
Despite the conservation of MmGroEL substrates, MmGroEL specific substrates exhibit 
significantly more frequent changes of the amino acid sequences compared to the homologues 
of GroEL lacking relatives of Methanosarcinales, such as M. burtonii. The presence of GroEL in 
Methanosarcina might have facilitated these sequence changes, but more likely the lack of 
GroEL in the relative M. burtonii might have caused the changes in the amino acid sequence at 
relevant positions to enable the cell to handle those proteins. 
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Most importantly, the substrate chaperonin interaction is probably driven mostly by physical 
features of a protein that might not be stringently reflected by the phylogenetic origin of the 
substrate protein. 
V.2.4 Structural features of substrate proteins 
The simultaneous analysis of the MmGroEL-substrate proteome along with the MmThs-
substrate proteome allows not only deducing certain features of the distinct chaperonin 
substrate proteins to de deduced and, the natural co-existence of both chaperonins sheds light 
on the specific need for group I and group II chaperonins. 
Size dependence 
A principal feature of the folding mechanism of chaperonins is the encapsulation of the 
client protein. The folding chamber formed by the seven member of the GroEL ring under the 
GroES lid provides limited space to accommodate proteins up to a size ~ 60 kDa. It has been 
shown that proteins exceeding this size can be assisted by the trans cavity (Farr et al., 2003), 
but because this mechanism is thought to be of minor impact for in vivo folding, large proteins 
are thought to interact with other chaperones like the Hsp 70/40 system. It is not clear wheter 
the size limitation is also valid for group II chaperonins. It has even speculated that due to the 
closing mechanism by the helical protrusions, proteins could be encapsulated in part, which 
would allow folding of large proteins via encapsulation. This speculation is driven by the fact 
that the group II chaperonin assists folding in the eukaryotic system and thus, has to deal with 
proteins of larger size on average. On the other hand, it has been shown by Thulasiraman et al. 
that the majority of proteins found associated with the TRiC are not exceeding the theoretical 
cavity size ~60 kDa and larger proteins preferentially interact with the eukaryotic Hsp70/40 
system (Hsc70). In addition, the majority of proteins that have been shown to interact with the 
eukaryotic TRiC are also found at a size range between 40kDa and 50 kDa (Dunn et al., 2001) . 
Most of the substrates of MmThs and MmGroEL are found at sizes between 10 kDa and 40 
kDa, clearly below the theoretical excluding volume of 60 kDa of the chaperonin cavity. 
Compared to the lysate, the average size of substrate proteins is larger. Surprisingly a 
substantial number of proteins smaller than 10 kDa are found among the MmThs specific 
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substrates, proteins of such low sizes would be expected to fold spontaneously. Unexpectedly, 
a significant number of MmThs specific substrates have masses between 60 kDa and 80 kDa, 
which exceeds the theoretical size limit of the cage. It has been shown previously that the 
eukaryotic group II chaperonin TRiC is able to assist folding of proteins in this size 
range(Frydman et al., 1992). These proteins would also be too large to fit the folding cavity, 
suggesting the same dimensions of the group II and the group I chaperonins. This up-shift of 
the size limit for substrates to 80 kDa raises the question of whether the specific closing 
mechanism might rather contribute to an enlargement of the cage volume, than to an “infinite” 
capapcity by the domain-wise folding theory. Proposing a closing mechanism, which is similar 
to an optical aperture, the volume of the chamber volume might be regulated to some extend. 
However, the flexibility to encapsulate proteins only in part can not be confirmed from this 
study. Very large proteins (>100 kDa) and also multi-domain proteins show no preferential 
interaction with MmThs, which would be expected if a partial encapsulation was possible. 
Similarly to the situation among class III EcGroEL substrates, the size distribution pattern of 
MmGroEL interactors differs significantly from the size distribution of proteins in the lysate and 
shows a broad maximum ~10-20 kDa above the sharp maximum peak maximum of the size 
distribution of lysate proteins.  In contrast, the size distribution pattern of MmThs reflects in 
principle the pattern of the size distribution in the lysate. 
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Figure 49 : Size distribution of Chaperonin substrates and EcGroEL class III substrates 
Proteins between 30 kDa and 50 kDa are about two fold more abundant on the group I 
chaperonins compared to lysate. Group II interacting proteins show deviation at the range 
between 60kDa-80 kDa from the average size of lysate proteins. 
 
Hydrophobicity of substrate proteins 
In contrast to other chaperones like Hsp 70, which is thought to recognize sequence motifs 
of client proteins, the interaction of chaperonins is probably driven by more global structural 
features of the substrate. The group I chaperonins are expected to bind hydrophobic surfaces 
via hydrophobic residues in the apical domain (Fenton and Horwich, 2003). Though, the 
hydrophobicity is not significantly stronger among MmGroEL substrates compared to MmThs 
substrates and lysate proteins. MmGroEL specific substrates however, show a significant shift 
to higher hydrophobicity, which is not the case for group II specific substrates. This is also 
supported by an overall pI up-shift of 0.5 units of MmGroEL substrates towards a neutral pH 
and an overall net charge distribution around 0. Also the binding of MmGroEL to some proteins 
harbouring trans-membrane domains might be driven by these hydrophobic interactions. GroEL 
is not expected to play a major role in the folding of trans-membrane proteins, but a principle 
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possibility of GroEL to interact with transmembrane proteins was shown in vitro (Sun et al., 
2005), however, the role of GroEL in maturation of membrane proteins in vivo requires further 
investigation.  
 
Net charge of substrate proteins 
Unlike GroEL positively charged amino acids are frequently found at relevant positions of 
the substrate binding domain of the group II TRiC (Pappenberger et al., 2002). These positively 
charged amino acids are thought to contribute to the interaction of group II chaperonins and 
substrates. Analysis of both substrate sets identified no preference of both chaperonins for 
charged proteins. Analysis of the specific interacting proteins though, revealed a high frequency 
of negative charges among only the MmThs specific substrates. The overrepresentation of 
negatively charged amino acid side chains among MmThs specific interactors might explain 
their preferential binding to the group II chaperonin. 
 
Structural determinants for chaperonin interaction 
Domain fold 
It has been shown that the domain fold play a major role in substrate selection by GroEL in 
E. coli and also the analysis of the domain fold distribution according to the SCOP database 
revealed a clear impact of the domain fold on the substrate spectra of the group I and the group 
II chaperonins (Figure 48). 
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Figure 50 : Representative structure images of domain folds of chaperonin substrates 
(A) A significant number of substrate proteins of the group I chaperonin exhibit c-class 
domain folds (mainly α/β folds). The most abundant are the TIM β/α barrel fold (c.1;parallel 
beta-sheet barrel), Adenine nucleotide alpha hydrolase-like (c.26; core : 3 layers, a/b/a; parallel 
beta sheet) and UDP-Glycosyltransferase/glycogen phosphorylase fold (c.87; 3 layers, a/b/a; 
parallel beta sheet of 6 strands). (B) Proteins with the ribonuclease H- like motif (c.55; a/b/a; 
mixed beta-sheet) and the OB-fold domain of mainly beta sheets (class b) show a strong 
dependency on the group II chaperonin for folding assistance. 
  
In M. mazei several members of the c-class fold, mainly α/β folds, showed a significantly 
increased interaction with MmGroEL. Most prevalent among these MmGroEL dependent c-
class folds (mainly α/β folds) was the TIM β/α barrel (c.1) fold- consistent with the study on the 
EcGroEL interaction proteome. Some representatives of this fold that were identified in the 
lysate were not found to interact with a chaperonin. This makes it unlikely that the TIM β/α 
barrel fold is a sufficient criterion to determine interaction of a protein with MmGroEL. The c.1 
fold is classified into a several superfamilies, and the most prominent superfamily found among 
MmGroEL interactors is the ribulose-phoshate binding barrel (c.1.2) superfamily  (6.0% of 
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MmGroEL-, 2.4% of MmThs substrates, 1% in lysate); only one protein sharing the c.1.2. 
superfamily domain fold was identified in the lysate but not found among the MmGroEL 
interactors.  
All members of the c-class fold adenine nucleotide alpha hydrolase-like (c.26) that were 
found in the lysate were also identified on MmGroEL, some were also found to interact with the 
group II chaperonin. Substrates sharing the c.26 domain fold are mainly represented by two 
superfamilies:  the nucleotidylyl transferase (c.26.1) superfamily and the adenine nucleotide 
alpha hydrolases-like (c.26.2) superfamily. No correlation of the c.26 fold or its superfamilies 
with any other structural features (i.e. net charge, hydrophobicity, molecular weight) could be 
detected that could determine interaction with MmGroEL. Depending on the individual protein, 
overlapping substrates sharing the c.26 domain fold show preference for either of the two 
chaperonins.   
The third c-class domain fold, which is frequently found with MmGroEL, is categorized as 
the UDP-glycosyltransferase/glycogen phosphorylase fold. This fold is represented by only one 
superfamily in M. mazei: the UDP-Glycosyltransferase/glycogen phosphorylase (c.87.1) 
superfamily. Proteins sharing this domain fold might be of a low abundance in the lysate, 
because they could only be detected among MmGroEL/substrate complexes and not in the 
lysate. Two proteins with this fold domain were also identified on MmThs. These proteins 
(gi|0905621 and gi|20906666) were found at lower abundance on MmThs compared to 
MmGroEL. Interestingly these proteins are negatively charged (-2.8168 and -0.5864) and have 
a low hydrophobicity index (0.4085 and 0.39) compared to strict MmGroEL interactors (0.43 at 
average), such features are typically found among MmThs (specific) substrates. 
The most prominent domain fold found to interact with MmThs exhibits the Ribonuclease H-
like motif (c.55).  With the exception of two proteins, all members of this fold class that were 
identified in the lysate interact with MmThs:  (i) the archaeal “conserved protein” (gi|20905336) 
was detected only in one of the MmThs substrate samples and was therefore not categorized 
as MmThs substrate and (ii) the DNA mismatch repair protein mutS (gi|20906191), which is a 
highly conserved protein (evolutionary scope of 0.77) and interacts specifically with MmGroEL. 
Interestingly, all but one of the c.55 MmThs substrates are negatively charged, which should 
promote their binding to MmThs. The most prominent superfamily found is the Actin-like 
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ATPase domain (c.55.1) superfamily (9 of the 13 substrates) and these proteins exclusively 
interact with the group II chaperonin, consistent with actin being an obligate substrate of the 
eukaryotic group II chaperonin TRiC. Surprisingly, 10 of the MmThs interacting proteins sharing 
the c.55 fold are of bacterial origin, but do not show a high conservation with evolutionary scope 
values below 0.75 - typically for bacterial proteins that interact with the archaeal chaperonin. 
Additionally 4 of these 6 bacterial proteins exhibit a size between 62 kDa and 74 kDa that is not 
favoured by the MmGroEL interactors, but more frequently found among MmThs (specific) 
substrates.  
MmThs substrates also include members of the b-class domain folds, such as the OB-fold 
(b.40). Most proteins of M. mazei exhibiting the b.40 domain fold are found among the 
superfamily of nucleic acid-binding proteins (b.40.4) and interact strictly with MmThs, with the 
exception of the Lysyl-tRNA synthetase2 (gi|20906448). This protein is highly conserved 
(evolutionary scope: 0.77) and the only OB fold protein in M. mazei of bacterial origin. Only one 
proteinwith the b.40 domain fold that was identified in the lysate, the inorganic pyrophophatase 
(gi| 20905923), which shows no association with any chaperonin. This has a fold of the 
superfamily inorganic pyrophophatases (b.40.5). Interestingly, proteins sharing the OB fold are 
strongly charged, but in contrast to the finding above, that suggests a preferential interaction of 
MmThs with negatively charged proteins, 4 of the 10 proteins are positively charged.  
 
Unknown folds 
The structural analysis is based on a limited number of the substrate proteins, as structural 
data about 30% of the total soluble proteome is still missing. Interestingly comparison of the 
abundance of these unknown folds between the lysate fraction and the substrate sets revealed 
a strong bias to unknown folds among MmThs specific substrates. Proteins of unknown folds 
are found twice as often in the MmThs substrate set as in the lysate or in the MmGroEL 
substrate set. This imbalance might have established because of technical problems in protein 
preparation for crystallisation. For purification, proteins are routinely over-expressed in bacterial 
cells and thus the overproduction of protein with a strong dependence on group II chaperonins 
would be doomed to fail in the bacterial host. This problem is less pronounced for MmGroEL 
dependent proteins, as GroEL/ES is available at least to a limited extent or it might even be co-
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overexpressed. In addition, the large scale crystallisation attempts using both E. coli as well as 
S. cerevisiae for high through-put purification of proteins might be again limited by the 
availability of the group II chaperonin in the yeast system (0.3 µM). 
This limited accessibility for proteins that depend on the assistance of a group II chaperonin 
by heterologous expression might also be a major cause for the substantial fraction of proteins 
among the MmThs substrates that can not be assigned to any known function. The inability to 
produce these proteins efficiently in the bacterial host is a major problem in studying the 
function of these proteins.  Apart from this technically caused correlation, the function of a 
protein seems to have no direct influence on its chaperonin requirement. 
 
Essentiality of the chaperonin substrates 
Chaperonins are the only chaperones that are known to be essential for the cell under all 
conditions. But because of the lack of tools to genetically manipulate M. mazei, it can only be 
speculated whether both chaperonins are essential in the archaeal cell. The similar expression 
level of both chaperonins under stress and non-stress conditions in the cell along with the 
significant number of potentially essential proteins that interact specifically with only one of the 
chaperonins suggests that both chaperonins are indispensable for viability of archaeal cell.  
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Importance of the study in M. mazei 
Identification of the substrates of the thermosome from M. mazei revealed for the first time 
a comprehensive picture of the substrate selectivity of group II chaperonins. But even more 
importantly,  many differences in the substrate specificity of Group I and Group II chaperonins, 
based on features such as hydrophobicity or net charge of the substrate, became apparent. 
Our results emphazise the importance of performing such a study in an organism, where both 
chaperonin groups co-exist. Comparison of isolated substrate sets from different organisms, i.e. 
the interaction proteome of EcGroEL and a group II chaperonin interactome - if there will be 
one available in the future- probably would not provide insights into the differences in substrate 
specificity of the two chaperonins systems.  
The study revealed that the affinity of proteins for either chaperonin is influenced by a 
combination of structural and physical properties, such as the domain fold, net charge, 
hydrophobicity and size. In addition, the chaperonin interaction is influenced by the evolutionary 
state of the substrate and, to some extent, by the phylogenetic origin of a protein - or rather the 
chaperonin interaction might influence the evolutionary state of the substrate protein. As an 
example, the protein MutS (gi|20906191) shares the c.55 domain fold with many MmThs 
substrates and might therefore be expected to bind preferentially to MmThs. The net charge of -
2.11 and a relative hydrophobicity of 4.11 should not influence the chaperonin selection. 
However, the combination of high conservation (evolutionary scope >0.75) and bacterial origin 
makes this protein a likely candidate for interaction with the Group I chaperonin. The size of 
100 kDa should enforce this tendency. In agreement with these predictions, MutS is one of only 
two proteins with a c.55 fold domain that interacts with MmGroEL. 
For future studies: the chaperone system of M. mazei provides all major components of de 
novo protein folding of the three domains of life, and this makes M. mazei an attractive model 
for investigation of possible chaperone networks (Figure 51).  
  V-122 
 
 
 
 
Figure 51 : Chaperonin system of Methanosarcina 
Main components of the machinery for folding of newly synthesized proteins. The 
monomeric Prefoldin and DnaK (together with its co-chaperone DnaJ and the nucleotide 
exchange factor GrpE) welcome the newly synthesized polypeptide and assist for folding or 
hand the non native protein over to the further downstream acting chaperonins GroEL/ES or 
Ths 
 
Interestingly, initial pull down experiments of the MmGimC and MmDnaK substrate 
complexes along with the chaperonin substrate complexes also revealed an interaction of 
MmDnaK and MmGimC. The Identification of the client proteins of MmDnaK and MmGimC will 
likely elucidate the basis of the interaction of these chaperones.  
In addition, comparison of substrate set of all M. mazei chaperones will elucidate the flux of 
proteins though the chaperone network. 
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VII. Appenices 
VII.1 Supplementary Figures 
Figure S1: GroEL- overlapping substrates, 2D-PAGE, silverstained 
 
Proteins from the MmGroEL/GroES immunoprecipitation were focused to their isoelectric point at 
a range between pH3 and pH10 and then separated by 16%- SDS PAGE. Proteins were detected by 
silver staining and spots were picked by visual inspection. Proteins that were identified by mass 
spectrometry in MmGroEL immunoprecipitations and MmThs immunoprecipitations are with pink 
arrows and labelled with the corresponding gi-accession number; these proteins are listed in table S1. 
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Figure S2: GroEL- specific substrates, 2D-PAGE, silverstained 
 
 
Proteins from the MmGroEL/GroES immunoprecipitation were focused to their isoelectric point at 
a range between pH3 and pH10 and then separated by 16%- SDS PAGE. Proteins were detected by 
silver staining and spots were picked by visual inspection. Proteins that were identified by mass 
spectrometry only in MmGroEL immunoprecipitations are with orange arrows and labelled with the 
corresponding gi-accession number; these proteins are listed in table S2. 
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Figure S3: Ths- overlapping substrates, 2D-PAGE, silverstained 
 
 
Proteins from the MmThs immunoprecipitation were focused to their isoelectric point at a range 
between pH3 and pH10 and then separated by 16%- SDS PAGE. Proteins were detected by silver 
staining and spots were picked by visual inspection. Proteins that were identified by mass 
spectrometry in MmGroEL immunoprecipitations and MmThs immunoprecipitations are with pink 
arrows and labelled with the corresponding gi-accession number; these proteins are listed in table S3. 
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Figure S4: Ths- specific substrates, 2D-PAGE, silverstained 
 
 
Proteins from the MmThs immunoprecipitation were focused to their isoelectric point at a range 
between pH3 and pH10 and then separated by 16%- SDS PAGE. Proteins were detected by silver 
staining and spots were picked by visual inspection. Proteins that were identified by mass 
spectrometry only in MmThs immunoprecipitations are marked with turquoise arrows and labelled with 
the corresponding gi-accession number; these proteins are listed in table S4. 
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Figure S5: GroEL- overlapping substrates, Ettan-DIGE 
 
 
MmGroEL/GroES substrate complexes were labelled with Cy3 and mixed with of MmThs 
substrate complexes labelled with Cy5 and the control sample labelled with Cy2. The sample was 
separated on 2D-PAGE and visualized by fluorescence on a Typhoon reader and intensities were 
overlaid for direct comparison. Proteins spots showing a more than 2.5 fold stronger signal in the 
MmGroEL IP compared to the MmThs IP were marked with red arrows, proteins with similar singal 
intensities from both co-IPs, but a 2.5 fold higher intensity than in the lysate sample are marked with 
lilac arrows. Proteins that were identified by mass spectrometry as overlapping substrates are labelled 
with the corresponding gi-accession number; these proteins are listed in table S5. 
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Figure S6: GroEL- specific substrates, Ettan-DIGE 
 
 
 
MmGroEL/GroES substrate complexes were labelled with Cy3 and mixed with of MmThs 
substrate complexes labelled with Cy5 and the control sample labelled with Cy2. The sample was 
separated on 2D-PAGE and visualized by fluorescence on a Typhoon reader and intensities were 
overlaid for direct comparison. Proteins spots showing a more than 2.5 fold stronger signal in the 
MmGroEL IP compared to the MmThs IP were marked with red arrows, proteins with similar singal 
intensities from both co-IPs, but a 2.5 fold higher intensity than in the lysate sample are marked with 
lilac arrows. Proteins that were identified by mass spectrometry as MmGroEL specific substrates are 
labelled with the corresponding gi-accession number; these proteins are listed in table S6.  
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Figure S7: Ths- overlapping substrates, Ettan-DIGE 
 
 
 
MmThs substrate complexes were labelled with Cy5 and mixed with of Mm GroEL/GroES 
substrate complexes labelled with Cy3 and the control sample labelled with Cy2. The sample was 
separated on 2D-PAGE and visualized by fluorescence on a Typhoon reader and intensities were 
overlaid for direct comparison. Proteins spots showing a more than 2.5 fold stronger signal in the 
MmThs IP compared to the MmGroEL IP were marked with turquois arrows, proteins with similar 
singal intensities in both co-IPs, but a 2.5 fold higher intensity than in the lysate sample are marked 
with lilac arrows. Proteins that were identified by mass spectrometry as overlapping substrates are 
labelled with the corresponding gi-accession number; these proteins are listed in table S7.  
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Figure S8: Ths- specific substrates, Ettan-DIGE 
 
 
 
MmThs substrate complexes were labelled with Cy5 and mixed with of Mm GroEL/GroES 
substrate complexes labelled with Cy3 and the control sample labelled with Cy2. The sample was 
separated on 2D-PAGE and visualized by fluorescence on a Typhoon reader and intensities were 
overlaid for direct comparison. Proteins spots showing a more than 2.5 fold stronger signal in the 
MmThs IP compared to the MmGroEL IP were marked with turquois arrows, proteins with similar 
singal intensities in both co-IPs, but a 2.5 fold higher intensity than in the lysate sample are marked 
with lilac arrows. Proteins that were identified by mass spectrometry as MmThs specific substrates 
labelled with the corresponding gi-accession number; these proteins are listed in table S8. 
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VII.2 Supplementary Tables 
Table S1: GroEL overlapping substrates, 2D-PAGE, silverstained 
gi|number name pI MW hydrophobicity net  charge 
20904460 Universal stress protein 5.33 16447 0.451 -1.9607 
20904462 Universal stress protein 5.41 16296 0.4527 -2.0269 
20905054 Mannose-6-phosphate isomerase (EC5.3.1.8)(EC2.7.7.22) 4.99 48988 0.4092 -4.1378 
20905160 conserved protein  6.58 28653 0.3961 -0.3921 
20905196 metallo cofactor biosynthesis protein  5.66 44810 0.4502 -1.7412 
20905439 Cell division protein 4.61 39359 0.4251 -4.278 
20905557 Hypothetical UPF0264 protein MM1114 4.73 24942 0.4658 -2.9914 
20905668 Aspartate carbamoyltransferase EC 2.1.3.2 Aspartate transcarbamyl 6.3 35096 0.4434 -0.9708 
20905750 Hypothetical protein MM1286 EC 3.1.2.6 5.58 23223 0.3944 -2.8168 
20905817 Fe-S oxidoreductase 7.53 41968 0.411 0.274 
20906018 Citrate synthase EC 4.1.3.7 5.33 40216 0.4394 -2.5351 
20906126 Conserved protein 5.73 36119 0.426 -0.9062 
20906153 Conserved protein 5.05 30806 0.4297 -3.0417 
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gi|number name pI MW hydrophobicity net  charge 
20906215 Imidazole glycerol phosphate synthase subunit hisF EC 4.1.3.- IGP 4.54 29691 0.4212 -5.4944 
20906617 IronIII dicitrate transport ATP-binding protein 5.8 29715 0.4684 -1.8586 
20906712 Cytidylate kinase EC 2.7.4.14 CK Cytidine monophosphate kinase CM 5.73 20587 0.392 -1.1363 
20907024 Glutamine amidotransferase subunit pdxT EC 2.6.-.- Glutamine amid 5.35 21425 0.4778 -2.463 
20907313 Hypothetical protein MM2693 7.06 40291 0.3846 0 
20907976 Transcriptional regulator 5.68 42892 0.4354 -2.1107 
20908029 Conserved protein EC 1.3.-.- 5.41 54567 0.4215 -2.2726 
 
Table S2: GroEL specific substrates, 2D-PAGE, silverstained 
gi|number Name pI MW hydrophobicity net  charge 
20905108 Hypothetical UPF0284 protein MM0708 5.34 37006 0.467 -2.0056 
20905169 Conserved protein 7.81 15867 0.4338 0 
20905556 Phosphoribosylformimino-5-aminoimidazole carboxamide ribotide iso 5.63 26068 0.4667 -1.2499 
20905756 Archaeosine tRNA-ribosyltransferase EC 2.4.2.- 6.63 69097 0.4222 -0.3209 
20905974 Methyltransferase EC 2.1.1.- 5.94 43319 0.4567 -0.7873 
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gi|number Name pI MW hydrophobicity net  charge 
20906195 ron-sulfur binding reductase 5.53 42148 0.3796 -1.3088 
20906942 Conserved protein 5.31 25144 0.4444 -3.111 
20907091 FO synthase subunit 1 EC 2.5.1.-  4.94 38308 0.4364 -3.1791 
20907465 Peptidyl-prolyl cis-trans isomerase EC 5.2.1.8 6.08 17083 0.4129 -1.2902 
 
Table S3: Ths overlapping substrates, 2D-PAGE, silverstained 
gi|number name pI MW hydrophobicity net charge 
20905096 Cell division protein 4.96 42234 0.4184 -2.806 
20905196 Metallocofactor biosynthesis protein 5.66 44810 0.4502 -1.7412 
20905224 Probable peroxiredoxin (EC 1.11.1.15) 7.09 24946 0.4566 0 
20905338 Conserved protein 6.36 34476 0.4502 -0.9645 
20905345 Agmatinase (EC 3.5.3.11) 4.31 32335 0.4467 -7.56 
20905543 Archaeosine tRNA-ribosyltransferase (EC 2.4.2.-) 6.06 55032 0.4367 -1.2244 
20905557 Hypothetical UPF0264 protein MM1114 4.73 24942 0.4658 -2.9914 
20905588 Glycosyltransferase (EC 2.4.1.-) 6.89 35654 0.3698 -0.3214 
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gi|number name pI MW hydrophobicity net charge 
20905621 UDP-N-acetylglucosamine 2-epimerase (EC 5.1.3.14) 5.3 39514 0.4085 -2.8168 
20905899 Small heat shock protein 4.82 17814 0.3856 -3.9215 
20906018 Citrate synthase (EC 4.1.3.7) 5.33 40216 0.4394 -2.5351 
20906153 Conserved protein 5.05 30806 0.4297 -3.0417 
20906505 Hypothetical protein MM1967 6.62 28659 0.4217 -0.4015 
20906617 Iron(III) dicitrate transport ATP-binding protein 5.8 29715 0.4684 -1.8586 
20906733 
F420-nonreducing hydrogenase II (Hydrogenase expression/formation 
protein) 4.7 17385 0.4845 -4.9688 
20906978 Long-chain-fatty-acid--CoA ligase (EC 6.2.1.3) 5.78 61380 0.4257 -2.0182 
20907313 Hypothetical protein MM2693 7.06 40291 0.3846 0 
20907452 Anthranilate synthase, component II (EC 4.1.3.27) 6.35 24072 0.4326 -0.9301 
20907455 Anthranilate phosphoribosyltransferase (EC 2.4.2.18) 8.2 39203 0.4405 0.5405 
20907976 Transcriptional regulator 5.68 42892 0.4354 -2.1107 
20908029 conserved protein  5.41 54567 0.4215 -2.2726 
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Table S4: Ths specific substrates, 2D-PAGE, silverstained 
gi|number Name pI MW hydrophobicity net charge 
20904599 Serine-pyruvate aminotransferase (EC 2.6.1.51) 6.14 42359 0.455 -0.7711 
20904643 Conserved protein 6.55 24843 0.4352 -0.4629 
20904948 Hypothetical protein MM0563 6.01 33339 0.3746 -1.0308 
20905154 Dihydropyrimidinase (EC 3.5.2.2) 6.25 69827 0.4408 -1.0902 
20905271 Conserved protein 7.18 45552 0.4706 0 
20905396 Coenzyme F420 hydrogenase beta subunit (EC 1.12.99.1) 7.31 37194 0.4215 0.2907 
20905482 GTP-binding protein 6.64 40758 0.3901 -0.5494 
20905704 conserved protein  4.93 45077 0.4331 -2.9196 
20905833 ABC transporter, ATP-binding protein 6.64 29748 0.4144 -0.3801 
20905897 Aspartate kinase (EC 2.7.2.4) 6.36 51914 0.4447 -0.835 
20905956 Tryptophanyl-tRNA synthetase (EC 6.1.1.2) (TrpRS) 5.71 55728 0.4121 -2.0201 
20906060 
Molybdenum formylmethanofuran dehydrogenase subunit (EC  
1.2.99.5) 5.92 65094 0.4007 -1.8835 
20906340 Conserved protein 5.16 31647 0.4296 -3.78 
20906844 DNA-directed RNA polymerase beta chain (EC 2.7.7.6) 5.6 67023 0.4023 -2.6489 
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gi|number name pI MW hydrophobicity net charge 
20907005 Type II DNA topoisomerase VI, subunit B  6.26 68760 0.4477 -0.9661 
20907008 DNA gyrase, subunit B  5.76 71068 0.3864 -1.7349 
20907381 conserved protein  8.12 83634 0.3796 0.5442 
20907564 Oxidoreductase 6.44 45114 0.3945 -0.5024 
 
Table S5: GroEL substrates, DIGE 
gi number name pI MW hydrophobicity net charge 
20905108 Hypothetical UPF0284 protein   MM0708 5.34 37006 0.467 -2.0056 
20905395 Glutamate synthase, large chain (EC.1.4.1.13) 6.43 26637 0.4211 -0.8096 
20905425 Precorrin-3B C17-methyltransferase (EC 2.1.1.131) 4.9 29087 0.4377 -2.6414 
20905439 Cell division protein 4.61 39359 0.4251 -4.278 
20905556 Phosphoribosylformimino-5-aminoimidazole       carboxamide ribotide iso 5.63 26068 0.4667 -1.2499 
20905771 Conserved protein 7.58 29025 0.433 0 
20906126 Conserved protein 5.73 36119 0.426 -0.9062 
20906195 Iron-sulfur binding reductase 5.53 42148 0.3796 -1.3088 
20906605 Putative nucleotidyltransferase (EC 2.7.7.-) 5.38 22360 0.4433 -0.9851 
20906942 Conserved protein 5.31 25144 0.4444 -3.111 
20906945 Shikimate kinase (EC 2.7.1.71)    4.94 30952 0.4437 -2.389 
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Table S6: Ths substrates, DIGE 
gi number name pI MW hydrophobicity net charge 
20904599 Serine-pyruvate aminotransferase (EC 2.6.1.51) 6.14 42359 0.455 -0.7711 
20904738 MoxR-like ATPase 5.24 36517 0.4321 -1.8518 
20905065 Acetolactate synthase large subunit (EC  4.1.3.18) 5.67 61858 0.4415 -1.7729 
20905287 Hypothetical UPF0219 protein   MM0871 5.39 37070 0.4441 -1.7191 
20905603 NDP-N-acetyl-D-galactosaminuronic acid  dehydrogenase (EC 1.1.1.-) 6.13 51826 0.4414 -0.8367 
20906018 Citrate synthase (EC 4.1.3.7) 5.33 40216 0.4394 -2.5351 
20906287 Pyruvate, phosphate dikinase (EC 2.7.9.1) 5.27 97107 0.4389 -2.0361 
20906757 DNA double-strand break repair rad50   ATPase 5.23 121981 0.3701 -2.5233 
20907177 methyltransferase  4.73 45591 0.4216 -4.4117 
 
Table S7: overlapping substrates, DIGE 
 
gi number name pI MW hydrophobicity net charge 
20906121 Divalent cation transport   protein 5.24 41395 0.4075 -2.4128 
20906505 Hypothetical protein MM1967 6.62 28659 0.4217 -0.4015 
20907313 Hypothetical protein MM2693 7.06 40291 0.3846 0 
20908039 Hypothetical protein MM3340 4.46 31481 0.461 -6.4406 
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Table S8: GroEL substrates, 1D-LCMS, proteins are sorted according to their relative abundance on MmGroEL, specific substrates are indicated with bold 
and italic gi|accession numbers 
gi number name genname function Phylogeny 
evolutionary 
scope hydrophobicity 
net 
charge pI MW scop code on EL 
20905556 
Phosphoribosylformimino-5-
aminoimidazole carboxamide 
ribotide isomerase (EC 5.3.1.16).     A 0.753229 0.4667 -1.2499 5.63 26068 c.1 2.62% 
20907313 Hypothetical protein MM2693.     A 0.641863 0.3846 0 7.06 40291 x 2.54% 
20906942 Conserved protein.     A 0.702047 0.4444 -3.111 5.31 25144 c.26 2.21% 
20905395 
Glutamate synthase, large chain 
(EC 1.4.1.13).     A 0.718357 0.4211 -0.8096 6.43 26637 b.80 1.77% 
20906605 
Putative nucleotidyltransferase (EC 
2.7.7.-).     A 0.701416 0.4433 -0.9851 5.38 22360 c.68 1.74% 
20906287 
Pyruvate, phosphate dikinase (EC 
2.7.9.1).     A 0.769966 0.4389 -2.0361 5.27 97107 
d.142. c.1. 
c.8 1.57% 
20906191 DNA mismatch repair protein mutS. MUTS   B 0.77053 0.4111 -2.111 5.37 100504 c.55 1.56% 
20906617 
Iron(III) dicitrate transport ATP-
binding protein.     A 0.770927 0.4684 -1.8586 5.8 29715 c.37 1.49% 
20905557 
Hypothetical UPF0264 protein 
MM1114.     A 0.627721 0.4658 -2.9914 4.73 24942 c.1 1.43% 
20904462 Universal stress protein.   
Signal transduction 
mechanisms genes A 0.763365 0.4527 -2.0269 5.41 16296 c.26 1.37% 
20906153 Conserved protein.     A 0.479189 0.4297 -3.0417 5.05 30806 a.4 1.28% 
20906505 Hypothetical protein MM1967.     A 0.667214 0.4217 -0.4015 6.62 28659 c.55 1.25% 
20905174 Glycosyltransferase (EC 2.4.1.-).     B 0.780968 0.4019 1.9293 8.94 36580 x 1.18% 
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gi number name genname function Phylogeny 
evolutionary 
scope hydrophobicity 
net 
charge pI MW scop code on EL 
20905898 
2,3-bisphosphoglycerate-
independent phosphoglycerate 
mutase (EC 5.4.2.1) 
(Phosphoglyceromutase) (BPG-
independent PGAM) (aPGAM). APGM   A 0.722395 0.4423 -3.8461 5.01 43175 c.76 1.10% 
20907980 Conserved protein     A 0.753149 0.4615 -2.0512 4.97 21622 b.45 1.03% 
20905318 Conserved protein.   
Transcription 
genes A 0.479189 0.4368 -1.5325 6 30471 a.4 1.03% 
20905439 Cell division protein. FTSZ   A 0.769563 0.4251 -4.278 4.61 39359 c.32. d.79 0.99% 
20906036 
Tetrahydromethanopterin S-
methyltransferase subunit B (EC 
2.1.1.86) (N5-
methyltetrahydromethanopterin--
coenzyme M methyltransferase 
subunit B). MTRB   A 0.501014 0.4722 -3.7036 4.38 11741 x 0.98% 
20905160 Conserved protein.   
Posttranslational 
modification, 
protein turnover, 
chaperones genes A 0.759662 0.3961 -0.3921 6.58 28653 x 0.97% 
20905992 
1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylidenea
mino] imidazole-4-carboxamide 
isomerase (EC 5.3.1.16)  HISA   A 0.7643 0.4553 -3.6584 4.67 25713 c.1 0.94% 
20904675 
Valyl-tRNA synthetase (EC 
6.1.1.9).   Translation genes A 0.770927 0.4304 -3.1069 5.05 99130 
b.51. c.26. 
a.27 0.94% 
20905108 
Hypothetical UPF0284 protein 
MM0708.   
Coenzyme 
transport and 
metabolism genes A 0.703438 0.467 -2.0056 5.34 37006 c.39 0.93% 
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gi number name genname function Phylogeny 
evolutionary 
scope hydrophobicity 
net 
charge pI MW scop code on EL 
20907454 
N-(5'-phosphoribosyl)anthranilate 
isomerase 1 (EC 5.3.1.24) (PRAI 
1). TRPF1   A 0.763212 0.4658 -2.564 5.01 25506 c.1 0.90% 
20905094 
Beta-phosphoglucomutase (EC 
5.4.2.6).   
General function 
prediction only 
genes A 0.769139 0.4912 -4.4247 4.71 25436 c.108 0.89% 
20904821 Cell division control protein.   
Posttranslational 
modification, 
protein turnover, 
chaperones genes A 0.770927 0.4432 -3.7878 4.9 88391 
c.37. c.37. 
d.31. b.52 0.88% 
20907691 
Lactoylglutathione lyase (EC 
4.4.1.5).     A 0.774758 0.4538 -0.7691 6.62 14796 d.32 0.86% 
20907267 Hypothetical protein MM2652.     B 0.501014 0.4968 -1.2902 5.28 16940 x 0.81% 
20904852 
Putative inosine-5'-monophosphate 
dehydrogenase (EC 1.1.1.205).   
General function 
prediction only 
genes A 0.756163 0.4675 -4.7336 4.73 18926 d.37. d.37 0.79% 
20905629 Glycosyltransferase (EC 2.4.1.-).     A 0.742385 0.4105 1.6529 9.12 41657 c.87 0.78% 
20905169 Conserved protein.   
Coenzyme 
transport and 
metabolism genes A 0.575975 0.4338 0 7.81 15867 d.190 0.78% 
20907465 
Peptidyl-prolyl cis-trans isomerase 
(EC 5.2.1.8).     A 0.770251 0.4129 -1.2902 6.08 17083 b.62 0.78% 
20904729 Hypothetical protein MM0363.   
Carbohydrate 
transport and 
metabolism genes A 0.702079 0.4554 -1.7856 6.09 12682 b.82 0.74% 
20904460 Universal stress protein.   
Signal transduction 
mechanisms genes A 0.760552 0.451 -1.9607 5.33 16447 c.26 0.73% 
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20907621 
Isoleucyl-tRNA synthetase (EC 
6.1.1.5).     A 0.770927 0.4319 -2.93 5.1 120411 
a.27. c.26. 
b.51 0.72% 
20906733 
F420-nonreducing hydrogenase II 
(Hydrogenase expression/formation 
protein). VHTD   A 0.706262 0.4845 -4.9688 4.7 17385 c.56 0.72% 
20907976 Transcriptional regulator.     A 0.750851 0.4354 -2.1107 5.68 42892 x 0.72% 
20906712 
Cytidylate kinase (EC 2.7.4.14) 
(CK) (Cytidine monophosphate 
kinase) (CMP kinase). CMK   A 0.661161 0.392 -1.1363 5.73 20587 c.37 0.70% 
20905732 
GMP synthase [glutamine-
hydrolyzing] subunit A (EC 6.3.5.2) 
(Glutamine amidotransferase). GUAAA   A 0.768004 0.4497 -8.4655 4.73 21138 c.23 0.69% 
20907635 Hypothetical protein MM2979.     B 0.764286 0.427 -3.3057 5.22 42680 x 0.68% 
20905090 
Transcription initiation factor IIE, 
alpha subunit.   
Transcription 
genes A 0.641088 0.4085 -3.0487 5.15 19145 a.4 0.67% 
20906635 
Orotidine 5'-phosphate 
decarboxylase (EC 4.1.1.23) (OMP 
decarboxylase) (OMPDCase) 
(OMPdecase). PYRF   A 0.764643 0.4955 -3.1817 4.79 23503 c.1 0.67% 
20905771 Conserved protein.     A 0.760666 0.433 0 7.58 29025 
d.37. d.37. 
d.37. d.37 0.65% 
20907600 Conserved protein.     A 0.220293 0.4296 2.963 9.62 15721 x 0.64% 
20906258 
Probable porphobilinogen 
deaminase (EC 2.5.1.61) (PBG) ( HEMC   A 0.768779 0.4146 -3.1645 5.04 34847 c.94. d.50 0.63% 
20907024 
Glutamine amidotransferase 
subunit pdxT (EC 2.6.-.-) 
(Glutamine amidotransferase 
glutaminase subunit pdxT). PDXT   B 0.742677 0.4778 -2.463 5.35 21425 c.23 0.63% 
20905985 Conserved protein.     A 0.694439 0.5158 -2.1052 4.93 10315 x 0.62% 
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20906215 
Imidazole glycerol phosphate 
synthase subunit hisF (EC 4.1.3.-) 
(IGP synthase cyclase subunit) 
(IGP synthase subunit hisF)  (ImGP 
synthase) HISF   A 0.764654 0.4212 -5.4944 4.54 29691 c.1 0.59% 
20906589 
Aspartate aminotransferase  
(EC 2.6.1.1).     A 0.768609 0.4427 -4.3256 4.74 43475 c.67 0.58% 
20906126 Conserved protein.     A 0.712044 0.426 -0.9062 5.73 36119 x 0.57% 
20905106 Thioredoxin 2.   
General function 
prediction only 
genes A 0.672582 0.4112 -4.2055 4.73 24120 x 0.56% 
20906904 Ech Hydrogenase, Subunit. ECHF   A 0.761782 0.4286 7.1429 9.13 14014 d.58 0.55% 
20907459 
Indole-3-glycerol phosphate 
synthase (EC 4.1.1.48).     B 0.764627 0.4682 -4.4943 4.84 29395 c.1 0.54% 
20904631 Hypothetical protein MM0275.     A 0.746497 0.3833 -0.3332 6.66 67664 x 0.54% 
20904632 
Superfamily II DNA and RNA 
helicase.   
Replication, 
recombination and 
repair genes A 0.755825 0.3929 -1.5685 5.46 144748 c.37 0.54% 
20904671 Conserved protein.     A 0.406275 0.3829 1.5823 8.51 36898 d.144 0.54% 
20905036 Conserved protein.     A 0.220293 0.3953 -4.054 4.87 33303 x 0.53% 
20906018 Citrate synthase (EC 4.1.3.7).     A 0.768742 0.4394 -2.5351 5.33 40216 a.103 0.53% 
20906553 
Phosphate import ATP-binding 
protein pstB (EC 3.6.3.27) 
(Phosphate- transporting ATPase) 
(ABC phosphate transporter). PSTB     0.770927 0.4147 1.1628 8.55 28977 c.37 0.53% 
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20905231 Conserved protein.   
Function unknown 
genes A 0.562052 0.4328 1.4925 8.73 14955 x 0.53% 
20906877 
Hypothetical UPF0173 metal-
dependent hydrolase MM2300.     B 0.754257 0.4478 -4.7825 5.1 24933 d.157 0.52% 
20905425 
Precorrin-3B C17-
methyltransferase (EC 2.1.1.131).     A 0.765161 0.4377 -2.6414 4.9 29087 c.90 0.51% 
20907745 Putative transcriptional regulator. SYRB   A 0.760653 0.4392 0.6757 9.09 15986 c.26 0.49% 
20906195 Iron-sulfur binding reductase.     A 0.76049 0.3796 -1.3088 5.53 42148 c.96. d.58 0.49% 
20907062 
Metallo cofactor biosynthesis 
protein.     A 0.739277 0.4147 0 7.09 24558 x 0.49% 
20907086 
F420H2 dehydrogenase subunit 
FpoB. FPOB   A 0.761565 0.413 0 7.06 20732 e.19 0.48% 
20905224 
Probable peroxiredoxin (EC 
1.11.1.15).   
Posttranslational 
modification, 
protein turnover, 
chaperones genes A 0.768515 0.4566 0 7.09 24946 c.47 0.47% 
20904778 Hypothetical protein MM0408.   
Secondary 
metabolites 
biosynthesis, 
transport and 
catabolism genes A 0.487257 0.4388 -1.4387 5.3 15512 b.45 0.47% 
20904330 
Dipeptide ABC transporter, ATP-
binding protein. DPPF 
Amino acid 
transport and 
metabolism genes B 0.770927 0.4039 1.9704 9.02 22741 c.37 0.47% 
20905115 
Fructose-bisphosphate aldolase 
(EC 4.1.2.13).   
Carbohydrate 
transport and 
metabolism genes A 0.748102 0.4304 -5.1779 4.77 34055 c.1 0.47% 
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20905723 
Xanthine-guanine 
phosphoribosyltransferase  
(EC 2.4.2.22).     A 0.743353 0.4118 -2.745 5.32 29374 c.61 0.46% 
20905667 
Aspartate carbamoyltransferase 
regulatory chain. PYRI   A 0.733567 0.4231 -0.6409 6.36 17011 g.41. d.58 0.44% 
20905668 
Aspartate carbamoyltransferase 
(EC 2.1.3.2) (Aspartate 
transcarbamylase) (ATCase). PYRB   A 0.76727 0.4434 -0.9708 6.3 35096 c.78. c.78 0.44% 
20904817 
Phosphoribosylglycinamide 
formyltransferase (EC 2.1.2.2).   
Nucleotide 
transport and 
metabolism genes B 0.772021 0.4455 -0.4949 6.63 22428 c.65 0.44% 
20905780 
Hypothetical UPF0200 protein 
MM1313.     A 0.662347 0.4171 -1.6042 5.46 20893 c.37 0.44% 
20905096 Cell division protein. FTSZ 
Cell cycle control, 
mitosis and meiosis 
genes A 0.768938 0.4184 -2.806 4.96 42234 d.79. c.32 0.43% 
20908029 Conserved protein (EC 1.3.-.-).     A 0.762771 0.4215 -2.2726 5.41 54567 c.3 0.43% 
20906666 Conserved protein.     B 0.625699 0.39 -0.5864 6.64 39363 c.87 0.43% 
20904820 
NH(3)-dependent NAD(+) 
synthetase (EC 6.3.1.5). NADE 
Coenzyme 
transport and 
metabolism genes A 0.767239 0.4219 -3.1249 4.9 27786 c.26 0.42% 
20906945 
Shikimate kinase (EC 2.7.1.71) 
(SK). AROK   A 0.657089 0.4437 -2.389 4.94 30952 d.58. d.14 0.42% 
20907311 Hypothetical protein MM2691.     B 0.703115 0.4962 -2.2555 4.98 14631 b.45 0.42% 
20905716 CdcH protein.     A 0.770927 0.4274 -2.7962 5.22 83906 
c.37. d.31. 
b.52. c.37 0.42% 
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20907557 
Phosphoserine aminotransferase 
(EC 2.6.1.52) (PSAT). SERC   A 0.759299 0.4324 -1.6215 5.49 41596 c.67 0.42% 
20904757 
Heterodisulfide reductase subunit 
HdrB (EC 1.97.1.-).   
Energy production 
and conversion 
genes A 0.70752 0.4013 -1.5923 6.06 35102 x 0.41% 
20906956 
Phosphoribosyl-ATP 
pyrophosphatase (EC 3.6.1.31) 
(PRA-PH). HISE   A 0.763686 0.3925 -6.542 4.9 12150 x 0.41% 
20907603 Hypothetical protein MM2951.     A 0.220293 0.4351 -4.5454 4.62 17806 x 0.40% 
20905906 Replication factor C subunit.     A 0.769859 0.4252 -2.9325 4.96 38349 c.37. a.80 0.40% 
20904876 Iron-sulfur flavoprotein.   
General function 
prediction only 
genes A 0.741766 0.4063 1.0417 7.85 21070 c.23 0.40% 
20906323 
Aspartate aminotransferase (EC 
2.6.1.1).     A 0.768389 0.4391 -3.2994 5.17 43578 c.67 0.40% 
20905065 
Acetolactate synthase large subunit 
(EC 4.1.3.18).   
Amino acid 
transport and 
metabolism genes A 0.76593 0.4415 -1.7729 5.67 61858 
c.31. c.36. 
c.36 0.40% 
20907017 
Methylthiol:coenzyme M 
methyltransferase. MTSA   B 0.763392 0.4659 -3.5421 4.81 40192 c.1 0.40% 
20906966 Conserved protein.     A 0.220293 0.406 -2.2555 5.32 14935 x 0.40% 
20905331 
Potassium/copper-transporting 
ATPase (EC 3.6.1.36).     A 0.766431 0.4699 -1.1277 5.47 29177 c.108 0.39% 
20906433 Hypothetical protein MM1902.     A 0.766222 0.3988 -0.6134 6.62 18551 d.108 0.39% 
20906188 
Precorrin-6Y C5,15-
methyltransferase (EC 2.1.1.132).     A 0.744608 0.4564 -2.0512 5.19 21018 c.90 0.39% 
20906560 
Nascent polypeptide-associated 
complex protein. NAC   B 0.639726 0.4417 -5.8332 4.38 12839 a.5 0.39% 
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20904986 
Hypothetical UPF0218 protein 
MM0598.   
Function unknown 
genes A 0.641997 0.4308 -1.5384 5.66 21900 x 0.38% 
20907452 
Anthranilate synthase, component 
II (EC 4.1.3.27).     A 0.768004 0.4326 -0.9301 6.35 24072 c.23 0.37% 
20907237 
DNA-directed RNA polymerase 
subunit P (EC 2.7.7.6). RPOP 
Transcription 
genes B 0.617192 0.2667 13.3333 9.57 5379 g.41 0.37% 
20906240 Heme biosynthesis protein. NIRD   B 0.706346 0.4486 -2.7026 5.23 21443 a.4 0.37% 
20905196 
Metallo cofactor biosynthesis 
protein.   
General function 
prediction only 
genes B 0.753541 0.4502 -1.7412 5.66 44810 d.115 0.36% 
20906586 Conserved protein.     A 0.220293 0.4074 3.7037 9 11891 x 0.36% 
20905062 Nitroreductase family protein.   
Energy production 
and conversion 
genes A 0.763627 0.45 -1.111 5.69 20152 d.90 0.35% 
20906081 Iron-sulfur flavoprotein.     A 0.702682 0.4 -2.7026 4.95 20310 c.23 0.35% 
20904704 
Amidophosphoribosyltransferase 
(EC 2.4.2.14).   
Nucleotide 
transport and 
metabolism genes A 0.768037 0.4144 -1.0308 6.21 53117 d.153. c.61 0.34% 
20904947 Hypothetical protein MM0562.     A 0.7327 0.4353 -0.862 5.96 26949 x 0.34% 
20904594 
Glycerol-3-phosphate 
cytidylyltransferase (EC 2.7.7.39).   
Cell 
wall/membrane 
biogenesis genes A 0.760285 0.4702 0 7.25 16859 c.26 0.34% 
20906125 Conserved protein.     A 0.220293 0.3028 -13.761 3.84 12288 x 0.33% 
20905017 
Nicotinamide-nucleotide 
adenylyltransferase (EC 2.7.7.1) 
(NAD(+) pyrophosphorylase) 
(NAD(+) diphosphorylase) (NMN 
adenylyltransferase).   
Coenzyme 
transport and 
metabolism genes A 0.704948 0.4365 0 7.64 19970 c.26 0.33% 
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20905546 Oxidoreductase.     A 0.744452 0.4208 1.039 8.68 42509 c.2. c.3 0.33% 
20905338 Conserved protein.     A 0.501014 0.4502 -0.9645 6.36 34476 x 0.33% 
20905817 Fe-S oxidoreductase.     A 0.677452 0.411 0.274 7.53 41968 x 0.33% 
20905345 Agmatinase (EC 3.5.3.11).   
Amino acid 
transport and 
metabolism genes A 0.758841 0.4467 -7.56 4.31 32335 c.42 0.32% 
20907091 FO synthase subunit 1 (EC 2.5.1.-)  COFG   A 0.741995 0.4364 -3.1791 4.94 38308 x 0.32% 
20905034 
Isocitrate dehydrogenase (EC 
1.1.1.42).   
Amino acid 
transport and 
metabolism genes A 0.764949 0.4606 -2.1211 5.18 35867 c.77 0.32% 
20905045 Glycosyltransferase (EC 2.4.-.-).   
Cell 
wall/membrane 
biogenesis genes A 0.76637 0.3779 2.6059 9.27 35839 c.68 0.31% 
20906241 Heme biosynthesis protein. NIRH   A 0.725238 0.4114 -0.6328 6.51 18042 d.58. a.4 0.31% 
20905750 
Hypothetical protein MM1286 (EC 
3.1.2.6).     A 0.761081 0.3944 -2.8168 5.58 23223 d.157 0.31% 
20905588 Glycosyltransferase (EC 2.4.1.-).     A 0.766298 0.3698 -0.3214 6.89 35654 c.68 0.31% 
20905899 Small heat shock protein.     A 0.74964 0.3856 -3.9215 4.82 17814 b.15 0.30% 
20907312 Hypothetical protein MM2692.     B 0.358138 0.3996 -1.7278 5.16 52553 c.3 0.30% 
20905193 
V-type ATP synthase subunit I (EC 
3.6.3.14) (V-type ATPase subunit 
I). AHAI,ATPI 
Energy production 
and conversion 
genes A 0.736091 0.4702 -2.29 5.6 71964 x 0.30% 
20907052 Methyltransferase (EC 2.1.1.-).     A 0.760958 0.3589 -3.1358 4.8 33057 c.66 0.30% 
20905368 Protein pcrB homolog. PCRB   A 0.701676 0.4777 -2.0242 5.31 25888 c.1 0.30% 
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20906929 
Ribosomal protein S6 modification 
protein.     A 0.764358 0.4419 -0.3321 6.52 33690 d.142 0.29% 
20905843 DNA repair protein.     A 0.77048 0.371 2.4194 9.08 27333 c.37 0.29% 
20905941 Conserved protein.     A 0.726229 0.4269 -1.1791 5.47 47156 x 0.29% 
20906466 
Methylcobalamin:coenzyme M 
methyltransferase. MTBA   B 0.760187 0.4721 -5.5717 4.41 36882 c.1 0.29% 
20906257 
Probable glutamate-1-
semialdehyde 2,1-aminomutase 
(EC 5.4.3.8) (GSA)  HEML   A 0.767014 0.441 -4.9527 4.73 46306 c.67 0.28% 
20905630 Glycosyltransferase (EC 2.4.1.-).     A 0.756837 0.4425 1.5345 8.46 44748 c.87 0.28% 
20905560 
Polysaccharide deacetylase (EC 
3.5.1.-).     A 0.757551 0.4053 -1.3288 6.23 34521 c.6 0.28% 
20907623 Conserved protein.     A 0.644291 0.4648 -3.2863 4.84 23537 c.100 0.28% 
20908007 Acetyltransferase (EC 2.3.1.-).     A 0.76462 0.3857 -1.4285 6.1 24393 d.108 0.27% 
20906121 Divalent cation transport protein.     A 0.767248 0.4075 -2.4128 5.24 41395 c.37 0.27% 
20905921 
Methylcobamide:CoM 
methyltransferase mtbA  
(EC 2.1.1.-)  MTBA   B 0.770577 0.4572 -3.2447 4.87 36582 c.1 0.27% 
20907866 
Ornithine decarboxylase (EC 
4.1.1.17)     B 0.767731 0.4154 -0.7691 6.46 44775 b.49. c.1 0.27% 
20905158 Conserved protein.   
General function 
prediction only 
genes A 0.762402 0.4156 -6.0605 4.5 25460 c.26 0.27% 
20907455 
Anthranilate 
phosphoribosyltransferase (EC 
2.4.2.18). TRPD   A 0.764138 0.4405 0.5405 8.2 39203 c.27. a.46 0.27% 
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20905770 Conserved protein.     A 0.761116 0.4591 -0.7116 6.52 31384 
d.37. d.37. 
d.37. d.37 0.27% 
20905621 
UDP-N-acetylglucosamine 2-
epimerase (EC 5.1.3.14).     A 0.765718 0.4085 -2.8168 5.3 39514 c.87 0.26% 
20904983 Conserved protein.   
General function 
prediction only 
genes A 0.639625 0.4711 4.1322 10.03 13660 c.120 0.26% 
20904640 
Leucyl-tRNA synthetase (EC 
6.1.1.4) (Leucine--tRNA ligase) 
(LeuRS). LEUS Translation genes A 0.770927 0.4253 -2.4716 5.32 110957 
b.51. a.27. 
c.26 0.26% 
20906869 
Type I restriction-modification 
system specificity subunit.     A 0.768421 0.4097 -2.4751 5.39 91505 c.66 0.26% 
20904706 Hypothetical protein MM0342.   
Function unknown 
genes A 0.751103 0.4015 -4.5454 4.91 14765 x 0.25% 
20905077 Conserved protein.   
Function unknown 
genes A 0.710184 0.3655 -7.1065 4.58 22214 x 0.25% 
20905340 
4-carboxymuconolactone 
decarboxylase (EC 4.1.1.44).     A 0.734486 0.4121 -5.4544 4.74 18664 a.152 0.25% 
20907577 Hypothetical protein MM2928.     B 0.722121 0.3256 -1.7441 5.43 19191 x 0.25% 
20905832 Hypothetical protein MM1359.     A 0.501543 0.4507 5.6338 10.08 15284 x 0.25% 
20904975 Conserved protein.   
Cell 
wall/membrane 
biogenesis genes A 0.765766 0.4053 0.4796 7.87 47730 c.87 0.25% 
20906506 Hypothetical protein MM1968.     A 0.604417 0.439 -6.0975 4.62 28035 b.82 0.25% 
20906080 
NADPH-flavin oxidoreductase (EC 
1.6.99.-).     A 0.757984 0.4713 0.5747 7.97 19485 d.90 0.25% 
20907414 
Suppressor protein SuhB homolog 
(EC 3.1.3.25).     A 0.767086 0.4157 -2.2471 5.46 28822 e.7 0.25% 
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20906820 Conserved protein.     B 0.220293 0.4151 0.9434 7.65 11810 x 0.24% 
20904956 
ABC transporter, ATP-binding 
protein.   
Inorganic ion 
transport and 
metabolism genes B 0.770927 0.4301 -2.2058 5.64 30186 c.37 0.24% 
20905831 Putative methyltransferase.     A 0.71642 0.4412 -7.3528 4.35 7543 x 0.24% 
20907109 Hypothetical protein MM2510.     A 0.697179 0.4245 -4.4024 4.68 34498 d.142 0.24% 
20904668 
Uroporphyrinogen-III synthase  
(EC 4.2.1.75).   
Coenzyme 
transport and 
metabolism genes A 0.748376 0.4349 -2.6021 5.09 29542 c.113 0.24% 
20905619 
DTDP-4-dehydrorhamnose 
reductase (EC 1.1.1.133).     A 0.766347 0.4052 -2.6021 5.34 30180 c.2 0.24% 
20906782 
Glucose-1-phosphate 
thymidylyltransferase (EC 
2.7.7.24).     B 0.766903 0.4234 -0.8064 6.14 27249 c.68 0.24% 
20905003 Conserved protein.   
Cell cycle control, 
mitosis and meiosis 
genes A 0.699645 0.4116 -1.1593 5.82 39275 c.26 0.24% 
20904985 
DNA-directed RNA polymerase 
subunit E' (EC 2.7.7.6).   
Transcription 
genes A 0.648493 0.4262 -1.6392 5.63 6881 x 0.24% 
20905574 Conserved protein.     A 0.63646 0.4368 0.2747 7.97 41029 c.87 0.23% 
20905403 Conserved protein.     A 0.603238 0.419 -1.6759 5.65 20296 x 0.23% 
20905178 Conserved protein.     A 0.220293 0.437 1.4815 9.05 15618 x 0.23% 
20905901 
F420-0:gamma-glutamyl ligase (EC 
6.3.2.-). COFE   A 0.732841 0.4449 -2.7558 4.95 27741 x 0.23% 
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20904725 
Sulfite reductase, assimilatory-type 
(EC 1.8.-.-).   
Energy production 
and conversion 
genes B 0.763421 0.4545 1.2987 8.53 24912 d.134. d.58 0.22% 
20907682 
ABC transporter, ATP-binding 
protein.     A 0.770927 0.411 -1.2711 5.82 26237 c.37 0.22% 
20906404 
Purine phosphoribosyltransferase  
(EC 2.4.2.7).     A 0.766566 0.4497 -3.7036 4.73 20679 c.61 0.22% 
20905510 Conserved protein.     B 0.768361 0.4 -2.3376 5.71 42368 c.37 0.22% 
20907999 
Threonyl-tRNA synthetase (EC 
6.1.1.3) (Threonine--tRNA ligase) 
(ThrRS). THRS   B 0.770927 0.4274 -1.7349 5.69 72765 d.104. c.51 0.22% 
20905756 
Archaeosine tRNA-
ribosyltransferase (EC 2.4.2.-).     A 0.65145 0.4222 -0.3209 6.63 69097 
c.1. b.122. 
d.17 0.22% 
20906591 Hypothetical protein MM2043.     A 0.627596 0.4477 -2.166 5.65 32631 x 0.22% 
20905974 Methyltransferase (EC 2.1.1.-).     A 0.747981 0.4567 -0.7873 5.94 43319 c.66. c.66 0.20% 
20905279 Glucoamylase (EC 3.2.1.3).   
Carbohydrate 
transport and 
metabolism genes B 0.736606 0.4119 -2.2795 5.45 75932 a.102 0.20% 
20907082 F420H2 dehydrogenase subunit. FPOI   A 0.762579 0.4011 1.6949 7.85 19459 d.58 0.19% 
20904722 
Glutamate dehydrogenase  
(EC 1.4.1.3).   
Amino acid 
transport and 
metabolism genes A 0.765583 0.484 -0.802 6.03 40534 c.2. c.58 0.19% 
20905697 Methyltransferase.     A 0.641873 0.411 -1.5336 5.73 36419 c.66 0.19% 
20904329 
Dipeptide ABC transporter, ATP-
binding protein. DPPD 
Amino acid 
transport and 
metabolism genes B 0.770858 0.4123 0.9231 8.23 35955 c.37 0.19% 
20904993 Conserved protein.     A 0.241334 0.395 -0.8402 6.15 13497 x 0.19% 
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20905543 
Archaeosine tRNA-
ribosyltransferase (EC 2.4.2.-).     A 0.767381 0.4367 -1.2244 6.06 55032 d.17. c.1 0.18% 
20907135 
Hypothetical UPF0217 protein 
MM2534.     A 0.65633 0.4028 -3.7914 5.27 23249 x 0.18% 
20904531 
Short chain 
dehydrogenase/reductase (EC 1.1.-
.-).   
Secondary 
metabolites 
biosynthesis, 
transport and 
catabolism genes A 0.770637 0.4431 -0.7842 5.48 27556 c.2 0.18% 
20906133 Iron-sulfur flavoprotein.     A 0.730466 0.4415 -1.0637 5.66 21070 c.23 0.18% 
20906251 Heme biosynthesis protein. NIRJ   A 0.761061 0.4069 -1.146 6.03 38802 x 0.18% 
20904436 
Serine/threonine protein 
phosphatase (EC 3.1.3.16).   
Signal transduction 
mechanisms genes A 0.736753 0.4322 -3.2966 5.07 31139 d.159 0.18% 
20905894 Conserved protein.     A 0.501014 0.4342 -1.9736 5.74 16878 c.115 0.17% 
20905578 
UDP-glucose 6-dehydrogenase 
(EC 1.1.1.22).     A 0.765484 0.4436 -1.6786 5.15 45605 
c.2. c.26. 
a.100 0.17% 
20906169 Conserved protein.     A 0.220293 0.3697 0.6061 7.5 19088 x 0.17% 
20906959 Conserved protein.     A 0.617818 0.479 -1.7963 5.76 18299 d.58 0.17% 
20905755 
(S)-2-hydroxy-acid dehydrogenase 
(EC 1.1.3.15).     A 0.767026 0.4587 -1.3042 5.52 49551 d.145. d.58 0.16% 
20904798 Rnase L inhibitor.   
General function 
prediction only 
genes A 0.770927 0.4082 -1.7006 5.58 65396 
c.37. d.58. 
c.37 0.16% 
20904390 
Tungsten formylmethanofuran 
dehydrogenase subunit  D (EC 
1.2.99.5).   
Energy production 
and conversion 
genes A 0.519204 0.3939 1.5152 9.31 14681 b.52 0.16% 
20905267 Conserved protein.   
General function 
prediction only 
genes A 0.762284 0.4309 -3.2519 5.87 27743 d.157 0.15% 
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20906289 
Transcription initiation factor IIB 
(TFIIB). TFB   A 0.67914 0.3858 2.9674 9.24 38290 
g.41. a.74. 
a.74 0.15% 
20904389 
Tungsten formylmethanofuran 
dehydrogenase subunit B (EC 
1.2.99.5).   
Energy production 
and conversion 
genes A 0.57674 0.4251 -0.7245 6.04 45473 c.81 0.15% 
20905700 
Methyl-coenzyme M reductase 
operon protein C.     A 0.501014 0.4223 1.4563 8.59 22427 x 0.14% 
20907428 Conserved protein.     A 0.763768 0.4139 1.9868 8.35 33668 c.26 0.14% 
20907920 
Hydroxyethylthiazole kinase (EC 
2.7.1.50) (4-methyl-5-beta- 
hydroxyethylthiazole kinase) (Thz 
kinase) (TH kinase). THIM   A 0.756852 0.4559 -1.9156 5.35 27555 c.72 0.14% 
20906937 
Probable diphthine synthase (EC 
2.1.1.98) (Diphthamide 
biosynthesis methyltransferase). DPHB   A 0.67914 0.4248 -2.6315 5.49 29397 c.90 0.14% 
20907487 Conserved protein.     A 0.220293 0.3615 -1.8778 6.08 25503 x 0.14% 
20908039 Hypothetical protein MM3340.     B 0.220293 0.461 -6.4406 4.46 31481 x 0.14% 
20905616 
DTDP-4-dehydrorhamnose 3,5-
epimerase (EC 5.1.3.13).     A 0.766065 0.3934 -0.5463 6.39 21004 b.82 0.14% 
20906978 
Long-chain-fatty-acid--CoA ligase 
(EC 6.2.1.3).     A 0.770339 0.4257 -2.0182 5.78 61380 e.23 0.13% 
20906189 
Putative cobalt-precorrin-6A 
synthase [deacetylating] (EC 2.1.1.-
). CBID   A 0.740599 0.4277 -2.0648 5.46 36315 x 0.13% 
20907456 
Tryptophan synthase alpha chain 
(EC 4.2.1.20). TRPA   B 0.765011 0.4649 -3.6899 4.69 29069 c.1 0.13% 
20905791 Chemotaxis protein. CHEC   A 0.720472 0.4528 -5.1886 4.42 23371 x 0.13% 
20906041 Conserved protein.     A 0.714573 0.3978 -4.8326 4.99 29514 c.1 0.13% 
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20906063 
Molybdenum formylmethanofuran 
dehydrogenase subunit (EC 
1.2.99.5). FMDB   A 0.751098 0.4345 -1.839 5.78 47740 c.81 0.13% 
20906451 Hypothetical protein MM1918.     A 0.199251 0.3849 -2.0021 5.83 105187 x 0.12% 
20905385 Nitrogen regulatory protein P-II.     A 0.764323 0.4174 1.7391 8.76 12861 d.58 0.12% 
20905043 Mannosyltransferase (EC 2.4.1.-).   
Cell 
wall/membrane 
biogenesis genes A 0.76544 0.4249 2.5496 9.43 40610 c.87 0.11% 
20906891 
F420-nonreducing hydrogenase I, 
large subunit (EC 1.12.2.-). VHOA   A 0.7398 0.4365 -2.7072 5.17 64243 e.18 0.11% 
20904486 Iron-sulfur flavoprotein.   
General function 
prediction only 
genes A 0.703765 0.4025 0.8475 7.91 26247 c.23 0.11% 
20908032 
Monomethylamine corrinoid protein 
2 (MMCP 2). MTMC2   A 0.765737 0.4633 -5.9632 4.42 23270 c.23. a.46 0.11% 
20904497 
Type IIS restriction enzyme (EC 
3.1.21.4) (EC 2.1.1.72).   
Defense 
mechanisms genes B 0.685957 0.4137 -2.9184 5.16 134098 c.66 0.11% 
20906239 Heme biosynthesis protein. NIRJ   A 0.761123 0.4 -1.4084 5.95 39379 x 0.10% 
20905526 Metal dependent hydrolase.     A 0.741609 0.4009 -4.9549 5.05 24425 d.157 0.10% 
20905769 Conserved protein.     A 0.742733 0.4414 1.8018 9.9 36798 c.80. d.37 0.10% 
20905590 Glycosyltransferase (EC 2.4.1.-).     A 0.762993 0.4529 2.5445 9.35 43734 c.87 0.10% 
20904818 
Putative HTH-type transcriptional 
regulatory protein MM0444.   
Transcription 
genes A 0.648493 0.422 -2.1406 5.22 36296 a.35 0.09% 
20905469 
Amino-acid acetyltransferase (EC 
2.3.1.1).     B 0.760691 0.4403 0 6.75 18041 d.108 0.09% 
20905408 
CoB--CoM heterodisulfide 
reductase 1 iron-sulfur subunit C 
(EC 1.8.98.1). HDRC   A 0.752359 0.3851 1.2422 7.74 18120 a.1 0.09% 
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20906412 Conserved protein.     B 0.624778 0.4511 -1.0869 5.43 19947 x 0.08% 
20904811 
Methylenetetrahydrofolate 
reductase (EC 1.5.1.20).   
Amino acid 
transport and 
metabolism genes B 0.761607 0.4384 -1.3698 5.87 31927 c.1 0.07% 
20907450 Metal dependent hydrolase.     A 0.705694 0.4393 -2.4999 5.69 31160 d.157 0.07% 
20907129 
N(2),N(2)-dimethylguanosine tRNA 
methyltransferase (EC 2.1.1.32) 
(tRNA(guanine-26,N(2)-N(2)) 
methyltransferase) (tRNA -2,2 
dimethylguanosine-26 
methyltransferase) 
(tRNA(m(2,2)G26)dimethyltransfera
se). TRM1   A 0.69755 0.4459 -0.5154 6.75 42784 c.66 0.04% 
20905871 
Probable molybdenum cofactor 
biosynthesis protein A. MOAA   A 0.761142 0.3952 1.1976 8.06 37691 x 0.04% 
20906757 
DNA double strand –dreak repair 
rad50 ATPase RAD50  A 0.766547 0.3701 -2.5233 5.23 12198 
e.10 
a.2 
c.37 0.04% 
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Table S9: Ths substrates, 1D-LCMS, proteins are sorted according to their relative abundance on MmThs, specific substrates are indicated with bold and italic 
gi|accession numbers 
gi number name genname function Phylogeny evolutionary 
scope 
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20906018 Citrate synthase (EC 4.1.3.7).   A 0.768742 0.4394 -2,5351 5,33 40216 a.103 1,67% 
20905557 Hypothetical UPF0264 protein 
MM1114. 
  A 0.627721 0.4658 -2,9914 4,73 24942 c.1 1,39% 
20907313 Hypothetical protein MM2693.   A 0.358138 0.3846 0 7,06 40291 x 1,37% 
20906896 Probable hydrogenase nickel 
incorporation protein hypA. 
HYPA  B 0.737554 0.3869 -10,2189 4,42 15135 x 1,28% 
20905439 Cell division protein. FTSZ  A 0.769563 0.4251 -4,278 4,61 39359 d.79, c.32 1,26% 
20905395 Glutamate synthase, large chain 
(EC 1.4.1.13). 
  A 0.718357 0.4211 -0,8096 6,43 26637 b.80 1,20% 
20905020 Zinc finger protein.  Function unknown 
genes 
A 0.465544 0.3816 -5,2631 5,36 8614 x 1,17% 
20906287 Pyruvate, phosphate dikinase (EC 
2.7.9.1). 
  A 0.769966 0.4389 -2,0361 5,27 97107 d.142, c.8, 
c.1 
0,99% 
20904665 conserved protein.   A 0.220293 0.3837 -4,6511 4,56 9945 x 0,92% 
20906894 Hydrogenase expression/formation 
protein. 
HYPC  A 0.735556 0.4302 -11,6278 4,16 9336 b.40 0,91% 
20905369 Methyl coenzyme M reductase 
system, component A2. 
  A 0.770927 0.4259 -3,0663 5,27 66215 c.37, c.37 0,90% 
20905899 Small heat shock protein.   A 0.74964 0.3856 -3,9215 4,82 17814 b.15 0,89% 
20906454 Hypothetical protein MM1921.   A 0 0.3571 -7,1428 4,52 12973 x 0,81% 
20904988 30S ribosomal protein S27ae. RPS27AE Translation genes A 0.670238 0.3265 12,2449 9,6 5559 x 0,78% 
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20904876 Iron-sulfur flavoprotein.  General function 
prediction only 
genes 
A 0.741766 0.4063 1,0417 7,85 21070 c.23 0,75% 
20905716 CdcH protein.   A 0.770927 0.4274 -2,7962 5,22 83906 b.52, c.37, 
d.31, c.37 
0,75% 
20907441 Phosphoribosylformylglycinamidine 
synthase I (EC 6.3.5.3) (FGAM 
synthase I). 
PURQ  B 0.762958 0.4181 -3,8792 4,88 25615 c.23 0,74% 
20907531 conserved protein.   A 0.757405 0.4143 -5,7142 4,79 8241 x 0,73% 
20905065 Acetolactate synthase large subunit 
(EC 4.1.3.18). 
 Amino acid transport 
and metabolism 
genes 
A 0.76593 0.4415 -1,7729 5,67 61858 c.31, c.36, 
c.36 
0,73% 
20907600 Conserved protein.   A 0.220293 0.4296 2,963 9,62 15721 x 0,70% 
20906153 Conserved protein.   A 0.479189 0.4297 -3,0417 5,05 30806 a.4 0,70% 
20906605 Putative nucleotidyltransferase (EC 
2.7.7.-). 
  A 0.701416 0.4433 -0,9851 5,38 22360 c.68 0,70% 
20904524 conserved protein.   A 0.220293 0.3955 -10,4477 4,27 15559 a.87 0,69% 
20905090 Transcription initiation factor IIE, 
alpha subunit. 
 Transcription genes A 0.641088 0.4085 -3,0487 5,15 19145 a.4 0,68% 
20906891 F420-nonreducing hydrogenase I, 
large subunit (EC 1.12.2.-). 
VHOA  A 0.7398 0.4365 -2,7072 5,17 64243 e.18 0,68% 
20906746 TATA-box binding protein 3 (TATA-
box factor 3) (TATA sequence-
binding protein 3) (TBP 3) (Box A 
binding protein 3) 
TBP3  A 0.67914 0.4541 -3,7837 4,66 20176 d.129, d.129 0,68% 
20905231 Conserved protein.  Function unknown 
genes 
A 0.562052 0.4328 1,4925 8,73 14955 x 0,64% 
20905732 GMP synthase [glutamine-
hydrolyzing] subunit A (EC 6.3.5.2) 
(Glutamine amidotransferase). 
GUAAA  A 0.768004 0.4497 -8,4655 4,73 21138 c.23 0,63% 
20907976 Transcriptional regulator.   A 0.762434 0.4354 -2,1107 5,68 42892 x 0,63% 
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20905096 Cell division protein. FTSZ Cell cycle control, 
mitosis and meiosis 
genes 
A 0.768938 0.4184 -2,806 4,96 42234 d.79, c.32 0,63% 
20907024 Glutamine amidotransferase subunit 
pdxT (EC 2.6.-.-) (Glutamine 
amidotransferase glutaminase 
subunit pdxT). 
PDXT  B 0.765737 0.4778 -2,463 5,35 21425 c.23 0,61% 
20907861 Ketoisovalerate oxidoreductase 
subunit. 
VORC  A 0.75875 0.378 -2,4389 5,55 9247 a.1 0,61% 
20905160 Conserved protein.  Posttranslational 
modification, protein 
turnover, 
chaperones genes 
A 0.759662 0.3961 -0,3921 6,58 28653 x 0,61% 
20907452 Anthranilate synthase, component II 
(EC 4.1.3.27). 
  A 0.765785 0.4326 -0,9301 6,35 24072 c.23 0,60% 
20906433 Hypothetical protein MM1902.   A 0.766222 0.3988 -0,6134 6,62 18551 d.108 0,59% 
20905673 ATP-dependent DNA helicase (EC 
3.6.1.-). 
RECQ  B 0.767816 0.3817 -1,0044 5,9 101234 c.37, c.37 0,59% 
20905017 Nicotinamide-nucleotide 
adenylyltransferase (EC 2.7.7.1) 
(NAD(+) pyrophosphorylase) 
(NAD(+) diphosphorylase) (NMN 
adenylyltransferase). 
 Coenzyme transport 
and metabolism 
genes 
A 0.704948 0.4365 0 7,64 19970 c.26 0,55% 
20906188 Precorrin-6Y C5,15-
methyltransferase (EC 2.1.1.132). 
  A 0.744608 0.4564 -2,0512 5,19 21018 c.90 0,54% 
20906733 F420-nonreducing hydrogenase II 
(Hydrogenase expression/formation 
protein). 
VHTD  A 0.706262 0.4845 -4,9688 4,7 17385 c.56 0,54% 
20905763 Probable RNA 2'-
phosphotransferase  (EC 2.7.-.-). 
KPTA  A 0.718464 0.3865 -2,4154 5,51 23845 x 0,53% 
20906617 Iron(III) dicitrate transport ATP-
binding protein. 
  A 0.770927 0.4684 -1,8586 5,8 29715 c.37 0,53% 
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20907052 Methyltransferase (EC 2.1.1.-).   A 0.742677 0.3589 -3,1358 4,8 33057 c.66 0,53% 
20905173 conserved protein.   A 0.220293 0.3884 -10,7437 4,23 13652 x 0,52% 
20905365 Adenylosuccinate lyase (EC 
4.3.2.2). 
  A 0.768895 0.4425 -2,876 5,52 50305 a.127 0,52% 
20905224 Probable peroxiredoxin (EC 
1.11.1.15). 
 Posttranslational 
modification, protein 
turnover, 
chaperones genes 
A 0.768515 0.4566 0 7,09 24946 c.47 0,51% 
20905992 1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylidenea
mino] imidazole-4-carboxamide 
isomerase (EC 5.3.1.16) 
(Phosphoribosylformimino-5-
aminoimidazole carboxamide 
ribotide isomerase). 
HISA  A 0.7643 0.4553 -3,6584 4,67 25713 c.1 0,51% 
20906553 Phosphate import ATP-binding 
protein pstB (EC 3.6.3.27) 
(Phosphate- transporting ATPase) 
(ABC phosphate transporter). 
PSTB   0.770927 0.4147 1,1628 8,55 28977 c.37 0,50% 
20907456 Tryptophan synthase alpha chain 
(EC 4.2.1.20). 
TRPA  B 0.764138 0.4649 -3,6899 4,69 29069 c.1 0,50% 
20905106 Thioredoxin 2.  General function 
prediction only 
genes 
A 0.672582 0.4112 -4,2055 4,73 24120 x 0,49% 
20904409 Hypothetical protein MM0077.  General function 
prediction only 
genes 
A 0.75124 0.3879 -3,8792 5,35 25929 d.159 0,49% 
20906258 Probable porphobilinogen 
deaminase (EC 2.5.1.61) (PBG) 
(Hydroxymethylbilane synthase) 
(HMBS) (Pre-uroporphyrinogen 
synthase). 
HEMC  A 0.768779 0.4146 -3,1645 5,04 34847 d.50, c.94 0,48% 
20905094 Beta-phosphoglucomutase (EC 
5.4.2.6). 
 General function 
prediction only 
genes 
A 0.769139 0.4912 -4,4247 4,71 25436 c.108 0,48% 
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20905723 Xanthine-guanine 
phosphoribosyltransferase (EC 
2.4.2.22). 
  A 0.743353 0.4118 -2,745 5,32 29374 c.61 0,47% 
20907801 Hypothetical protein MM3127.   B 0.757805 0.45 -6,9999 4,36 11496 x 0,47% 
20905832 Hypothetical protein MM1359.   A 0.501543 0.4507 5,6338 10,08 15284 x 0,47% 
20906289 Transcription initiation factor IIB 
(TFIIB). 
TFB  A 0.67914 0.3858 2,9674 9,24 38290 a.74, a.74, 
g.41 
0,47% 
20905647 DTDP-glucose 4,6-dehydratase (EC 
4.2.1.46). 
  A 0.767599 0.4685 -0,7873 6,34 27840 c.2 0,47% 
20904823 SAM-dependent methyltransferases.  Cell wall/membrane 
biogenesis genes 
B 0.747675 0.4322 -6,3558 4,6 27076 c.66 0,47% 
20905287 Hypothetical UPF0219 protein 
MM0871. 
 Lipid transport and 
metabolism genes 
A 0.76643 0.4441 -1,7191 5,39 37070 c.95, c.95 0,47% 
20904399 N-methylhydantoinase (ATP-
hydrolyzing) (EC 3.5.2.14). 
 Amino acid transport 
and metabolism 
genes 
B 0.748048 0.4526 -1,5788 5,41 61663 c.55 0,46% 
20905154 Dihydropyrimidinase (EC 3.5.2.2).  Amino acid transport 
and metabolism 
genes 
B 0.746053 0.4408 -1,0902 6,25 69827 c.55, c.55, 
c.55 
0,46% 
20906945 Shikimate kinase (EC 2.7.1.71) 
(SK). 
AROK  A 0.657089 0.4437 -2,389 4,94 30952 d.14, d.58 0,45% 
20906087 conserved protein.   A 0.220293 0.3581 -2,7026 5,34 15269 x 0,45% 
20906928 Methyltransferase (EC 2.1.1.-).   A 0.751607 0.4086 -3,5841 5,09 32482 c.66 0,45% 
20905588 Glycosyltransferase (EC 2.4.1.-).   A 0.766298 0.3698 -0,3214 6,89 35654 c.68 0,44% 
20906120 conserved protein.   A 0.35631 0.3824 -7,843 4,76 11932 x 0,44% 
20907237 DNA-directed RNA polymerase 
subunit P (EC 2.7.7.6). 
RPOP Transcription genes B 0.67914 0.2667 13,3333 9,57 5379 g.41 0,43% 
20906269 conserved protein.   A 0.525073 0.4767 0 7,26 19428 x 0,43% 
20905750 Hypothetical protein MM1286 (EC 
3.1.2.6). 
  A 0.761081 0.3944 -2,8168 5,58 23223 d.157 0,43% 
20906845 DNA-directed RNA polymerase beta 
chain (EC 2.7.7.6). 
  A 0.770899 0.4068 -4,8963 4,81 60584 e.29 0,43% 
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20907603 Hypothetical protein MM2951.   A 0.220293 0.4351 -4,5454 4,62 17806 x 0,42% 
20907978 Hypothetical protein MM3286.   A 0.750851 0.3171 -7,317 4,45 14524 x 0,42% 
20905680 conserved protein.   A 0.501014 0.3241 -3,7036 4,83 12239 x 0,42% 
20906359 conserved protein.   A 0.646017 0.4271 -7,2916 4,67 10667 x 0,42% 
20906240 Heme biosynthesis protein. NIRD  B 0.706346 0.4486 -2,7026 5,23 21443 a.4 0,42% 
20905417 conserved protein.   A 0.645071 0.3884 -2,4792 4,8 12269 c.55 0,42% 
20906505 Hypothetical protein MM1967.   A 0.667214 0.4217 -0,4015 6,62 28659 c.55 0,42% 
20905396 Coenzyme F420 hydrogenase beta 
subunit (EC 1.12.99.1). 
  A 0.690724 0.4215 0,2907 7,31 37194 d.58 0,41% 
20907708 Coenzyme F420 hydrogenase, delta 
subunit (EC 1.12.99.1). 
  A 0.220293 0.4691 -8,0246 4,24 17734 c.56 0,41% 
20904330 Dipeptide ABC transporter, ATP-
binding protein. 
DPPF Amino acid transport 
and metabolism 
genes 
B 0.770927 0.4039 1,9704 9,02 22741 c.37 0,41% 
20905345 Agmatinase (EC 3.5.3.11).  Amino acid transport 
and metabolism 
genes 
A 0.758841 0.4467 -7,56 4,31 32335 c.42 0,41% 
20905578 UDP-glucose 6-dehydrogenase (EC 
1.1.1.22). 
  A 0.765484 0.4436 -1,6786 5,15 45605 c.26, a.100, 
c.2 
0,41% 
20905115 Fructose-bisphosphate aldolase (EC
 4.1.2.13). 
 Carbohydrate 
transport and 
metabolism genes 
A 0.748102 0.4304 -5,1779 4,77 34055 c.1 0,41% 
20904640 Leucyl-tRNA synthetase (EC
 6.1.1.4) (Leucine--tRNA
 ligase) (LeuRS). 
LEUS Translation genes A 0.770927 0.4253 -2,4716 5,32 110957 c.26, a.27, 
b.51 
0,41% 
20905338 Conserved protein.   A 0.501014 0.4502 -0,9645 6,36 34476 x 0,41% 
20906877 Hypothetical UPF0173 metal-
dependent hydrolase MM2300. 
  B 0.754257 0.4478 -4,7825 5,1 24933 d.157 0,40% 
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20907157 Acetyltransferase (EC 2.3.1.-).   B 0.65633 0.3871 -3,6865 5,04 25671 d.108 0,40% 
20905416 conserved protein.   A 0.682655 0.3719 -5,785 5,1 13025 c.55 0,40% 
20906904 Ech Hydrogenase, Subunit. ECHF  A 0.761782 0.4286 7,1429 9,13 14014 d.58 0,40% 
20906655 conserved protein.   A 0.771936 0.416 0,3817 7,72 30683 x 0,39% 
20906402 LPPG:FO 2-phopspho-L-lactate 
transferase (EC 2.7.1.-). 
COFD  A 0.736632 0.4422 -5,6105 4,49 33357 x 0,39% 
20904643 Conserved protein.   A 0.387076 0.4352 -0,4629 6,55 24843 x 0,39% 
20905612 UDP-N-acetylglucosamine 4-
epimerase. 
  A 0.767303 0.4012 -2,3951 5,2 36853 c.2 0,39% 
20907454 N-(5'-phosphoribosyl)anthranilate 
isomerase 1 (EC 5.3.1.24) (PRAI 1). 
TRPF1  A 0.768004 0.4658 -2,564 5,01 25506 c.1 0,39% 
20907086 F420H2 dehydrogenase subunit 
FpoB. 
FPOB  A 0.762579 0.413 0 7,06 20732 e.19 0,38% 
20904852 Putative inosine-5'-monophosphate 
dehydrogenase (EC 1.1.1.205). 
 General function 
prediction only 
genes 
A 0.756163 0.4675 -4,7336 4,73 18926 d.37, d.37 0,38% 
20907125 Hypothetical protein MM2525.   A 0.58989 0.4024 -4,0649 5,01 27663 a.4 0,38% 
20905318 Conserved protein.  Transcription genes A 0.479189 0.4368 -1,5325 6 30471 a.4 0,37% 
20904462 Universal stress protein.  Signal transduction 
mechanisms genes 
A 0.763365 0.4527 -2,0269 5,41 16296 c.26 0,37% 
20905258 Hypothetical protein MM0844.  Transcription genes B 0.220293 0.3511 -5,3434 4,74 14433 a.4, g.39 0,37% 
20906947 GTP-binding protein.   A 0.774113 0.426 -0,8968 6,35 24560 c.37 0,37% 
20904725 Sulfite reductase, assimilatory-type 
(EC 1.8.-.-). 
 Energy production 
and conversion 
genes 
B 0.763421 0.4545 1,2987 8,53 24912 d.134, d.58 0,36% 
20907433 conserved protein.   A 0.66689 0.3846 -3,5502 4,96 18714 x 0,36% 
20905506 Two-component response regulator.   A 0.770727 0.4797 -7,317 4,69 14175 c.23 0,36% 
         VII-172 
 
 
 
gi number name genname function Phylogeny evolutionary 
scope 
hydrophobicity net charge pI MW scop code on Ths 
20905077 Conserved protein.  Function unknown 
genes 
A 0.710184 0.3655 -7,1065 4,58 22214 x 0,36% 
20906820 Conserved protein.   B 0.220293 0.4151 0,9434 7,65 11810 x 0,36% 
20905526 Metal dependent hydrolase.   A 0.741609 0.4009 -4,9549 5,05 24425 d.157 0,36% 
20905516 conserved protein.   B 0.747624 0.4456 -1,9373 5,5 73552 c.55, c.55 0,36% 
20907459 Indole-3-glycerol phosphate 
synthase (EC 4.1.1.48). 
  B 0.765223 0.4682 -4,4943 4,84 29395 c.1 0,35% 
20906586 Conserved protein.   A 0.220293 0.4074 3,7037 9 11891 x 0,35% 
20906380 Archaeal flavoprotein.   A 0.741419 0.4142 -1,6735 5,42 26491 c.34 0,34% 
20906917 Translation initiation factor 1A-2 
(aIF-1A-2). 
EIF1A2  A 0.674859 0.3774 9,434 10,74 12288 b.40 0,34% 
20906216 conserved protein.   A 0.751544 0.5 -4,5454 4,78 17553 x 0,34% 
20906572 Hypothetical protein MM2026.   A 0 0.3795 -1,0255 5,39 21559 x 0,34% 
20906288 Hypothetical protein MM1771.   A 0.56294 0.4382 8,9888 10,94 9972 x 0,34% 
20905840 Ribonucleoside-triphosphate 
reductase activating enzyme. 
  A 0.757979 0.4183 -2,2813 5,31 29249 x 0,34% 
20906954 GTP-binding protein.   A 0.770927 0.4438 -2,9585 5,01 38289 c.37 0,34% 
20905410 Iron-sulfur binding protein.   A 0.677115 0.3803 -1,4084 5,62 15992 x 0,33% 
20905158 Conserved protein.  General function 
prediction only 
genes 
A 0.762402 0.4156 -6,0605 4,5 25460 c.26 0,33% 
20906724 Hydrogenase expression/formation 
protein. 
HYPC  A 0.736329 0.4302 -13,9534 4 9384 b.40 0,33% 
20906635 Orotidine 5'-phosphate 
decarboxylase (EC 4.1.1.23) (OMP 
decarboxylase) (OMPDCase) 
(OMPdecase). 
PYRF  A 0.764643 0.4955 -3,1817 4,79 23503 c.1 0,33% 
20905517 conserved protein.   B 0.747624 0.4424 -0,1557 6,91 70382 c.55 0,33% 
20905543 Archaeosine tRNA-
ribosyltransferase (EC 2.4.2.-). 
  A 0.767381 0.4367 -1,2244 6,06 55032 d.17, c.1 0,33% 
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20907236 LSU ribosomal protein L37AE.   A 0.746644 0.3404 18,0851 11,13 10447 g.41 0,33% 
20906757 DNA double-strand break repair 
rad50 ATPase. 
RAD50  A 0.766547 0.3701 -2,5233 5,23 121981 a.2, c.37, 
e.10 
0,32% 
20905812 Pyruvate synthase delta subunit (EC
 1.2.7.1). 
  A 0.76101 0.3 0,9091 7,37 12595 d.58 0,32% 
20905675 Fe-S oxidoreductase.   A 0.706853 0.4133 -0,867 5,57 38575 x 0,31% 
20907745 Putative transcriptional regulator. SYRB  A 0.722586 0.4392 0,6757 9,09 15986 c.26 0,31% 
20907005 Type II DNA topoisomerase VI 
subunit B (EC 5.99.1.3) (TopoVI-B). 
TOP6B  B 0.691206 0.4477 -0,9661 6,26 68760 d.14, a.156, 
d.122 
0,31% 
20905141 conserved protein.  Function unknown 
genes 
A 0.673186 0.3701 -2,3621 5,09 13553 x 0,31% 
20906844 DNA-directed RNA polymerase beta 
chain (EC 2.7.7.6). 
  A 0.770899 0.4023 -2,6489 5,6 67023 e.29 0,31% 
20904947 Hypothetical protein MM0562.   A 0.7327 0.4353 -0,862 5,96 26949 x 0,31% 
20906152 conserved protein.   A 0.479189 0.4258 -5,4687 4,65 29854 a.4 0,30% 
20905604 conserved protein.   B 0.55017 0.3822 -0,2873 6,8 41066 c.6 0,30% 
20905036 Conserved protein.   A 0.220293 0.3953 -4,054 4,87 33303 x 0,30% 
20906988 conserved protein.   A 0.241334 0.3676 -7,3528 4,3 7615 x 0,30% 
20905791 Chemotaxis protein. CHEC  A 0.720472 0.4528 -5,1886 4,42 23371 x 0,30% 
20906121 Divalent cation transport protein.   A 0.767248 0.4075 -2,4128 5,24 41395 c.37 0,30% 
20905197 Geranyltranstransferase 
 (EC 2.5.1.-).  
 Coenzyme transport 
and metabolism 
genes 
A 0.768678 0.4271 -5,7626 4,76 32747 a.128 0,30% 
20906869 Type I restriction-modification 
system specificity subunit. 
  A 0.768421 0.4097 -2,4751 5,39 91505 c.66 0,29% 
20905894 Conserved protein.   A 0.501014 0.4342 -1,9736 5,74 16878 c.115 0,29% 
20905283 Methionyl-tRNA synthetase (EC 
6.1.1.10) (Methionine--tRNA ligase) 
(MetRS). 
METG Translation genes A 0.770927 0.4139 -3,0707 5,5 79964 b.40, c.26, 
a.27, g.41 
0,28% 
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20906966 Conserved protein.   A 0.220293 0.406 -2,2555 5,32 14935 x 0,28% 
20906328 Protein translation initiation factor 2 
subunit alpha. 
  A 0.768752 0.3985 0,369 7,95 30416 b.40 0,28% 
20905603 NDP-N-acetyl-D-galactosaminuronic 
acid dehydrogenase (EC 1.1.1.-). 
  A 0.765484 0.4414 -0,8367 6,13 51826 c.2, c.26, 
a.100 
0,28% 
20907183 Hypothetical protein MM2577.   A 0.718043 0.4505 4,3956 10,01 10038 b.34 0,28% 
20905845 Archaeal protein translation initiation 
factor 2B subunit 1. 
  A 0.74415 0.4766 -3,5087 4,69 37371 x 0,27% 
20905403 Conserved protein.   A 0.603238 0.419 -1,6759 5,65 20296 x 0,27% 
20905196 Metallo cofactor biosynthesis 
protein. 
 General function 
prediction only 
genes 
B 0.753541 0.4502 -1,7412 5,66 44810 d.115 0,27% 
20907953 Coenzyme F420 hydrogenase beta 
subunit (EC 1.12.99.1). 
  A 0.766801 0.3818 1,0135 7,69 32412 d.58, d.134, 
d.58 
0,26% 
20906712 Cytidylate kinase (EC 2.7.4.14) (CK) 
(Cytidine monophosphate kinase) 
(CMP kinase). 
CMK  A 0.661161 0.392 -1,1363 5,73 20587 c.37 0,26% 
20905667 Aspartate carbamoyltransferase 
regulatory chain. 
PYRI  A 0.733567 0.4231 -0,6409 6,36 17011 g.41, d.58 0,26% 
20905876 DNA-directed RNA polymerase 
subunit M (EC 2.7.7.6). 
  A 0.67982 0.3271 0,9346 7,5 12259 g.41, g.41 0,26% 
20905061 Putative nickel-responsive regulator 
1. 
 Transcription genes A 0.725492 0.3699 -6,1643 5,05 16601 a.43 0,26% 
20904675 Valyl-tRNA synthetase (EC 6.1.1.9).  Translation genes A 0.770927 0.4304 -3,1069 5,05 99130 b.51, c.26, 
a.27 
0,26% 
20907577 Hypothetical protein MM2928.   B 0.764291 0.3256 -1,7441 5,43 19191 x 0,25% 
20907082 F420H2 dehydrogenase subunit. FPOI  A 0.739277 0.4011 1,6949 7,85 19459 d.58 0,25% 
20908006 Transcriptional regulator, AraC 
family. 
  A 0.722475 0.4545 -2,3922 5,14 23172 c.23 0,25% 
20904970 conserved protein.   A 0.386683 0.4053 -0,7575 6,26 29731 x 0,25% 
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20907008 DNA gyrase, subunit B (EC 
5.99.1.3). 
  A 0.774877 0.3864 -1,7349 5,76 71068 d.14,d.122, 
e.11 
0,25% 
20907062 Metallo cofactor biosynthesis 
protein. 
  A 0.760958 0.4147 0 7,09 24558 x 0,24% 
20905038 3-isopropylmalate dehydratase small 
subunit 1 (EC 4.2.1.33) 
(Isopropylmalate isomerase 1) 
(Alpha-IPM isomerase 1)  
LEUD1 Amino acid transport 
and metabolism 
genes 
A 0.763699 0.4438 -1,1833 5,92 18489 c.8 0,24% 
20904800 conserved protein.  Translation genes A 0.710122 0.413 -2,3598 5,9 37434 d.157 0,24% 
20907018 Methylthiol:coenzyme M 
methyltransferase. 
MTSB  A 0.763392 0.4436 -5,0908 4,68 29878 a.46, c.23, 
c.1 
0,24% 
20907455 Anthranilate 
phosphoribosyltransferase (EC 
2.4.2.18). 
TRPD  A 0.763212 0.4405 0,5405 8,2 39203 a.46, c.27 0,24% 
20908004 conserved protein.   B 0.358138 0.4184 -4,6024 5,17 27919 c.69 0,24% 
20905755 (S)-2-hydroxy-acid dehydrogenase 
(EC 1.1.3.15). 
  A 0.767026 0.4587 -1,3042 5,52 49551 d.58, d.145 0,24% 
20905408 CoB--CoM heterodisulfide reductase 
1 iron-sulfur subunit C (EC 1.8.98.1). 
HDRC  A 0.752359 0.3851 1,2422 7,74 18120 a.1 0,24% 
20905088 conserved protein.  Translation genes A 0.65145 0.4266 -2,8248 5,11 39681 x 0,24% 
20905924 Hypothetical protein MM1442.   B 0.220293 0.4318 -2,2726 4,9 28289 c.5 0,23% 
20908029 Conserved protein (EC 1.3.-.-).   A 0.765262 0.4215 -2,2726 5,41 54567 c.3 0,23% 
20905482 GTP-binding protein.   A 0.770927 0.3901 -0,5494 6,64 40758 c.37 0,23% 
20905833 ABC transporter, ATP-binding 
protein. 
  A 0.770927 0.4144 -0,3801 6,64 29748 c.37 0,23% 
20905704 conserved protein.   A 0.638281 0.4331 -2,9196 4,93 45077 g.38 0,23% 
20906041 Conserved protein.   A 0.714573 0.3978 -4,8326 4,99 29514 c.1 0,23% 
20907621 Isoleucyl-tRNA synthetase (EC 
6.1.1.5). 
  A 0.220293 0.4319 -2,93 5,1 120411 c.26, a.27, 
b.51 
0,22% 
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20905409 CoB--CoM heterodisulfide reductase 
1 subunit B (EC 1.8.98.1). 
HDRB  A 0.742551 0.4135 -3,205 5,05 33068 x 0,22% 
20905054 Mannose-6-phosphate isomerase 
(EC 5.3.1.8) (EC 2.7.7.22). 
 Cell wall/membrane 
biogenesis genes 
A 0.763988 0.4092 -4,1378 4,99 48988 b.82, c.68 0,22% 
20905863 Hypothetical protein MM1386.   A 0.520626 0.3676 -5,3921 4,78 23051 x 0,22% 
20905469 Amino-acid acetyltransferase (EC 
2.3.1.1). 
  B 0.760691 0.4403 0 6,75 18041 d.108 0,22% 
20905700 Methyl-coenzyme M reductase 
operon protein C. 
  A 0.501014 0.4223 1,4563 8,59 22427 x 0,22% 
20907682 ABC transporter, ATP-binding 
protein. 
  A 0.762626 0.411 -1,2711 5,82 26237 c.37 0,21% 
20904460 Universal stress protein.  Signal transduction 
mechanisms genes 
A 0.760552 0.451 -1,9607 5,33 16447 c.26 0,21% 
20906241 Heme biosynthesis protein. NIRH  A 0.725238 0.4114 -0,6328 6,51 18042 a.4, d.58 0,21% 
20905901 F420-0:gamma-glutamyl ligase (EC
 6.3.2.-). 
COFE  A 0.732841 0.4449 -2,7558 4,95 27741 x 0,21% 
20905941 Conserved protein.   A 0.726229 0.4269 -1,1791 5,47 47156 x 0,21% 
20905668 Aspartate carbamoyltransferase (EC 
2.1.3.2) (Aspartate 
transcarbamylase) (ATCase). 
PYRB  A 0.76727 0.4434 -0,9708 6,3 35096 c, c.78.78 0,21% 
20905621 UDP-N-acetylglucosamine 2-
epimerase (EC 5.1.3.14). 
  A 0.765718 0.4085 -2,8168 5,3 39514 c.87 0,21% 
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20904518 Methanol corrinoid protein. MTAC General function 
prediction only 
genes 
A 0.765737 0.4654 -6,923 4,49 28549 c.23 0,21% 
20905334 conserved protein.   A 0.501014 0.415 -1,3604 5,76 16496 x 0,20% 
20905405 F420-dependent NADP reductase 
(EC 1.6.8.-). 
  A 0.665591 0.4809 -1,2765 5,84 25188 c.2 0,20% 
20906506 Hypothetical protein MM1968.   A 0.604417 0.439 -6,0975 4,62 28035 b.82 0,20% 
20906963 5'-methylthioadenosine 
phosphorylase (EC 2.4.2.28). 
  A 0.757515 0.4109 -1,1627 6,19 28545 c.56 0,20% 
20907529 Putative metalloendopeptidases.    A 0.686473 0.393 -2,985 5,19 22832 b.29 0,20% 
20904599 Serine-pyruvate aminotransferase 
(EC 2.6.1.51). 
 Amino acid transport 
and metabolism 
genes 
A 0.759611 0.455 -0,7711 6,14 42359 c.67 0,20% 
20907557 Phosphoserine aminotransferase 
(EC 2.6.1.52) (PSAT). 
SERC  A 0.220293 0.4324 -1,6215 5,49 41596 c.67 0,19% 
20906215 Imidazole glycerol phosphate 
synthase subunit hisF (EC 4.1.3.-
) (IGP synthase cyclase subunit) 
(IGP synthase subunit hisF)  (ImGP 
synthase) 
HISF  A 0.764654 0.4212 -5,4944 4,54 29691 c.1 0,19% 
20906956 Phosphoribosyl-ATP 
pyrophosphatase (EC 3.6.1.31) 
(PRA-PH). 
HISE  A 0.763686 0.3925 -6,542 4,9 12150 x 0,19% 
20906067 conserved protein.   A 0.489556 0.406 -0,5969 6,44 38311 d.108 0,19% 
20906340 conserved protein.   A 0.613732 0.4296 -3,78 5,16 31647 x 0,19% 
20905389 conserved protein.   A 0.220293 0.3333 -7,9999 5,29 8604 x 0,19% 
20904811 Methylenetetrahydrofolate reductase 
(EC 1.5.1.20). 
 Amino acid transport 
and metabolism 
genes 
B 0.761607 0.4384 -1,3698 5,87 31927 c.1 0,19% 
20907381 conserved protein.   A 0.641863 0.3796 0,5442 8,12 83634 x 0,19% 
20904993 Conserved protein.   A 0.241334 0.395 -0,8402 6,15 13497 x 0,19% 
20905363 Putative flagella related protein H.   A 0.714888 0.395 -2,1007 5,19 26637 c.37 0,18% 
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20906412 Conserved protein.   B 0.624778 0.4511 -1,0869 5,43 19947 x 0,18% 
20908007 Acetyltransferase (EC 2.3.1.-).   A 0.760626 0.3857 -1,4285 6,1 24393 d.108 0,18% 
20907457 Tryptophan synthase beta chain 1 
(EC 4.2.1.20). 
TRPB1  A 0.765011 0.4094 -2,3621 5,53 43753 c.79 0,18% 
20906960 conserved protein.   A 0.220293 0.3846 1,2146 8,4 27903 c.108 0,18% 
20905353 Nitrogen regulatory protein P-II.  Amino acid transport 
and metabolism 
genes 
B 0.7761 0.3917 -1,6666 5,27 12921 d.58 0,18% 
20905415 conserved protein.   A 0.693806 0.4683 -3,521 4,73 30760 c.37 0,18% 
20906280 Isopentenyl-diphosphate delta-
isomerase (EC 5.3.3.2) (IPP 
isomerase) (Isopentenyl 
pyrophosphate isomerase). 
FNI  A 0.746633 0.4685 -4,9314 4,57 38789 c.1 0,18% 
20905164 NifB protein. NIFB General function 
prediction only 
genes 
A 0.758838 0.4179 -2,388 5,43 37767 x 0,18% 
20904821 Cell division control protein.  Posttranslational 
modification, protein 
turnover, 
chaperones genes 
A 0.770927 0.4432 -3,7878 4,9 88391 c.37, d.31, 
c.37, b.52 
0,17% 
20904948 Hypothetical protein MM0563.  Replication, 
recombination and 
repair genes 
B 0.764293 0.3746 -1,0308 6,01 33339 x 0,17% 
20905464 Chromosome partition protein.   A 0.769171 0.3855 -3,4042 4,94 133838 d.215, c.37 0,17% 
20905335 conserved protein.   A 0.501014 0.4412 -4,7058 4,66 19010 g.41 0,17% 
20905059 Glutamate synthase, large chain  
(EC 1.4.1.13). 
B 0.766164 0.4158 -1,7057 5,39 50566 x 0,17% 
20907435 Hypothetical protein MM2802.    A 0.552797 0.3665 -4,7119 4,64 21861 a.118 0,17% 
20905897 Aspartate kinase (EC 2.7.2.4).   A 0.767979 0.4447 -0,835 6,36 51914 c.73 0,17% 
20908039 Hypothetical protein MM3340.   B 0.765737 0.461 -6,4406 4,46 31481 x 0,17% 
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20906857 DNA/pantothenate metabolism 
flavoprotein. 
  A 0.766541 0.412 -1,502 5,88 50459 c.34, c.5 0,17% 
20905194 A1AO H+ ATPase subunit H.  Energy production 
and conversion 
genes 
A 0.625384 0.4 -5,5555 4,74 10157 x 0,17% 
20906821 Tetrahydromethanopterin S-
methyltransferase, subunit A (EC 
2.1.1.86). 
  A 0.568873 0.4286 -3,2966 4,79 19646 x 0,17% 
20904378 conserved protein.  Signal transduction 
mechanisms genes 
A 0.770079 0.4198 -6,1068 4,41 14776 c.23 0,16% 
20905796 Chemotaxis protein. CHEY  A 0.770725 0.5106 -2,8368 5,24 15791 c.23 0,16% 
20905906 Replication factor C subunit.   A 0.769859 0.4252 -2,9325 4,96 38349 a.80, c.37 0,16% 
20905452 Methylated-DNA--protein-cysteine 
methyltransferase (EC 2.1.1.63) (6-
O- methylguanine-DNA 
methyltransferase) (MGMT) (O-6-
methylguanine-DNA- 
alkyltransferase). 
OGT  B 0.767784 0.4241 4,4304 9,57 17996 a.4, c.55 0,16% 
20904798 Rnase L inhibitor.  General function 
prediction only 
genes 
A 0.770927 0.4082 -1,7006 5,58 65396 c.37, c.37, 
d.58 
0,16% 
20906853 Chlorohydrolase family protein (EC 
3.8.1.-). 
  A 0.759931 0.4311 -3,2822 5,28 50014 b.92, c.1 0,15% 
20907177 Methyltransferase (EC 2.1.1.-).   A 0.765131 0.4216 -4,4117 4,73 45591 a.4, c.66 0,15% 
20907204 Hypothetical protein MM2596.    A 0.75597 0.4316 -1,9548 5,37 73324 c.55 0,15% 
20906361 RNA methylase.    A 0.761657 0.4208 -0,7721 6,27 28514 c.116 0,15% 
20906220 conserved protein.   A 0.658251 0.3778 0,4444 8,42 25317 a.4 0,15% 
20904985 DNA-directed RNA polymerase 
subunit E' (EC 2.7.7.6). 
 Transcription genes A 0.648493 0.4262 -1,6392 5,63 6881 x 0,15% 
20907135 Hypothetical UPF0217 protein 
MM2534. 
  A 0.582928 0.4028 -3,7914 5,27 23249 x 0,15% 
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20906864 Hypothetical protein MM2289.   B 0.753787 0.4533 -5,1401 5,25 23218 c.6 0,15% 
20907094 Hypothetical protein MM2497.   A 0.761164 0.4279 -4,3268 4,8 23051 x 0,15% 
20905322 Putative methyltransferase.  Secondary 
metabolites 
biosynthesis, 
transport and 
catabolism genes 
A 0.742501 0.405 -3,2257 5,04 32193 c.66 0,15% 
20905045 Glycosyltransferase (EC 2.4.-.-).  Cell wall/membrane 
biogenesis genes 
A 0.76637 0.3779 2,6059 9,27 35839 c.68 0,14% 
20905831 Putative methyltransferase.   A 0.71642 0.4412 -7,3528 4,35 7543 x 0,14% 
20905193 V-type ATP synthase subunit I (EC 
3.6.3.14) (V-type ATPase subunit I). 
AHAI,ATPI Energy production 
and conversion 
genes 
A 0.736091 0.4702 -2,29 5,6 71964 x 0,14% 
20906377 conserved protein.   A 0.666506 0.4359 -5,1281 4,72 38520 x 0,14% 
20907690 Deoxycytidylate deaminase (EC 
3.5.4.12).  
  A 0.770927 0.4128 -2,9069 5,02 18831 c.97 0,14% 
20905931 Hypothetical UPF0251 protein 
MM1448. 
  A 0.674599 0.3559 2,8249 8,61 18017 a.4 0,14% 
20905780 Hypothetical UPF0200 protein 
MM1313. 
  A 0.662347 0.4171 -1,6042 5,46 20893 c.37 0,13% 
20906126 Conserved protein.   A 0.712044 0.426 -0,9062 5,73 36119 x 0,13% 
20906260 Probable dihydroorotate 
dehydrogenase electron transfer 
subunit. 
PYRK  A 0.755612 0.4324 -1,5443 5,44 28187 b.43, c.25 0,13% 
20907483 Hypothetical protein MM2845.    A 0.764627 0.3955 -3,7312 4,64 15133 b.85 0,13% 
20907593 conserved protein.   B 0.722121 0.4211 -4,3859 4,62 12674 x 0,13% 
20907866 Ornithine decarboxylase (EC 
4.1.1.17) 
  B 0.709727 0.4154 -0,7691 6,46 44775 b.49, c.1 0,13% 
20904984 DNA-directed RNA polymerase 
subunit E' (EC 2.7.7.6). 
 Transcription genes A 0.736541 0.4381 -4,1236 4,84 21432 b.40, d.230 0,13% 
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20905524 Hypothetical protein MM1084.   A 0.489393 0.3697 3,6364 9,23 18292 g.41 0,13% 
20904454 CTP synthase (EC 6.3.4.2) (UTP--
ammonia ligase) (CTP synthetase). 
PYRG Nucleotide transport 
and metabolism 
genes 
A 0.770553 0.4026 -2,8089 5,33 59718 c.23, c.37 0,13% 
20906063 Molybdenum formylmethanofuran 
dehydrogenase subunit (EC 
1.2.99.5). 
FMDB  A 0.751098 0.4345 -1,839 5,78 47740 c.81 0,12% 
20905271 conserved protein.  Function unknown 
genes 
A 0.648582 0.4706 0 7,18 45552 x 0,12% 
20904956 ABC transporter, ATP-binding 
protein. 
 Inorganic ion 
transport and 
metabolism genes 
B 0.770927 0.4301 -2,2058 5,64 30186 c.37 0,12% 
20906920 Translation initiation factor 1A. EIF-1A  A 0.674859 0.4237 5,0847 9,96 7017 b.40 0,12% 
20907790 Transcriptional regulator, MarR 
family. 
  A 0.606889 0.3813 2,1583 8,41 16105 a.4 0,12% 
20906059 Molybdenum formylmethanofuran 
dehydrogenase subunit (EC 
1.2.99.5). 
FMDF  A 0.764086 0.3931 -2,6011 5,11 37380 d.58, d.58 0,12% 
20908026 conserved protein.   A 0.763817 0.406 -3,4187 5,36 27156 c.23 0,11% 
20904632 Superfamily II DNA and RNA 
helicase. 
 Replication, 
recombination and 
repair genes 
A 0.755825 0.3929 -1,5685 5,46 144748 c.37 0,11% 
20905412 conserved protein.   A 0.640527 0.3911 -1,9801 5,07 22879 x 0,11% 
20905263 Bacterioferritin comigratory protein.  Posttranslational 
modification, protein 
turnover, 
chaperones genes 
A 0.768702 0.375 0,625 7,98 18168 c.47 0,11% 
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20905167 conserved protein.  Defense 
mechanisms genes 
A 0.241334 0.46 -9,9999 4,26 11546 x 0,11% 
20905817 Fe-S oxidoreductase.   A 0.677452 0.411 0,274 7,53 41968 x 0,11% 
20905076 Hypothetical UPF0285 protein 
MM0679. 
 Function unknown 
genes 
A 0.501014 0.4492 -3,0768 5,33 34772 c.55 0,11% 
20904385 CoB--CoM heterodisulfide reductase 
1 iron-sulfur subunit A (EC 1.8.98.1). 
HDRA Energy production 
and conversion 
genes 
A 0.743471 0.425 -2,3959 5,37 86803 d.58, c.3 0,11% 
20907312 Hypothetical protein MM2692.   B 0.617192 0.3996 -1,7278 5,16 52553 c.3 0,11% 
20906761 conserved protein.   A 0.220293 0.317 1,1321 8,07 30920 x 0,11% 
20908027 Phosphoglycolate phosphatase (EC 
3.1.3.18). 
  A 0.762592 0.4224 -1,724 5,85 26041 c.108 0,10% 
20906978 Long-chain-fatty-acid--CoA ligase 
(EC 6.2.1.3). 
  A 0.770339 0.4257 -2,0182 5,78 61380 e.23 0,10% 
20907410 Hypothetical protein MM2780.    A 0.746342 0.4403 -5,4607 4,6 32588 x 0,10% 
20906700 LSU ribosomal protein L19E.   A 0.67914 0.3399 16,3399 11,04 17334 a.94 0,10% 
20906082 Transcriptional regulator, MarR 
family. 
  A 0.764996 0.3984 2,3438 8,82 14584 a.4 0,10% 
20905436 Zinc finger protein.   A 0.674353 0.3602 2,4845 8,88 18477 a.35 0,10% 
20905956 Tryptophanyl-tRNA synthetase (EC 
6.1.1.2) (Tryptophan--tRNA ligase) 
(TrpRS). 
TRPS  A 0.68265 0.4121 -2,0201 5,71 55728 c.26 0,10% 
20906786 Hypothetical protein MM2219.   A 0.764126 0.3897 3,0769 8,96 22233 c.66 0,10% 
20907921 Thiamine-phosphate 
pyrophosphorylase (EC 2.5.1.3) 
(TMP pyrophosphorylase) (TMP-
PPase) (Thiamine-phosphate 
synthase). 
THIE  A 0.655175 0.3708 -0,8332 5,98 25817 c.1 0,10% 
20906558 Translation initiation factor 1A-1 
(aIF-1A-1). 
EIF1A1  A 0.674859 0.4286 8,7912 10,71 12798 b.40 0,09% 
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20907817 Type I restriction-modification 
system restriction subunit (EC 
3.1.21.3). 
  A 0.220293 0.4092 -1,9936 5,43 110297 c.37, c.37 0,09% 
20905391 Glutamine synthetase (EC 6.3.1.2).   A 0.766261 0.4295 -2,237 5,59 50593 d.15, d.128 0,09% 
20905178 Conserved protein.   A 0.220293 0.437 1,4815 9,05 15618 x 0,09% 
20906591 Hypothetical protein MM2043.   A 0.627596 0.4477 -2,166 5,65 32631 x 0,09% 
20907199 Hypothetical protein MM2592.    A 0.746459 0.4004 -3,5299 4,94 213324 c.37 0,09% 
20907093 FO synthase subunit 2 2 (EC 2.5.1.-) 
(7,8-didemethyl-8-hydroxy-5- 
deazariboflavin synthase subunit 2 
2). 
COFH2  A 0.761565 0.4031 -1,0203 5,94 43094 c.1 0,09% 
20904794 conserved protein.  Replication, 
recombination and 
repair genes 
A 0.220293 0.3944 0,7042 8,5 16554 x 0,08% 
20904862 Hypothetical protein MM0484.  Function unknown 
genes 
A 0.711894 0.4271 -5,025 4,71 21907 x 0,08% 
20907629 Hypothetical protein MM2974.   B 0.770927 0.4147 -7,834 4,38 25163 x 0,08% 
20907692 conserved protein.   A 0.773725 0.3626 1,0989 7,72 21425 x 0,08% 
20907771 Hypothetical protein MM3100.   A 0.760653 0.3808 -1,6735 5,77 28102 x 0,08% 
20904986 Hypothetical UPF0218 protein 
MM0598. 
 Function unknown 
genes 
A 0.641997 0.4308 -1,5384 5,66 21900 x 0,07% 
20904471 Threonine synthase  
(EC 4.2.99.2).  
 Amino acid transport 
and metabolism 
genes 
A 0.742634 0.4327 -3,6057 4,75 45396 c.79 0,07% 
20907188 Hypothetical protein MM2582.   A 0.656604 0.4059 -2,9411 5,52 19676 d.113 0,07% 
20905880 Phosphatidylserine decarboxylase 
proenzyme (EC 4.1.1.65) 
PSD  A 0.753647 0.4519 1,4423 9,07 23416 b.84 0,07% 
20908032 Monomethylamine corrinoid protein 
2 (MMCP 2). 
MTMC2  A 0.762771 0.4633 -5,9632 4,42 23270 c.23, a.46 0,06% 
20905368 Protein pcrB homolog. PCRB  A 0.701676 0.4777 -2,0242 5,31 25888 c.1 0,06% 
20907871 Hypothetical UPF0204 protein 
MM3190. 
  A 0.767731 0.4108 -3,0302 5,49 32782 x 0,06% 
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20904645 Probable deoxyhypusine synthase 2 
(EC 2.5.1.46) (DHS 2). 
DYS2 Posttranslational 
modification, protein 
turnover, 
chaperones genes 
A 0.710433 0.4298 -3,7248 5,38 38042 c.31 0,06% 
20904373 Hypothetical ANK-repeat protein 
MM0045. 
 General function 
prediction only 
genes 
B 0.775062 0.4167 -4,1666 4,58 39044 d.211, d.211 0,06% 
20907645 conserved protein.   A 0.519884 0.4393 -0,6556 6,36 34765 c.37 0,06% 
20904486 Iron-sulfur flavoprotein.  General function 
prediction only 
genes 
A 0.703765 0.4025 0,8475 7,91 26247 c.23 0,06% 
20906666 Conserved protein.   B 0.625699 0.39 -0,5864 6,64 39363 c.87 0,05% 
20905402 Xaa-Pro aminopeptidase (EC 
3.4.11.9). 
  B 0.770471 0.4275 -1,9999 5,41 44634 c.55, d.127 0,05% 
20908010 N-(5'-phosphoribosyl)anthranilate 
isomerase 2 (EC 5.3.1.24) (PRAI 2). 
TRPF2  A 0.76462 0.4466 0,3953 7,88 24760 c.1 0,05% 
20904497 Type IIS restriction enzyme (EC 
3.1.21.4) (EC 2.1.1.72). 
 Defense 
mechanisms genes 
B 0.685957 0.4137 -2,9184 5,16 134098 c.66 0,05% 
20904339 Methyltransferase (EC 2.1.1.-).   Secondary 
metabolites 
biosynthesis, 
transport and 
catabolism genes 
A 0.765499 0.44 -1,9999 5,57 22759 c.66 0,05% 
20906239 Heme biosynthesis protein. NIRJ  A 0.761123 0.4 -1,4084 5,95 39379 x 0,04% 
20907564 Oxidoreductase, ALDO/KETO 
reductase family. 
  A 0.759299 0.3945 -0,5024 6,44 45114 a.1, c.1 0,04% 
20906609 Histidinol-phosphate 
aminotransferase. 
  A 0.768389 0.4194 -3,4273 5,03 55532 c.67 0,04% 
20905047 Glycosyltransferase involved in cell 
wall biogenesis (EC 2.4.-.- ). 
 Cell wall/membrane 
biogenesis genes 
B 0.764405 0.3871 0 6,9 29073 c.68 0,04% 
20905871 Probable molybdenum cofactor 
biosynthesis protein A. 
MOAA  A 0.761142 0.3952 1,1976 8,06 37691 x 0,04% 
20904389 Tungsten formylmethanofuran 
dehydrogenase subunit B (EC 
1.2.99.5). 
 Energy production 
and conversion 
genes 
A 0.57674 0.4251 -0,7245 6,04 45473 c.81 0,04% 
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20906060 Molybdenum formylmethanofuran 
dehydrogenase subunit (EC 
1.2.99.5). 
FMDA  A 0.71511 0.4007 -1,8835 5,92 65094 b.92 0,03% 
20906574 Hypothetical protein MM2028.   A 0.605772 0.3926 -0,7991 6,25 114238 a.118, d.160 0,02% 
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VII.3 Abbreviations 
Units are expressed according to the international system of units (SI), including outside 
units accepted for use with the SI. 
Amino acids are abbreviated with their one or three letter symbols. 
Protein names are abbreviated according to their SWISSPROT database entries. 
 
ADP   adenosine 5'-diphosphate 
Amp   ampicillin 
APS   ammonium peroxodisulfate 
ATP    adenosine 5'-triphosphate 
BLAST    Basic Local Alignment Search Tool 
β-NADH     β-nicotinamide adenine dinucleotide 
BSA    albumin bovine serum 
COG    Clusters of Orthologous Groups of proteins 
DIGE   Differentiated Gel Electrophoresis 
DNA    deoxyribonucleic acid 
DnaJ   bacterial Hsp40 chaperone 
DnaK   bacterial Hsp70 chaperone 
DTT   dithiothreitol 
E. coli   Escherichia coli 
EDTA   ethylenediaminetetraacetic acid 
emPAI      exponentially modified (→¨) PAI 
FAD   flavine adenine dinucleotide 
FPLC   Fast Protein Liquid Chromatography 
g     acceleration of gravity, 9.81 m/s2 
GdnHCl     guanidinium hydrochloride 
GimC   Genes involved in microtubule biogenesis C 
GroEL   bacterial Hsp60 chaperonin 
GroES      bacterial Hsp10 cochaperonin 
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GTP   guanosin 5'-triphosphate 
Hsp   heat shock protein 
Hr     hour 
IPTG   isopropyl-β-D-1-thiogalactopyranoside 
LB      Luria Bertani 
LCMS   coupled Liquid Chromatography - Mass Spectrometry 
MES   2-morpholinoethanesulfonic acid 
Mm   Methanosarcina mazei Gö1 
M. mazei   Methanosarcina mazei Gö1 
Mt    Methanobacterium thermoautotrophicum 
MOPS   3-(N-morpholino)propanesulfonic acid 
MS    mass spectrometry 
NADPH   β-nicotinamide adenine dinucleotide 2'-phosphate 
OD    optical density 
PAGE   PolyAcrylamide Gel Electrophoresis 
PAI    Protein Abundance Index 
PCR   Polymerase Chain Reaction 
PDB   Protein Data Bank. Repository for processing and distribution of 
 3-D structure data of proteins and nucleic acids. 
   http://www.rcsb.org/pdb/ 
PEDANT      Protein Extraction, Description and ANalysis Tool 
Pefabloc   4-(2-aminoethyl)benzenesulfonylfluoride HCl 
SCOP   database of protein structures (Structural Classification of Proteins) 
SDS    sodiumdodecylsulfate 
Ta      Thermoplasma acidopilum 
TCA   trichloroacetic acid 
TCP-1   tailless complex polypeptide 
TEMED   N,N,N',N'-tetramethylethylenediamine 
TF    trigger factor 
TFA   trifluoroacetic acid 
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Ths   Thermsome 
TOF   time Of Flight. Mass spectrometry ion detector 
TRiC   TCP-1 containing ring complex  
Tris HCl   tris(hydroxymethyl)aminomethane hydrochloride 
Triton X-100    t-Octylphenoxypolyethoxyethanol 
Tween 20   Polyoxyethylen-Sorbitan-Monolaurat 
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